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Ostrich farming in South Africa is an important industry but it often suffers from high 
mortality rates among the ostrich chicks. This is thought to be due in part to environmental 
stress, leading to the delay in the development of the microbiota, thus making invasion by 
pathogens likely. Very little is known about the microorganisms inhabiting the ostrich 
gastrointestinal tract, however they do play an important role in humans and animals and 
disturbance of this community can be fatal. It has been established that probiotic bacteria 
such as Lactobacillus and Bifidobacterium spp. play an important role in the health of the 
host. In order to discover novel probiotic strains, bacteria should be isolated from the host, 
identified, characterised in-vitro to screen their potential suitability, and finally these results 
should be confirmed in-vivo. The aim of this study was to follow these guidelines in order to 
find a successful probiotic mix to decrease the mortality observed on ostrich farms, and to 
compare the effects of the probiotic mix to that of the antibiotic, tylosin, on the microbiota of 
the gastrointestinal tract (GIT).  
The isolation and identification of probiotic strains from faecal or gut samples is the first 
stage in the process of selection, however, the number of strains isolated may be restricted by 
the commonly used growth media and conditions. The most common probiotics belong to 
Lactobacillus or Bifidobacterium spp. In this study, four Lactobacillus spp. and one 
Bifidobacterium spp. were used, based on the initial screening which showed them to tolerate 
bile and acid, and to produce antimicrobial substances against important pathogens.  
The ability of the strains to survive the harsh conditions encountered in the gut was tested in-
vitro. The five strains used in this study showed good potential for use as probiotics, 
tolerating 2% bile and pH 2, as well as demonstrating autoaggregation and coaggregation 
with four common pathogens. All five strains and their combinations showed good adhesion 
capability to mucous and could inhibit and displace the pathogens in most cases. Only the 
probiotic combinations were able to out-compete the pathogens. The strains produced 
antimicrobial substances active against important pathogens and produced enzymes essential 
to the ostrich diet.  These in-vitro conditions cannot, however, mimic those found in the gut, 
and therefore strains showing potential in-vitro were now tested in-vivo in feeding trials. 
The ostrich chicks were divided into pens (n = 17) and assigned to specific treatments of 















a normal diet and the microbial content of their faeces and mucosa was studied at intervals 
over nine weeks, using both culture and molecular techniques. Three methods were used here 
in an attempt to get a more comprehensive overview of the bacterial populations in each 
treatment group.  
During the feeding trial no significant differences in feed conversion or weight gain were 
observed between treatments, however the chicks receiving the probiotic mix as well as the 
control group showed noticeably higher mortality rates than the chicks receiving tylosin. 
Culturing of faecal samples from chicks in the feeding trial did not show significant 
differences between treatments, however, chicks in treatment E showed visibly higher counts 
of C. perfringens. When comparing the faecal counts over time, most groups showed 
increasing trends. The mucosal samples showed increasing trends for total bacteria, LAB and 
Enterobacteriaceae. At slaughter one (at two weeks), C. perfringens was present in all areas 
of the gut of chicks in treatment E, and by slaughter two (at five weeks), was only detected in 
the caecum and colon of chicks in treatment ET. Post-mortems confirmed this pathogen to be 
the likely cause of death of the chicks.  
DGGE analysis of faecal samples showed the diversity of total bacteria and Lactobacillus 
spp. to be unaltered by probiotics alone, but the Bifidobacterium spp. changed with this 
treatment. In combination with tylosin, the probiotics did not affect the diversity of total 
bacteria or the Bifidobacterium spp. population, however the diversity of the lactobacilli 
present was decreased.   
Ostrich chicks were rapidly colonised by bacteria one week post-hatching as shown by FISH-
FC on faecal and mucosal samples. Faecal samples were found to be initially dominated by 
the C. coccoides/E. rectale group of bacteria, but by week seven Bacteroides was most 
abundant. The caecum and colon were both found to harbour predominantly butyrate-
producers belonging to the C. coccoides/E. rectal group and the duodenum mostly by 
Bacteroides. C. perfringens was detected throughout the gut, but its proportions were found 
to be highest in the duodenum.    
This is the first study to confirm that C. perfringens is a major pathogen in ostrich chick 
mortality. This particular probiotic mix alone was not effective against C. perfringens but, 
together with tylosin, it not only prevented this pathogen from causing death of the chicks, 















a new probiotic strain or mix which is more capable of competitively excluding C. 
perfringens needs to be investigated for use in these chicks without the antibiotic tylosin.  
































bp  : base pair(s) 
CFU  : colony forming units 
DGGE  : denaturing gradient gel electrophoresis 
DNA  : deoxyribonucleic acid 
EDTA  : ethylenediaminetetra-acetic acid 
FISH  : fluorescent in-situ hybridisation 
h  : hour(s) 
kb  : kilobase pair(s) 
kDa  : kilodalton(s) 
kg  : kilogram 
log  : logarithmic 
M  :  molar 
mg   : milligram 
MIC  : minimum inhibitory concentration 
min  : minute(s) 
ml  : millilitre 
mM  : millimolar 
MW  : molecular weight 
NCBI  : National Centre for Biotechnology Information 
nm  : millimetre  















OD600  : optical density measured at wavelength of 600 nm 
OD620  : optical density measured at wavelength of 620 nm 
ORF  : open reading frame 
PCR  : polymerase chain reaction 
qPCR  : quantitative real-time PCR 
RNA  : ribonucleic acid 
rRNA  : ribosomal RNA 
s  : second(s) 
SDS  : sodium dodecyl sulphate 
spp.  : species 
Tris  : tris(hydroxymethyl)aminomethane 
U  : units 
v/w  : volume per volume (in ml per 100 ml)  
 
w/v  : weight per volume (in grams per 100 ml) 
w/w  : weight per weight (in grams per 100 grams) 
α  : alpha  
 
β   : beta  
 
γ   : gamma  
 
Δ  : delta  
 
λ  : lambda  
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1.1. The ostrich 
Ostriches (Struthio camelus) belong to the family Ratitae, which are the flightless or running 
birds. In the wild, adult ostriches reach a height of between two and three m and weigh 
between 100 and 150 kg (Dunning, 1993). After six months, ostriches have reached their full 
size and at 24 months have reached sexual maturity (Cooper et al., 2004). Wild ostriches 
have become increasingly rare in many areas of their natural range due to over-hunting, loss 
of habitat due to encroaching domestic stock, over-cultivation and predation (Cooper et al., 
2010). They live in nomadic groups of five to fifty birds (Donegan, 2002), the larger groups 
having the advantage of rapid predator detection.   
 
1.1.1. Diet and digestion in the ostrich 
 
The ostrich is herbivorous and studies on the contents of the stomach of wild ostriches 
confirmed this but also showed the presence of insects, bones, teeth (presumably ingested 
with the plants) and antelope faeces (Williams et al., 1993; Cooper 2006). The ostrich is a 
selective feeder, but adapts its feed intake according to food availability, ingesting green 
annual grasses and forbs when available, or leaves, flowers and fruits from succulents and 
woody plants (Milton et al., 1994). Small stones and grit are ingested and used in the gizzard 
to grind food and thus aid digestion (Cooper et al., 2004).  
 
Ostrich chicks are born with a sterile GIT and in the wild are coprophagic, pecking at their 
parents’ faeces, thereby receiving the first inoculum of beneficial bacteria which are thought 
to aid in fibre digestion as well as aid in the development of the immune system (Cooper, 
2006). Ostriches are monogastric herbivores with a digestive tract comparable to other avian 
species but with some unique adaptations, allowing it to survive in arid and semi-arid 
conditions. They lack teeth and a crop (an extended muscular pouch near the gullet used for 
storing food) and only certain areas of the digestive tract secrete enzymes (about 25% of 
GIT), in comparison to other avian counterparts where enzymes are secreted by the entire 
inner surface of the proventriculus (Fowler, 1991). In addition, it is thought that enzyme 
















duodenum is short until around day 72. This factor is considered important in the mortality of 
young chicks (Iji et al., 2001). The oesophagus empties into the glandular stomach 
(proventriculus; Fig. 1.1), where digestive enzymes and acids are secreted (Aganga et al., 
2003), and the food then passes into the gizzard containing grit, used to grind up the feed. 
This grinding, together with the acid conditions (pH 1.2 – 2.1), could play a major role in the 
exposure of fibre fractions to microbial fermentation in the lower intestinal tract (Swart et al., 
1993a).  
 
Figure 1.1. The digestive system of an adult ostrich (Cooper et al., 2004).  (A), 
proventriculus (glandular stomach); (B), ventriculus (gizzard); (C), small intestine; (D) caeca; 
(E) colon; (F) hindgut. 
 
The ratites have both similarities and differences in their GIT (Table 1.1). None have a crop, 
a feed storage organ in other avian species (Angel et al., 1995). Ostriches have a relatively 
small proportion of their GIT represented by the small intestine (36% compared to 90% of 
the chicken and 88.5% in the emu; Table 1.1). In comparison, the caecum represents only 7% 
of the intestine, as in the chicken. The most prominent difference between the ostrich and 
















3% in the chicken, and below 15% for the emu and rhea. The modifications of the hindgut in 
the ostrich include an extremely long, capacious, haustrated colon (57% of digestive tract; 
Table 1.1) and a well-developed sacculated caeca (Bezuidenhout, 1986), which indicates the 
use of fermentative digestion of plant fibre (Swart et al., 1993b).  
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Small intestine 512     36 61       90 315    88.5 132     63.2 
Cecum 94       7 5         7 12      3.3 46      22 
Colon 800     57 2         3 29      8.2 31      14.8 
a   
adult 122kg female ostrich 
b   
adult chicken 
c  
adult emu 38.3kg 
d   




% of total length of intestinal tract (from duodenum to end of colon) 
 
Ostriches are known as hindgut fermenters like donkeys, horses and rabbits. It is therefore 
critical that their intestines are colonized with the beneficial microorganisms as soon as 
possible (Aganga et al., 2003). High concentrations of volatile fatty acids (VFAs) are 
produced in these fermentation chambers and digestion of hemicellulose and cellulose is 
carried out here by the resident bacteria present. The VFAs detected in the ostrich include 
acetate, found in the proventriculus, gizzard and small intestine, and acetate, butyrate, 
propionate, isobutyrate, isovalerate and valerate, found in the hindgut (Swart et al., 1993b). 
The VFAs are absorbed and metabolized as an energy source, providing as much as 76% 
metabolizable energy requirements of a growing ostrich (Swart et al., 1993b). Ammonia is 
the product of microbial proteolytic activity, deamination of amino acids and urease activity, 
















(Swart et al., 1993b). An increase in pH is noted from the proventriculus and gizzard (pH 2 - 
3) to the small intestine (pH7 - 8). The retention time of food in ostriches has been known to 
be as long as 76 hours, compared to 5.5 hours for emus (Swart et al., 1993a). This extended 
retention time, together with the advantageous pH values, is thought to create optimal 
anaerobic conditions in the hind gut for microbial fermentation and absorption of water and 
volatile fatty acids (Swart et al., 1993b).  
 
1.2. Intestinal microbiota 
 
Intestinal flora includes a mixture of approximately 10
14 
bacteria, mostly obligate anaerobes, 
which play important roles in the host’s metabolism (Mitsouka, 1992).
 
These roles include 
synthesis of vitamins B and K, non-specific activation of the immune system, production of 
short-chain fatty acids which act as an energy source for the host’s tissues, conversion of 
ingested carcinogens to inactive compounds and prodrugs to active drugs (Shanahan, 2002). 
The commensal flora also acts as a barrier to invading pathogens, preventing their attachment 
by competition for niches and nutrients in the gut (competitive exclusion) and their 
production of toxic compounds such as hydrogen peroxide and other bacteriocins (Havenaar 
and Huis, 1992). Their importance becomes obvious when an antibiotic is administered and 
the colonization of the gut by pathogenic bacteria occurs (Shanahan, 2002). The method by 
which this protection occurs is unknown but it is thought to involve cross-talk between the 
host cells and the commensal bacteria where the probiotics secrete soluble compounds which 
inhibit processes of pathogenicity such as binding of pathogens to the gut and increased 
production of mucous (Cook and Sellin, 1998). 
 
The harsh conditions in the gut make survival for many bacteria a challenge and they are 
often flushed out by peristalsis or cannot endure the effects of the antimicrobial chemicals 
produced by the gut (Quigley, 2010). Bacterial survival in the gut can be achieved by either 
increasing the growth rate to overcome the rate of removal via peristalsis, or by their 

















There is only limited information on the microbiota in the gastrointestinal tract of the ostrich. 
Matsui et al. (2010b) showed the ostrich caeca to have a rich and diverse microbial 
community, the majority of which have not yet been cultivated. The study showed Firmicutes 
to be the major phylum present (50.9% of total number of sequences), followed by 
Bacteroidetes (39.4%), Fibrobacter (6.5%), Euryarchaeota (1.9%), Spirochaetes (1.0%), and 
Verrucomicrobia (0.3%). Clostridium coccoides and Clostridium leptum were the 
predominant phylotypes in the Firmicutes. A faecal isolate from the study showed 93 and 
90% similarity to Fibrobacter succinogenes and Fibrobacter intestinalis, respectively, 
suggesting a new species of Fibrobacter in the ostrich caeca. This report, by Matsui et al. 
(2010b) is the most extensive study, to date, on ostrich microbiota. Studies on the culturable 
ostrich microbiota described a Ruminococcus flavefaciens isolated from caecal digesta of 
mature ostriches (Matsui et al., 2010a), as well as five fibrolytic bacteria. The latter was 
isolated from ostrich faecal matter and included an unknown Fibrobacter species, assumed to 
be involved in fibre digestion in the ostrich caeca, and Propionibacteria acnes, both having 
been detected in ostrich faecal matter (van Gylswyk et al., 1998).  
In contrast to ostriches, the chicken GIT is well studied (Zhu et al., 2002; Lu et al., 2003, Zhu 
and Joerger, 2003; Amit-Romach et al., 2004; Apajalahti et al., 2004; Apajalahti and 
Kettunen, 2006; Collado and Sanz, 2007a; Gong et al., 2007; Rehman et al., 2007; Brisbin et 
al., 2008; Gérard et al., 2008; Lee et al., 2010).  Even though there are significant differences 
between the two systems, one can use some strategic aspects of the chicken microbiota 
studies and findings as a platform to investigate the bacterial flora of the ostrich gut.   
The caecum of chickens has been suggested to offer a relatively stable environment and to 
harbour the largest and most complex microbial community within the GIT (Mead, 1997; 
Zhu et al., 2002). Microbial fermentation leads to the formation of short chain fatty acids 
(SCFAs) and lactate (Ricke et al., 2004), as in the ostrich, however they are not important 
energy sources in the chicken, as they are for the ostrich (Swart et al., 1993a, b).   
 
1.3. Ostrich farming 
 
Hunting ostriches for their meat, skin and feathers is an ancient practice, being featured in 
















lack of control, the species became extinct in several natural habitats (Cooper et al., 2009). 
To remedy this, domestication and breeding practices have been implemented and have 
shown successful repopulation in many countries around the world (Shanawany, 1995).   
Ostrich farming began in South Africa in the middle of the 18
th
 century and the climate 
conditions here are ideal for ostrich breeding. The ostrich industry is one of the few 
agricultural industries in the world where South Africa is regarded as the undisputed world 
leader (National Agricultural Marketing Council, 2003), rearing and slaughtering 
approximately 340 000 ostriches in 2002. In 2005 the export of ostrich products amounted to 
ZAR1 200 000 accounting for approximately 5% of South African agricultural exports 
(Brand and Jordaan, 2010). The Western Cape is the leading producer of ostrich products, 
contributing 75% to the total ostrich production. Ostrich meat is increasingly popular in 
Europe where it is considered to be a healthier meat because it contains less cholesterol, 
sodium and fat, and more protein and iron compared to other meats (Table 1.2; Thomson, 
1997; South African Ostrich Business Chamber, 2010). Importantly the Western Cape ostrich 
industry employs approximately 20 000 workers, representing 14% of labourers (McDonald 
and Punt 2001). Hence, this industry has a significant impact on the economy of South Africa 
and a decrease in ostrich production would have severe social and economic consequences.  
Ostriches were originally domesticated for gathering of the feathers, but now it offers a range 
of products in addition to the meat and feathers, which include durable high quality hide, 
curios and agri-tourism services (Table 1.2; South African Ostrich Business Chamber, 2002). 
In order for ostrich farming to be successful, the farmer needs to raise sufficient numbers of 
viable and healthy ostrich chicks to slaughter age. This can be a challenge given the high 
mortality rates reported around the world for ostrich chicks up to three months of age (Smith 
et al., 1995; Adams and Revell, 1998; Glatz and Miao, 2008, Jarvis, personal 
communication). The mortality rate can reach up to 80% (Cloete et al., 2001) and could be 
due to inadequate knowledge on feeding and management of young chicks, stress or the 
delayed development of the microbiota (Glatz and Miao, 2008). Ostriches are naturally 
coprophagous but due to the conditions under which they are farmed, they are separated from 
their mothers at birth and can therefore not acquire the natural flora usually obtained from the 

















Table 1.2. Comparison of nutritional value of ostrich, beef, pork, chicken and lamb meat  
Nutritional information/100g raw, extra-trim meat 
Type of Meat Energy Value KJ Protein (g) Fat (g) 
Ostrich fillet 392 KJ 21.3 g 0.80 g 
Beef fillet  543 KJ 19.0 g 5.95 g 
Pork fillet 498 KJ 19.5 g 4.50 g 
Chicken breast fillet 458 KJ 21.5 g 2.50 g 
Lamb stir-fry 619 KJ 19.0 g 8.00 g 
Source: South African Ostrich Business Chamber 
 
An unbalanced microbiota can lead to the colonization of the gut by pathogens such as 
Salmonella, Campylobacter and Escherichia coli which are the main pathogens in chickens 
and cause serious illness in humans if consumed (Garriga et al., 1998). Not much is known 
about the diseases affecting ostriches, but gastrointestinal pathogens are known to have a 
highly detrimental effect on these birds (Shivaprasad, 1993). To this end it has been 
suggested to include rabbits in the raising of ostrich chicks (Madeiros, 1998). Not only does 
the rabbit supplement the mother figure, but also improves the welfare of the newly hatched 
chick by providing faeces which the chicks eat, obtaining vitamins B and K and receiving the 
beneficial inoculums to promote a healthy gut microbiota.  
 
The growth of the ostrich chicks depends on their food intake, which is determined by their 
current weight and size and the energy content and ration of the food (Kreibech and Sommer, 
1995). The ostrich chick loses weight in the first seven days post-hatching due to utilisation 
of the yolk sac, but hereafter gains weight at 1.3kg/week up to 12 weeks old (Mushi et al., 
1998). Ostrich chicks have highly efficient feed conversion to body mass ratio up until the 
















management (Cooper, 2005). The diet of the ostrich requires evaluation and knowledge of the 
farming environment for good growth and nutrition (Cooper et al., 2004). Verwoerd et al. 
(1999) recommended feeding chicks ad libitum with a high quality diet at least for the first 
four months. Mushi et al. (1998) added that rearing chicks of the similar weight together can 
improve chick growth. The rapid growth rate of the chicks in the first four months is thought 
to lead to leg deformities which in turn can lead to death of the chicks (Musa et al., 2005). 
This can be avoided by feeding the chicks a high fibre diet and allowing them more exercise. 
However, there are conflicting reports on feeding fibre to ostrich chicks. Angel (1993) 
reported that ostrich chicks are able to forage in the wild 48 h after hatching. Poultry chicks 
are born without gut microbes but these appear within a few days (Mead, 2000). More 
research is needed into the quantity and source of fibre fed to ostrich chicks (Ganz and Miao, 
2008).  
 
The main expenses in ostrich farming are feed and health control, contributing 80% (Brand 
and Gous, 2006) and 10% (Bhiya, 2006) of the gross expenditure per bird, respectively. The 
farmer therefore needs to ensure an adequate number of birds are slaughtered to cover this 
cost (Cooper et al., 2004). The average age of slaughtering ostriches is nine to 12 months, as 
this is when their food conversion ratio declines, and when the ostrich is small enough to 
make skinning and eviscerating cost-effective (Cooper et al., 2004). However, there has been 
a suggestion to lower the slaughter age to seven months to decrease the cost involved in 
raising the chick to slaughter age (Mike Jarvis, personal communication). This would require 
effective management and facilities, knowledge on the diet required, and good genetic 
selection. Growth promoting supplements (such as probiotics), excluding antibiotics, could 
also be beneficial.  
 
1.4. Ostrich health 
 
In the first few months of life, ostrich chicks are particularly susceptible to disease and 
infection, various disorders and stress (Huchzermeyer, 1994; Samson, 1997). It is imperative 
to keep young ostrich chicks warm, with the correct diet, in a stress free environment and 
















lose weight after hatching, and may require individual attention in a stress-free environment 
if they are to have a chance of surviving (Glatz and Miao, 2008). Once clinical symptoms 
have developed, there is little chance of the chick being saved. Navel and yolk sac infections 
are other major contributors to the high mortality rates seen in chicks (Glatz and Miao, 2008). 
Ostrich chicks are sensitive to stress, originating from transport, handling, noise, heat, toe 
trimming and over-crowding in pens, amongst other things (Glatz and Miao, 2008) and these 
factors should be kept to a minimum for optimal health of the chicks. Ostriches are 
susceptible to diseases found in avian species including Salmonella typhimurium, Escherichia 
coli and Clostridium spp. infection. Other diseases that can affect ostriches include Newcastle 
disease, various strains of avian influenza that have been isolated from ostriches in Zimbabwe 
and South Africa, fading chick syndrome, enteritis and Tibiotarsal rotation (Huchzermeyer, 
2002).  
 
1.5. The use of growth-promoting antibiotics in animal farming 
 
Farm animals are susceptible to bacterial imbalances which may lead to detrimental effects 
such as inefficient digestion of food, poor nutrient assimilation, the risk of pathogenic 
infections and increased mortality. To minimise economic losses and mortality, antibiotics 
are commonly used in animal feed as supplements for disease control, for their growth 
promoting properties and to increase feed conversion. These attributes are thought to be due 
to induced changes in the gut microbiota (Singer and Hofacre, 2006). Antibiotics such as 
tylosin are thought to reduce the microbial load in the gut and therefore make more nutrients 
available to the host. Tylosin is a macrolide-class antibiotic commonly used in veterinary 
medicine. It has a broad spectrum of activity against gram positive bacteria (Staphylococcus 
spp., Streptococcus spp. and Clostridum spp.), as well as some Mycoplasma and Chlamydia, 
and a narrower range against gram negative bacteria (Campylobacter spp., Helicobacter 
pylori, and Pasteurella spp). It is used for both treatment of bacterial infections, as well as its 
growth promoting properties. However, antibiotic resistance has increased and is becoming a 
worldwide problem and a threat to public health. Antibiotic resistant enterococci have been 
isolated from animals, water, food and soil (Aarestrup, 2000; Abriouel et al., 2008). The 
isolation of multi-drug resistant bacteria, such as vancomycin-resistant enterococci (VRE) 
















Union banned the use of antibiotics as growth promotants in animal production (Bager et al., 
1997).  
 
1.6. Effect of antibiotics on the commensal microbiota  
 
The use of antimicrobials may lead to alterations in intestinal microbiota, although faecal 
microbiota has been shown to be resilient to short-term administration of antibiotics albeit 
some species remaining depressed for several months (Collier et al., 2003). The mode of 
action of growth-promoting antibiotics is not known, but given the fact that germ-free 
chickens did not show any change in growth rate when fed these antibiotics, it has been 
suggested that its growth-promoting properties are due to their inhibitory effect against 
certain intestinal bacteria that produce toxins or compete with the host for available nutrients 
(Coates et al., 1963; Engberg et al., 2000). The effect the antibiotic has on the commensal 
microbiota is antibiotic-specific. Tylosin, used in this study, is commonly used in animal 
husbandry, and is often used for the treatment of chronic enteropathies in dogs (Suchodolski 
et al., 2009). It is currently unknown if the therapeutic use of tylosin has a direct effect on 
intestinal pathogens or if it leads to a more general alteration of the intestinal microbiota in 
dogs with diarrhoea, with the subsequent improvement in digestion and absorption. It is also 
used to treat canine small-intestine bacterial overgrowth and tylosin-responsive diarrhoea, 
and Clostridium perfringens and Campylobacter spp. are generally sensitive to tylosin 
(Marks and Kather, 2003). In addition, an anti-inflammatory property has been proposed for 
tylosin due to the modulation of cyclooxygenase-2, nitric oxidase synthase, and several 
cytokines (Cao et al., 2006). Suchodolski et al. (2009) found that treating dogs with tylosin 
for 28 days resulted in a significant shift in the intestinal microbial population, with an 
increase in Proteobacteria and a decrease in Firmicutes, Actinobacteria, Bacteroidetes and 
Tenericutes, to mention a few.  Macrolide antibiotics, including tylosin, showed high 
minimum inhibitory concentrations (MICs) against several C. perfringens strains isolated 
from chickens with necrotic enteritis (Gharaibeh et al., 2010). Although tylosin is usually 
reported to be effective against C. perfringens (Suchodolski et al., 2009), Gharaibeh et al. 
(2010) suggested this resistance was due to the prophylactic use of macrolides in the 
treatment of  Mycoplasma gallisepticum, rampant in chickens in Jordan. Poole et al. (2003) 
















microbiota aided in the persistence of pathogenic E. coli 0157:H7 and suggested that the use 
of low-level, growth-promoting antimicrobials may compromise the ability of normal 
microbiota that serve as a natural host defence against infection. Tylosin has also been shown 
to significantly reduce total bacteria counts, while selecting for Lactobacillus species, 
commensals known to competitively exclude potential pathogens from colonising the 
intestine (Collier et al., 2003). It is evident that the effect of antibiotics on the commensal 
microbiota is strain specific and should be examined to avoid detrimental side effects when 
used. To avoid antibiotic-resistance developing in these bacterial communities, it would be 




Probiotics have been defined in several ways, initially by Kollath in 1953 who defined them 
as being all organic and inorganic food complexes in contrast to harmful antibiotics (Kollath, 
1953). A more recent and more commonly used definition regards probiotics as live 
microbial feed substances which beneficially affect the host by improving its intestinal 
microbial balance (Fuller, 1989). They are now defined as “live organisms that, when 
administered in adequate amounts, confer a health benefit on the host” (Sanders, 2008). 
Research into probiotics has taken a large leap forward, as their potential for use in health 
supplements for humans and animals is being realised. As early as the 19
th
 century, Escherich 
(1885) described the microbiota and the advantages to digestion of the colonization of the 
gastrointestinal tract (GIT) of young children. Metchnikoff (1907) published ideas on the 
benefits of lactic acid bacteria (LAB) in fermented milk products, and proposed that normal 
gut flora was detrimental to the health of the host, but that their replacement by yoghurt 
bacteria was beneficial. Since then, health benefits of probiotics have been shown to include 
prevention of lactose intolerance in humans, treatment of diarrhoea and antibiotic-related 
gastrointestinal side effects, treatment of allergies, treatment of Clostridium difficile colitis 
and Helicobacter pylori infection, amongst many others (Doron and Gorbach, 2006). Those 
used in animal husbandry usually include Lactobacillus spp., Bifidobacterium spp., Bacillus 
subtilis and Saccharomyces spp. (Lim and Tan, 2009) and are thought to provide protection 
by the production of antimicrobial substances like bacteriocins and lactic acid, and the 
















1.7.1. Studies in animals 
 
Probiotics are useful in the treatment of disorders caused by disturbed intestinal microbiota 
and increased gut permeability and have been shown to encourage growth and feed 
utilisation, decrease mortality and increase feed conversion in farmed animals such as pigs, 
chickens and calves (Lim and Tan, 2009). The use of probiotics in ostriches has not been 
studied, their effects on other farmed animals such as pigs and calves, and the closest model 
animal, the chicken, is reported here. In animals, probiotics have been shown to improve 
body weight gain and feed conversion as well as decrease the number of cases of diarrhoea in 
pigs and calves (Abe et al., 1995). Probiotics are also thought to neutralise the toxin produced 
by E. coli which is pathogenic for pigs (De Mitchell and Kenworhty, 1976). A combination 
of live yeast and Pediococccus acidilactici in piglet diets was found to improve the piglet’s 
intestinal mucosa, which is critical to nutrient absorption and immunity against pathogens 
(Lim and Tan, 2009). Varying success has been obtained since the 1970s using fungi, yeasts, 
and bacteria to increase milk production and weight gain, improve health status and 
resistance to diseases in ruminants. 
 
Probiotics do not only result in positive outcomes however. They have been known to cause 
detrimental effects such as sepsis in murine models. Wagner et al. (1997) colonised neonatal 
mice with various probiotic strains and reported LGG and L. reuteri to be fatal, suggesting 
the presence of immune-deficiency in neonates put them at risk of sepsis. Cilieborg et al. 
(2011) found that a mixture of Lactobacillus paracasei, Bifidobacterium animalis and 
Streptococcus thermophilus (2.4 X 10
10
/day) fed to new-born piglets, as dead or live bacteria, 
resulted in intestinal weights being lower and the incidences of necrotizing enterocolitis to be 
higher in pigs receiving the probiotics compared to the control group. In addition, the 
probiotics were found to minimally affect the colonisation of the gut and resulted in lower 
bacterial diversity in the distal intestinal mucosa and lower SCFA concentrations in the colon. 
They suggest these detrimental effects were due to the specific strain and dose combination, 
and the immature gut immune system of these new-born piglets. In a rat model of 
indomethacin-induced enteropathy, provision of LGG increased intestinal ulceration (Kamil 
et al., 2007). It is therefore clear that in some circumstances, certain probiotic strain(s) may 
















1.7.2. Probiotics in poultry farming 
 
Chicken farming experiences the same problems as ostrich farming concerning enteric 
diseases which lead to loss of productivity, increased mortality and contamination of poultry 
products for human consumption (Patterson and Burkholder,, 2003). Probiotics have been 
shown to protect chickens from diseases such as Salmonella, as well as increase the growth 
rate, decrease mortality rate by competitive exclusion and improve the feed conversion rate 
(Abe et al., 1995; Schneitz, 2004). Lee et al. (2006) investigated the use of Aspergillus 
oryzae as a potential probiotic and found it increased the number of Lactobacillus which 
consequently lowered the number of Salmonella and E. coli in the faeces of chickens fed 
Aspergillus oryzae. Han et al. (1999) found probiotics to improve digestion in broilers, and 
postulated that amylolytic and proteolytic enzymes produced by the probiotics were affecting 
digestion of the layers. Kim et al. (2003) showed a decrease in serum cholesterol levels in 
broilers fed Aspergillus oryzae which is thought to produce a compound which inhibits 
cholesterol biosynthesis. Bacillus subtilis was found to significantly increase body weight 
gain and feed efficiency in turkeys, as well as increase the crop and caecal counts of this 
strain (Jiraphocakul et al., 1990). Nahashon et al. (1994) reported increases in body weight 
gain, passage rates of digesta and retention of calcium, phosphate, cobalt and magnesium, as 
well as increased egg weight and size in layers that were fed Lactobacillus (Lacto). Protexin 
(Lactobacillus plantarum, Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus 
rhamnosus, Bifidobacterium bifidum, Streptococcus thermophilus, Enterococcus faecium, A. 
oryzae, Candida pintolopessi) is a probiotic mix commonly used in animals, and was shown 
to increase live weight gains as well as the carcass yield, breast and leg weights and antibody 
titre in broilers (Kabir et al., 2004). An increase in feed conversion ratios and body weight 
gain was observed in broilers fed Bacillus coagulans (Cavazzoni et al., 1998). Chickens and 
ducks fed 4 X 10
10 
Lactobacillus sp./day were found to gain weight significantly faster than 
the control groups (Angelakis and Raoult, 2010). Liver mass was also found to be higher in 
those birds receiving the inoculums and Lactobacillus sp. was detected more abundantly in 




















Gibson and Roberfroid (1995) described prebiotics as a non-digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and/or activity of one or a 
limited number of bacteria in the colon. Common prebiotics include fructooligosaccharide 
products (inulin for example), lactulose, glucooligosaccharides, raffinose and sucrose 
(Patterson and Burkholder, 2003). They have shown potential for inclusion into food products 
for humans as they increase the efficiency of probiotics (Holzapfel and Schillinger, 2002), 
and it has been shown that they increase the faecal Bifidobacterial count (Bouhnik et al., 
2004). The combination of a probiotic with a prebiotic is known as a synbiotic, and is thought 
to improve its transit through the GIT, reaching the caecum to benefit bacterial groups 
(Holzapfel et al., 2002). Synbiotics have been shown to have increased performance on the 
host compared to either probiotics or prebiotics alone (Rowland et al., 1998). Prebiotics are 
also considered to offer protection to the probiotic during processing, drying and storage. 
Conrad et al. (2000) demonstrated the thermoprotectant effect of trehalose, non-fat milk 
solids and adonitol on Lactobacillus acidophilus before spray drying, and Carvalho et al. 
(2004) showed the cryoprotection offered by fructose, lactose or mannose on Lactobacillus 
bulgaricus before freeze drying. In both cases, viability of the test strains was improved.  
Thus prebiotics can be seen to have beneficial effects on probiotics during processing and 
during transit through the GIT. 
 
1.9. The transit of probiotic strains through the gastrointestinal tract 
 
The beneficial effects of probiotics have been realised, but their suitability for use as 
probiotics requires further research. The probiotics need to survive the transit through the 
GIT, remaining viable after exposure to bile and stomach acids, and be able to colonize the 
GIT adequately to provide a barrier to incoming pathogens, as well as surviving the 
manufacturing and storage process. Some of their beneficial properties include their non-
pathogenic nature, oxygen and heat tolerance, bile and acid tolerance, ability to adhere to 
intestinal cells, bacteriocin production and antibiotic resistance. Suitable probiotic strains 
















survival through the GIT, probiotics can be encapsulated in a protectant, or be administered 
with prebiotics. 
 
1.10. Selection of appropriate probiotics 
 
Several factors need to be taken into consideration when choosing a probiotic for therapeutic 
use. To be beneficial, the bacterial strain must have the following properties: 
 
1.10.1. Origin and identity 
 
A probiotic should be chosen on its history of non-pathogenicity and on the knowledge of 
strain-specific risk factors. Identifying the bacteria is therefore important. Lactobacilli and 
Bifidobacteria very rarely cause disease and can therefore be assumed to be non-pathogenic 
in use as a probiotic (Holzapfel, 2005). Administering a bacterial strain from a homologous 
species increases the chances of the bacteria’s survival in the GIT and also decreases the 
chances of causing disease in the animal due to host specificity (Garriga et al., 1998). 
 
The amplification of the 16S rRNA region is among the most widely used methods of 
identification used (O’Sullivan, 1999). Depending on the level of discriminatory power 
needed, there are several regions of the rRNA genes which can be studied.  Sequencing of 
half of this gene (750bp) is sufficient for reliable identification of the strain, however, it is 
recommended to use the full gene to establish phylogenetic relationships (Tannock, 1999). 
Less than 97% homology between the two 16S rRNA genes being compared means they have 
less than 60-70% DNA similarity over the whole chromosome and are therefore unlikely to 
belong to the same species (Stackebrandt and Goebel, 1994). A drawback of this method is 
that species within a genus often show very high relatedness of 16S rRNA sequences and 
thus exact identification is not always ensured (Botina et al., 2005). When looking at 
phlyogenetic trees derived from 16S rRNA data, it is important to remember that the 
















region analyzed, and the number and choice of organisms analyzed (Stachebrandt and 
Goebel, 1994). It is therefore necessary to include as wide a range of organisms, related or 
not, in a phylogenetic tree.  
 
Another more discriminating method of identification is to use the 16S-23S intergenic spacer 
region (ITS), which can resolve the difference between closely related species such as 
Lactobacillus plantarum and Lactobacillus pentosus (Tannock et al., 1999). The spacer 
region between the 16S and 23S genes is extremely variable in length and sequence (Garcia-
Martinez et al., 1999). In comparison to the 16S rRNA gene, where the entire gene 
(approximately 1500 bp) should preferentially be sequenced for accurate identification, only 
200 bp of the intergenic region (if the short spacer region is used) needs to be sequenced 
(Tilsala-Timisjarvi and Alatossava, 1998; Berthier et al., 1998, Nour, 1998, and Nakagawa et 
al., 1994).  The variable spacer region, which is responsible for the species-specific banding 
pattern obtained, is due to the presence of several functional units, tRNA genes for example, 
or sequences required for recognition of enzymes such as the ribonuclease III, or boxA 
(Garcia-Martinez et al., 1999). Lactobacillus species characteristically show 3 bands when 
the spacer region is amplified. This is due to the presence, absence and number of tRNA 








1.10.2. Technical properties 
 
Growth features of the strain in vitro are important in assessing the potential for use as a 
probiotic. A suitable strain should have a relatively high growth rate to make production of 
large volumes feasible and more economical (Margolles et al., 2009).  Methods to keep the 
strains viable during transport and storage are still under investigation, but include freeze- 



















1.10.3. Physiological properties 
1.10.3.1. Acid tolerance 
The number of bacteria ingested is greatly diminished by the bactericidal effects of gastric 
juice and bile acid (Begley et al., 2004), and although dead bacteria do exert probiotic effects 
(Sanders and Veld, 1999), the delivery of live bacteria would be preferable for the maximum 
effect to be seen. The pH in the stomach of humans is approximately 2 – 2.5 and may reach 
as low as 1.5 (Waterman and Small, 1998) and in ostriches reaches as low as 1.9 in the 
gizzard (Swart et al, 1993a; Jarvis, 2002, unpublished). The ability of bacteria to survive 
transit through the GIT is therefore based on its acid tolerance. Dunne (1999) showed that 
Bifidobacteria are less acid tolerant than Lactobacilli. Lactobacillus acidophilus has been 
shown to survive exposure at pH 4 for 2 hours and at pH2 for several mi utes but not for 45 
minutes (Hood et al., 1988). The use of a protective food carrier such as cheddar cheese has 
shown to enhance microbial survival in acid environments and a buffering effect has been 
proposed (Standton et al., 1998). Charteris et al. (1998) demonstrated that milk or milk 
proteins added to gastric juice increase the pH, thereby increasing survival of some 
Bifidobacterium and Lactobacillus spp., and again, a buffering effect was suggested. Isolating 
LAB from harsh environments like the GIT, often results in the isolation of particularly acid-
resistant strains (McLauchlan et al., 1998). This method can isolate strains which are both 
acid and bile tolerant and may be more resistant to other stresses like hydrogen peroxide and 
storage at low temperatures. Lorca et al. (2002) showed that exposing L. acidophilus CRL 
639 to sub lethal acid condition (pH 5.0) increased their survival when exposed to lethal 
conditions at pH 3.0. The acid tolerance response of Streptococcus mutans has been 
thoroughly studied (Matsui and Cvitkovitch, 2010). Bacteria living in acidic environments 
risk the acidification of the internal cytoplasm which could lead to loss of glycolytic enzyme 
activity, structural damage to the cell membrane, DNA and proteins (Lindahl and Nyberg, 
1972). S. mutans was found to be able to survive these acidic conditions by repairing and 
protecting cellular macromolecules (Quivey et al., 1995), altering its metabolic activity in 
response to pH fluctuations (Len et al., 2004), increase cell numbers and form biofilms (Li et 
al., 2008) and by maintaining the internal pH homeostasis by altering the composition of the 
membrane fatty acids, end product efflux via lactic acid and increasing the expression of 
proton pumps (Kuhnert et al., 2004; Shibata et al., 2009). Other LAB may also utilise one or 

















1.10.3.2. Bile tolerance 
Bile acids are synthesized from cholesterol in the liver and are secreted from the gall-bladder 
into the duodenum in their conjugated form where they are involved in emulsification, 
digestion and absorption of lipids (Hoffman et al., 1983). Microbial activity in the colon 
modifies the bile acids by deconjugation, dehydroxylation and dehydrogenation. 
Deconjugation of bile salts is carried out by bile salt hydrolases, an enzyme present in 
Lactobacillus and Bifidobacterium spp. and catalyses the hydrolysis of glycine and/or taurine 
conjugated bile salts, resulting in a free amino acid and an unconjugated bile acid molecule 
(Tannock, 1998). The connection between deconjugation of bile acid and colonization of the 
gut is not apparent as neither product of deconjugation is used by the bacteria. Bile salts act 
as a detergent, permeabilizing the bacterial cell wall and leading to cell death (Pumbwe et al., 
2007). On the other hand, bile salts have been shown to increase biofilm formation, stimulate 
bacterial co-aggregation and adhesion to human cells (Pumbwe et al., 2007). B. fragilis was 
shown to have increased fimbria and cellular vesicle formation as a signal for attachment to 
host cells and other bacteria, suggesting that bile salts increase bacterial adhesion properties 
(Pumbwe et al., 2007). Both conjugated and non-conjugated bile salts are toxic to bacteria, 
but some species are more tolerant to the deconjugated product than others (Tannock, 1998). 
It has been suggested that there may be differences in efficiency of cell membrane-associated 
transport mechanisms between strains that maintain intercellular levels of unconjugated bile 
acid at non-toxic concentrations. McAuliffe et al. (2005) reported the identification of two 
genes encoding bile salt hydrolysis in the genome of L. acidophilus, having different 
substrate specificities. While bshA activity is dependent on the steroid nucleus, bshB 
specificity is dependent on the absence of taurine in the bile salt structure. 
 
1.10.3.3. Adhesion potential 
For probiotics to have an effect on their host, it is necessary for them to adhere to the 
intestinal mucosa (Dunne et al., 2001). This is important for temporary colonization, 
antagonism against pathogens and modulation of the immune system (Salminen et al, 1998), 
and has been said to be host species specific (Fuller, 1973). This is a desirable property of 
















of interspecies probiotics has not been fully studied, but it has been shown that LAB of 
human origin can adhere well to canine (Rinkinen et al., 2000) and fish mucosa 
(Nikoskelainen et al., 2001), and some dairy species have relatively good adhesion in humans 
(Rinkinen et al., 2000). Probiotics intended for animal use are often used for more than one 
species (Rinkinen et al, 2003). Rinkinen et al. (2003) suggest that LAB adhesion to the 
mucosa is more dependent on strain species and the intestinal microbiota than on host 
specificity. 
 
The adhesion of probiotic strains to the intestine prevents the subsequent attachment of 
pathogens (Patterson and Burkholder, 2003). This is known as competitive exclusion (CE) 
and has been shown to reduce the colonization and shedding of Salmonella and 
Campylobacter spp. in day-old chicks (Patterson and Burkholder, 2003). CE is 100% 
biological, does not leave any residues and one treatment on the first day of hatching was 
reported to be sufficient, either by spraying the hatchery or applying the probiotics to the 
drinking water (Schneitz, 2005). CE is thought to work via production of volatile fatty acids 
(VFAs) and the occupation of attachment sites on the mucosa. VFAs decrease the growth rate 
and maximum optical densities of pathogens, as shown by the decrease in numbers of 
Enterobacteriaceae in the presence of VFAs (Schneitz, 2005). Seuna (1979) showed that 
chicks challenged with Salmonella one to two hours after CE treatment were well protected 
from colonisation of the pathogen. Administration of Lactobacillus plantarum has lead to the 
inhibition of enterotoxigenic Escherichia coli (Pretzer et al., 2005). This is thought to be due 
to the competitive exclusion of E. coli by recognition of the same binding sites on the 
intestinal membrane.  
 
The host epithelium has mannose-containing glycoconjugates which are targets for many 
pathogenic bacteria having type one fimbriae. These fimbriae are responsible for mannose-
specific adherence to the host epithelial cells. L. plantarum has been shown to specifically 
bind to mannose-containing sugar moieties and to human intestinal cell lines, leading to 
competitive exclusion of pathogens (Adlerberth et al., 1996). This adhesion is thought to be 
due to a lectin-like element in the bacterial cell wall (Kinoshita et al., 2005). Apart from this 
protein, lactobacilli cell surfaces contain lipoteichoic acid, teichoic acid, extracellular 
















in the bacterial cell wall recognizes the sugar chains on human colonic mucin (HCM), a high 
molecular weight glycoprotein. L. plantarum was shown to have a higher adhesion value to 
HCM, containing sugar moieties, than to BSA which has no sugar chains. 
 
Other possible adhesion factors include a mucin-binding protein, a fibronectin-binding 
protein and a surface layer protein (Buck et al., 2005). Inactivation of the gene, slpA, 
encoding the surface layer protein, resulted in an 84% decrease in adherence (Buck et al., 
2005). The function of the surface layer of a bacterial cell involves cell shape, protection, 
epitope display and epithelial-cell attachment. It is therefore not surprising that the 
inactivation of this gene leads to such a significant decrease. Fibronectin is a secreted protein, 
thought to be responsible for Lactobacillus spp. adhesion (Kapczynski et al., 2000). It has 
been shown that inactivation of a surface-associated protein, FbpA, leads to a 76% reduction 
in L. acidophilus.  Glycoproteins called mucins are present in the mucus surrounding host 
intestinal cells (Kapczynski et al., 2000). Mub, a mucin-binding protein in L. reuteri, has 
been shown to be associated with the cell surface (Roos and Jonsson, 2002). A strain having a 
mutation in this protein showed a decrease in adherence of 65%. 
 
1.10.3.4. Oxygen and temperature tolerance 
During processing of the bacterial culture to produce a probiotic in a form suitable for the 
host to consume, the strain undergoes various environmental stresses such as high 
temperature and oxyge  exposure (Crittenden, 2009). Since most potential probiotics are 
anaerobic, they need to be able to survive processing and storage conditions without losing 
viability. Thermal inactivation of bacteria is thought to come about by denaturation of cell 
components like RNA and DNA. Oxygen-induced inactivation is brought about when there 
are high levels of reactive oxygen species (ROS) present (Kullisaar et al., 2002). ROS cause 
DNA, protein and lipid damage. Aerobic and facultative anaerobic bacteria produce the 
enzymes catalase and superoxide dismutase (SOD), amongst others, which reduce ROS to 
harmless substances. Bifidobacteria are strict anaerobes, but differ slightly in their oxygen 
tolerance.  Kaizu et al. (1993) showed that some Lactobacilli have antioxidative activity and 
can reduce the accumulation of ROS during ingestion of food. Screening microorganisms 
















reported by Niamsup et al. (2003), who isolated Lactobacillus species from chicken faeces 
under high temperature. 
 
1.10.3.5. Enzyme production 
An effective probiotic is one which has functional properties useful to the host. One of these 
properties is the production of enzymes to aid in the digestion of food and therefore 
increasing the availability of minerals to the host (Guarner and Schaafsma, 1998).  A good 
example is the hydrolysis of phytic acid. Mono-gastric animals do not produce phytases 
(Brindch-Pederson et al., 2002) which break down phytic acid to phosphates and minerals, 
essential to animal health. They therefore depend on the microbiota to produce phytases. If 
the gut flora is not established, due to the use of antibiotics, problems such as bone diseases 
appear. Many bacteria, Bifidobacterium in particular have been identified as phytase 
producers (Haros et al., 2005). Interestingly, many phytase-producing bacteria are found in 
wild birds, suggesting that their diet supports these bacteria more readily than does the 
artificial diet, where phytic acid-rich food is prevalent. Enzymes that aid in the digestion of 
fibre, such as cellulases and xylanases, would also be beneficial to the ostrich as they live on 
a high fibre diet which is a major source of energy to growing chicks (Swart et al., 1993a).    
 
1.10.3.6. Antibiotic resistance 
There are several mechanisms employed by antibiotic resistant bacteria. These include: 
decreased uptake of antibiotic, increased export of the antibiotic, inactivation/modification of 
antibiotic target, introduction of new antibiotic-resistant target, hydrolysis of antibiotic, 
modification of antibiotic, or prevention of activation of the antibiotic (Ammor et al., 2007).  
The wide use of antibiotics worldwide has lead to the appearance of antibiotic-resistant 
bacterial strains. Resistant bacteria can have intrinsic or acquired resistance. Acquired 
resistant is achieved by either one or more sequential mutations or by the incorporation of 
new genes (Ammor et al., 2007).  The latter presents the highest risk of horizontal spread. 
Teuber et al., (1999) have proposed that beneficial commensal bacteria may be responsible 
for the transfer of resistance genes to pathogenic bacteria.  Probiotic strains have shown 
sensitivities to different antibiotics, allowing for the use of various antibiotics in media for 
















resistance seen also allows for the use of antibiotic treatment while using a multistrain 
probiotic preparation as not all strains will be affected.  These advantageous properties may 
lead to the uncertainty of the safety of the probiotics. For human consumption, all strains 
need to be graded as Generally Regarded As Safe (GRAS). With the presence of resistance 
genes, the risk of gene transfer to pathogenic bacteria is possible. When characterising a 
possible probiotic strain, it is important to check for signs of transferable antibiotic resistance. 
 
1.10.4. Monostrain, multistrain or multispecies probiotics 
 
Probiotics have been shown to prevent a variety of diseases, but their modes of action against 
these various diseases differ and it has been postulated that a multispecies preparation would 
be more efficacious. Monostrain preparations contain a single strain and may have less 
chance of successfully colonizing the gut (Famularo et al., 1999) whereas since probiotic 
responses are strain-specific, multistrain preparations, containing more than one strain of the 
same species or genus may overcome the challenges faced in the gut more efficiently 
(Timmerman et al., 2004). In addition, a multispecies mixture, containing strains of more 
than one genus, would be more appropriate (Timmerman et al., 2004). Mixed cultures are 
also thought to have synergistic effects and to complement each strain’s health effect. A 
downside of a multistrain or multispecies probiotic mix is that secreted antimicrobial 
compounds may not only affect the target organism, but each other too (Kailasapathy and 
Chin, 2000). Therefore, in the development of a multistrain mixture, the effect of each strain 
must be thoroughly investigated, and the safety of the overall effect of the blend must be 
known.  
 
1.10.5. The development of ostrich probiotics 
 
The five strains used in this study were originally isolated by a PhD student (Law-Brown, 
2005, unpublished) as part of a study where 71 strains were isolated from faecal or intestinal 
















 Intestinal extracts of ostriches fed on 15 different artificial diets containing no 
antibiotics 
 Intestinal extracts from culled wild ostriches (Law-Brown, 2005, unpublished) 
 Freshly excreted faeces from ostriches on a commercial farm to which antibiotics 
were regularly administered.  
The sampling points for the intestinal samples included the caecum, the small intestine and 
the large intestine or rectum. 
The samples were cultured on media known to favour the growth of Gram positive bacteria 
especially Bifidobacterium spp. and lactic acid bacteria. In addition, samples were screened 
on media designed for the detection of useful enzymes such as cellulases and xylanases 
(Law-Brown, 2005, unpublished). The 71 strains were presumptively identified and 34 were 
subjected to preliminary screening for bile tolerance, aggregation capabilities and the 
production of antimicrobial compounds (Juste-Poinepen, 2008). In this way, the best ten 
strains were selected for more intensive investigation of probiotic properties. Five of these 
strains have been further characterised in this thesis.   
 
1.11. Aims of current research 
 
The main aim of this project was to develop a probiotic mixture to improve the health and 
survival rates of farmed ostrich chicks in South Africa. The probiotic mixture would be tested 
in feeding trials on ostrich chicks over nine weeks. The aims fall under three main categories, 
namely:  
1. To identify and characterise the five probiotic strains previously isolated from ostrich 
faecal and gastrointestinal samples. These five strains were chosen based on 
preliminary screening of their functionality as potential probiotics, particularly the 
acid and bile tolerance (Law-Brown, 2005, unpublished; Juste-Poinapen, 2008). The 
identification of these strains will be confirmed using molecular techniques and 
further characterised in-vitro to assess their ability to survive the transit through the 
















2. To plan and carry out two feeding trials to test the probiotic effects of these five 
strains in-vivo in the ostrich chick in the presence and absence of the growth 
promoter, tylosin. This will include the development of a mode of delivering the 
probiotic mix to the ostrich chicks successfully, monitoring of the weights, feed 
conversion and mortality rates of the chicks, and collection of fresh faecal samples as 
well as gut mucosal scrapings, and the processing and storage thereof.   
3. To analyse the effects of the probiotics on the diversity of the faecal and mucosa-
associated microbes in the ostrich chicks and to monitor the transition of the 
microbiota with age using culture-dependent and independent methods. This is to get 
an overview of the effect of probiotics and tylosin on the microbiota of young ostrich 
chicks and assess whether the probiotic mix is able to successfully colonise the gut or 
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The identification of five potential probiotic strains, isolated from ostriches, was confirmed 
using various molecular techniques and they were screened for some of the advantageous 
properties of probiotics.  Four Lactobacillus spp. and one Bifidobacterium spp. were shown 
to tolerate up to 2% bile and a pH of 2 and to have the ability to auto-aggregate and co-
aggregate with four tested pathogens. The single strains and their various combinations were 
all able to inhibit these pathogens to different extents, and all were able to displace the 
pathogens except the strains alone against C. difficile.  However, the probiotic combinations, 
as well as Lp6039.3, were unable to out-compete all the pathogens. This highlights the strain-
specificity of these mechanisms. All five strains produced antimicrobial compounds against 
the important ostrich pathogens, E. coli and S. typhimurium. However, only Lr136.2.2 was 
active against C. perfringens. The potential probiotics produced enzymes for hydrolysis of 
plant fibre material and would be capable of playing a role in the digestion of food in the 
ostrich gut. The antibiotic resistance profile of the strains against ten common antibiotics, as 
well as tylosin, the growth promoting antibiotic used in this feeding trial, was also 
investigated. All probiotics were found to be resistant to kanamycin, streptomycin and 
tylosin. Only the Bifidobacterium Bp303.3.2 was sensitive to vancomycin and resistant to 
erythromycin. All five strains were sensitive to cephalothin, ampicillin, penicillin G, 
rifampicin, tetracycline and chloramphenicol. All strains were able to maintain a sufficient 
viability after incubation at 60°C for 10min. The above characteristics are some of the 
beneficial properties required for the success of a probiotic and the tested strains show 
promise as good candidates for use in the ostrich farming industry in replacing growth 
promoting antibiotics such as tylosin.   
 
2.2. Introduction 
In recent years there has been an increase in the demand for the correct strain identification of 
probiotics, especially for Lactobacillus spp. and Bifidobacterium spp., which are thought to 
exert health benefits to their consumers (Ammor et al., 2007). Correct identification of these 
bacteria to the species/strain level is mandatory as probiotic effects are known to be species 















genetic techniques to accomplish the identification and classification of the potential 
probiotics. Further characterisation is needed to study the functional aspects of the strain as 
well as safety assessment. Figure 2.1 shows the process by which a novel potential probiotic 
strain is isolated and screened by in vitro methods in order to gain knowledge of the 
mechanisms by which the strain exerts its probiotic effect. Hereafter, in vivo tests are 
performed.  
2.2.1. Isolation of probiotic strains 
As described in Chapter one, 74 original isolates were screened for functionality as 
probiotics. Of these, five strains including four Lactobacillus spp. and one Bifidobacterium 
spp. were chosen based on their beneficial characteristics for inclusion in this study, 
following the outline described in Fig. 2.1.  This process is described in detail in Chapter one.  
 
 
Figure 2.1.  Process followed in this study to isolate and characterise novel probiotic strains 
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In order to determine the strain specificities of the potential probiotics, a number of different 
approaches are taken. Morphological studies under the microscope, growth studies and 
biochemical testing are usually performed. Further phenotypic identification methods include 
the Gram stain, enzyme production profile, determination of metabolites and the ability to 
utilise sugars. Although necessary, phenotypic identification is not always reproducible due 
to culture conditions, metabolic status of the cell and sometimes the lack of stability of 
certain genetic determinants for the resulting phenotype (Margolles et al., 2009).  
Molecular methods for identification are more reliable and reproducible (Tannock, 1999) and 
are mostly based on the 16S ribosomal RNA genes, allowing for the establishment of 
phylogenetic relatedness at the species and genus level. These tools can also be used to trace 
LAB during and post- ingestion of probiotic feed supplements, as well as from intestinal 
samples of subjects ingesting the probiotics.  
The mucous-adhesion promoting protein (MapA) has been identified as one of the adhesion 
factors on the surface of L. reuteri, allowing it to adhere to mucous, as well as to the 
intestinal epithelial cells (Miyoshi et al., 2006). In addition to providing information on the 
adhesion probability of the strains, the mapA gene was also used for identification of the 
strains, and as it is less conserved between species, was hoped to be useful for differentiation 
of strains of the same species.  
Another rapid and convenient method of identification of strains is the use of the random 
amplified polymorphic DNA (RAPD) technique, a useful tool to study genetic 
polymorphisms of DNA. It allows for the differentiation between closely related bacteria 
through the use of PCR using short primers which bind to the two strands of DNA at several 
locations, thus generating a unique fingerprint (Manan et al., 2009). This method has been 
used to distinguish closely related strains (Johansson et al., 1995) as well as to identify a 
selected strain from a mixture of bacteria (Tilsala-Timisjarvi and Alatossava, 1998). RAPD 

















2.2.3. Characterisation of probiotic strains 
As outlined in Figure 2.1 and described in Chapter one, several criteria are used for the 
characterisation of potential probiotics. The main obstacles to successful colonisation of the 
host by probiotic bacteria is passage through the harsh conditions of the GIT, the ability to 
colonise the gut which is related to the adhesion ability of the strain to the mucous or 
epithelial cells, and the antimicrobial activity of the potential probiotic, through the 
production of antimicrobial substances or its ability to inhibit or displace pathogens.  
Aims and objectives of this study 
The aim of this study was to further characterise five chosen potential probiotic strains. These 
five strains were chosen from 74 originally isolated microbes of ostrich origin based on their 
identity, acid and bile tolerance profiles and activity against certain pathogens. The intention 
was to select suitable strains that could eventually be used for the development of novel 
gastrointestinal probiotics, capable of replacing the use of growth-promoting antibiotics.  
 
2.3. Materials and methods 
 
2.3.1. Bacterial strains and growth condition 
Bacterial strains were previously isolated by Law-Brown (2005, unpublished) and partially 
characterised. Ostrich gut microbiota samples were collected from three sources, namely: 
faecal samples from healthy ostriches from a commercial show farm, samples from the small 
intestine, caecum, large intestine and rectum were collected from healthy adult birds on 15 
different diets at an experimental research centre, and from wild adult birds. Five of these 
were chosen based on the preliminary characterisation studies and characterised further in 
this study.   
The ostrich faecal isolates were inoculated into 5 ml MRS broth (Biolab) supplemented with 
0.05% cysteine-hydrochloride (MRS-Cys) or MRS agar (1.5% w/v) supplemented with 
0.05% cysteine HCL (Sigma), and incubated for 48 hr at 37°C in an anaerobic chamber 















In addition, pathogenic strains used in the antimicrobial assay were grown as follows: E. coli 
ATCC25922, Salmonella typhimurium, and Staphylococcus aureus were incubated 





 were incubated anaerobically on BHI agar.  
For the mucous adhesion studies, four bacterial pathogens were used: Clostridium difficile 
DSM 1296, Clostridium perfringens DSM 756, E. coli NTCT 9001 and Salmonella enteric 
serovar Typhimurium ATCC 12028 and were grown in Gifu anaerobic medium (GAM Nissui 
Pharmaceutical, Tokyo, Japan) under anaerobic conditions for 18 h. Bacteria were 





, Amersham Biosciences, Little Chalfont, UK) to the growth medium.  
2.3.2. Extraction of genomic DNA 
Pure bacterial cultures (10 ml) were grown for 18 hours in MRS broth under anaerobic 
conditions and the purity of the cultures was assessed by Gram staining. Genomic DNA was 
extracted using the Fermentas Genomic DNA purification kit (K0512, Fermentas Life 
Sciences) with some modifications. Briefly, cultures were centrifuged at 6000 rpm 
(Eppendorf centrifuge 5415 C) for 2 min. The pellets were resuspended in a lysozyme-
containing lysis buffer (20mM TrisCl pH8, 2mM EDTA, 1.2% Triton X-100, 20mg/ml 
lysozyme) prepared according to the Council for Scientific and Industrial Research (CSIR) 
for the lysis of Corynebacterium species, and incubated at 37ºC for 1 hour. Proteinase K (20 
mg/ml) was then added, and incubated for a further 1 hour. Hereafter, the standard kit 
protocol was followed. Prior to the precipitation step, RNase (10µg/ml) was added and the 
samples were incubated for 20 min at 37ºC. DNA concentration was measured 
spectophotometrically using a Nanodrop (Nanodrop Technologies) and DNA quality was 
assessed by agarose gel electrophoresis using a 0.8% agarose gel in TAE buffer (40mM Tris-
acetate, 0.5mM EDTA) at 5.5 V.cm
-1
 for one hour and visualised using ethidium bromide 



















2.3.3.  Identification of strains  
2.3.3.1. Primers and PCR conditions 
Table 2.1. Primers used in the identification of the probiotic strains 
 
2.3.3.2. PCR reactions  
PCR amplification of the 6 chosen strains was performed using a GeneAmp PCR System 
9700 (Applied Bio Systems).  A 50 µl reaction contained 25 µl Fermentas Master Mix (0.05 
units of Taq DNA polymerase/µl of reaction buffer, 0.4mM of each dNTP), 12.5 pmol of 
each primer (Table 2.1), 200 ng of genomic DNA and 18 µl nuclease free sterile water 
(Fermentas) and were amplified using the conditions below (Table 2.2).  PCR products were 


















acg git acc ttg tta cga ctt Wheeler et al., 1996
Lac 16S-
f
agc agt agg gaa tct tcc a Walter et al., 2001
Lac 16S-
r
cac cgc tac aca tgg ag Walter et al., 2001
lm26-f gat tct ggc tca gga tga acg Kaufman et al., 1997
lm3-r cgg gtg cti ccc act ttc atg Kaufman et al., 1997
OPL-05 acg agg cac
Tilsala-Timisjarvi and 
Alatossava, 1998
PL-1 acg cgc cct
Tilsala-Timisjarvi and 
Alatossava, 1998
16-1A gaa tcg cta gta atc g Tannock et al., 1999
23-1B ggg ttc ccc cat tcg ga Tannock et al., 1999
mapA-f








mapA gene fragment 600 53



























Table 2.2. Polymerase chain reaction conditions 
 
2.3.3.3. Cloning of PCR products for sequencing 
The PCR products were purified using the Biospin PCR Purification kit (Bioflux, Japan) as 
per manufacturer’s instructions, and the pure products were ligated into the pTZ57R/T vector 
(Fermentas) and transformed into E. coli DH5α. Colony PCR was used to confirm the 
presence of the correct construct and  three of these plasmids were sequenced using the M13-
forward and reverse primers.  
In the case of the 16S-23S intergenic spacer region (ITS) PCR however, the smallest band of 
the Lactobacillus species and the only band of the Bifidobacterium was excised from the 
agarose gel and the fragment extracted using the Biospin Gel Extraction kit (Bioflux, Japan), 
and cloned as described above. Plasmid extraction and determination of the nucleotide 
sequence data was done by Macrogen Inc., Seoul, Korea. Further sequence analysis and 
editing was carried out using the DNAman software programme (Lynnon Biosoft, version 
4.13). The closest match of the product was determined by searching the GenBank and NCBI 
databases using the BLAST algorithm (Altschul et al., 1997). A similarity of 97% or more to 
96°C 95°C 55°C 72°C 72°C
2 min 30 sec 30 sec 1.5 min 3 min
94°C 94°C 56°C 68°C 68°C
5 min 30 sec 20 sec 40 sec 7 min
94°C 94°C 57°C 68°C
5 min 30 sec 30 sec 1.5 min
94°C 94°C 55°C 72°C 72°C
2 min 30 sec 1 min 1 min 10 min
94°C 94°C 37°C 72°C 72°C
2 min 15 sec 30 sec 2 min 10 min
94°C 94°C 53°C 72°C 72°C


































the 16S rRNA gene sequences of type strains was used as a basis for identification. 
Phylogenetic analysis was performed using MEGA (version 4; Tamura et al., 2007). 
 
2.3.3.4. Optimisation of randomly amplified polymorphic DNA (RAPD) 
PCR (Guan et al., 2003). 
A single, pure colony was picked and resuspended in 1 ml of nuclease free water (Fermentas) 
and was added to a 2ml screw cap eppendorf containing 0.1 mm sterile zirconia/silica beads 
and bead beaten for 70, 100 or 140sec at 4800 oscillations/min using a Mini-Beadbeater-1 
(Biospec Products, Oklahoma, U.S.A). 140 sec bead beating was found to be optimal for cell 
shearing. PCR reactions were set up using this sheared cell suspension and the standard 
RAPD PCR conditions and primers were used. For optimisation purposes, the reaction 
mixtures varied.  
 A 25 µl reaction contained 2.5 µl 10 X PCR buffer, 200 µM concentration of each 
deoxynuleoside triphosphate, 2mM MgCl2, 12.5 pmol each primer, 0.25U Taq DNA 
polymerase (Fermentas), and 0.5, 1 or 1.5 µl cell supernatant  
 A 25 µl reaction contained 12.5 µl Kappa Ready Mix (0.05 units of Taq DNA 
polymerase/µl of reaction buffer, 0.4mM of each dNTP), 12.5 pmol of each primer, 
and 0.5, 1 or 1.5 µl cell supernatant.   
 A 25 µl reaction contained 12.5 µl Fermentas Master Mix (0.05 units of Taq DNA 
polymerase/µl of reaction buffer, 0.4mM of each dNTP), 12.5 pmol of each primer, 
and 0.5, 1 or 1.5 µl cell supernatant. 
 A 25 µl reaction contained 1x buffer B (at 1.5mM magnesium chloride), 0.2mM 
dNTP mix, 2mM MgCl2, 12.5 pmol each primer, 0.5U Kapa2G Robust Taq (Kapa 
Biosystems, R.S.A.), and 0.5, 1 or 1.5 µl cell supernatant. 
For reproducible results, this procedure was repeated at least twice. 
2.3.3.5. API identification 
API strips specific for anaerobic bacteria and Lactobacillus species, 50CHL  were used to 
identify the six chosen strains. The methods followed the manufacturers’ (Biomérieux, 















Scientific) for 48 hours, and results were analysed using the API software (API Plus V 3.3.3 
software). 
2.3.4. Characterisation of strains 
2.3.4.1. Bile salt and acid tolerance assay 
The bacterial strains were tested for their ability to grow in the presence of Ox bile salts 
(LP0055, Oxoid – sodium glycholate and sodium taurocholate at 1%, 2% and 3% (w/v)) and 
at low pH ranging from 1-3 using a 50% solution of concentrated HCl added to MRS broth. 
An overnight culture of the test strain was adjusted to OD600 = 0.5, and used to inoculate 20 
ml of MRS-Cys broths at different pH or bile salt concentrations and incubated anaerobically 
at 37°C. MRS-Cys broth was used as the control. The absorbance was read at 620nm and 
560nm for the acid and bile tolerance assays, respectively. Readings were taken every 2 h for 
the first 8 h and finally at 24 h in a S1000 Diode Array Spectrophot meter (Labotec).  
2.3.4.2. Autoaggregation assays with probiotic strains  
Overnight cultures of the probiotic strains were harvested by centrifugation at 3,200 x g at 
4°C for 10 min (Eppendorf, centrifuge 5415 C). The cells were washed three times with PBS 
buffer and resuspended in 1 ml of the same buffer and adjusted to A600 = 0.25 (approximately 
10
8
 cfu/ml). Each strain and probiotic combination was incubated at 20 °C and the 
absorbance was monitored after 1, 2, 4 and 20 h of incubation. When autoaggregation was 
measured in a combination of probiotic mixes, equal volumes of cell suspensions (A600  = 
0.25) were mixed in a 1:1 ratio. The percentage aggregation was calculated as follows using 
the formula [(Atime – Amix)/ Atime] x 100, where Atime represents the absorbance of the mix 
containing the probiotic at time 0 h, and  Amix represents the absorbance of the culture at 
different incubation times.  
2.3.4.3. Bacterial coaggregation analysis 
Cells of probiotic and pathogen cultures were harvested as described for autoaggregation. 
Equal volumes of pathogen and probiotic strains (1:1 v/v) were mixed and incubated at 20 °C 
without agitation. Again, the absorbance was monitored at 1, 2, 4 and 20 h and the 
percentages of coaggregation were calculated as [(Apath + Aprob)/2 – (Amix)/(Apath + Aprob)/2] x 
100, where Apath  and Aprob represent  A600 of the separate bacterial suspensions in control 















incubation times. The results of the auto- and coaggregation assays were expressed as the 
average of four experiments (n=4), each experiment performed in quadruplicate to correct for 
intra-assay variation.  
2.3.4.4. Mucous adhesion assay 
Chicken intestinal mucous from different regions of the small and large intestine (duodenum, 
ileum, jejunum, colon and caecum) was collected as previously described (Ouwehand, et al., 
2002) and stored at -80°C until use. Before use the protein concentration of the mucous was 
determined and diluted to 0.5 mg/ml in HEPES (N-2-hydroxyethylpiperazine-N-2-
ethanosulphonic acid)-Hanks buffer (HH; 10 mM HEPES, pH7.4). 100 µl of this was 
immobilized into polystyrene microtitre plate wells (Maxisorp, Nunc, Roskilde, Denmark) by 
incubation at 4°C for 18 h. Radiolabelled bacteria were collected by centrifugation at 6000 
rpm for 7 min and washed twice with PBS and the absorbance (A600) was standardized to 
0.25.  Of this, 100 µl was added to the wells and incubated at 37°C for 1 h. The wells were 
washed twice with 200µl HH buffer to remove unattached bacteria and the adhering bacteria 
were released and lysed  by incubation with 1% (wt/vol) sodium dodecyl sulphate in 0.1M 
NaOH (200 µl per well) and incubation at 60°C for 1 h. The contents of each tube were added 
to 1 ml of scintillation liquid (OptiPhase “HiSafe 3”, Wallac, Milton Keynes, UK) in a 
microcentrifuge tube and the radioactivity was measured by liquid scintillation. Adhesion 
was expressed as the percentage of radioactivity recovered after adhesion relative to the 
radioactivity of the bacterial suspension added to the immobilized mucous. Adhesion was 
determined in three independent experiments, and each assay was performed in triplicate. 
2.3.4.5. Inhibition of pathogen adhesion 
To test the ability of the probiotic strains to competitively exclude the pathogens, 100 µl 
unlabelled probiotic strains were added to wells containing immobilized mucous and 
incubated for 1 h at 37°C. Nonbound probiotics were removed by washing the wells twice 
with PBS and adding 100 µl radiolabeled pathogens and incubating for a further hour at 
37°C. The wells were then washed to remove unbound labeled bacteria, and bound bacteria 
were released and lysed by addition of 1% (wt/vol) SDS in 0.1 M NaOH and incubation at 
60°C for an hour. Radioactivity was measured by liquid scintillation.  The results were 
calculated as the percentage of radioactivity recovered after adhesion relative to radioactivity 















measured as the difference in adhesion of the pathogen in the absence versus the presence of 
the probiotics. This assay was done in triplicate and in three independent experiments. 
2.3.4.6. Displacement of pathogens 
The ability of the probiotics to displace already adhered pathogens was tested as follows. 
Radiolabeled pathogens were added to the wells containing immobilized mucous and 
incubated for 1 h at 37°C. The wells were washed to remove unbound pathogens, and 100 µl 
of non-radiolabeled probiotics were added and the plates were incubated at 37°C for 1 h. The 
wells were washed, the bound bacteria released and lysed and radioactivity measured with 
liquid scintillation. The percentage of displacement of pathogens was calculated as the 
difference in adhesion before versus after addition of probiotics. Experiments were carried 
out in triplicate. 
2.3.4.7. Inhibition by competition assay 
Equal quantities of bacterial suspension of probiotic and radiolabeled pathogens were mixed 
and added to the immobilized mucous. This was incubated for 1 h at 37°C. The cells of the 
pathogen bound to the mucous were released and lysed as above. The competitive inhibition 
of the probiotics was measured as the percentage of pathogens bound after the combination 
with probiotic combinations relative to pathogens bound in the absence of probiotic strains 
(control).  
2.3.4.8. Antimicrobial properties  
Five µl of a pure overnight culture of the test strain was spotted in duplicate onto MRS-Cys 
agar plates and incubated anaerobically for 48h at 37ºC. The colonies obtained were killed by 
exposure to chloroform for 20min. Hereafter, the plates were overlaid with 6ml 0.75% sloppy 
agar inoculated with a calculated volume of the indicator strain (Table 2.3) and incubated 
under the respective conditions, suitable to the indicator strain for 48h. This experiment was 
done in triplicate. The zones of inhibition were calculated as the distance between the total 






























2.3.4.9. Enzyme assays  
Modified BYG plates (Table 2.4) were used to assess the enzymatic properties of the strains. 
Five µl of a pure overnight culture was spotted onto the BYG agar with various substrates 
added, and incubated anaerobically at 37ºC for 48 h. All colonies, except those on the casein 
plates, were scraped off with a glass spreader under running water and tested for enzymatic 
activity.  
In addition to these modified BYG agar plate tests, the API strips gave information on production of 














E. coli ATCC25922 OD600 x µl = 4 Luria agar Aerobic 
S. typhimurium OD600 x µl = 4 Luria agar Aerobic 
S. typhimurium 
(sewerage) 
OD600 x µl = 4 Luria agar Aerobic 
S. aureus OD600 x µl = 160 Luria agar Aerobic 
C. botulinum OD600 x µl = 160 BHI agar Anaerobic 
C. perfringens OD600 x µl = 160 BHI agar Anaerobic 
E. faecium vanR OD600 x µl = 160 BHI agar Anaerobic 
















Table 2.4. Analysis of enzyme activities on specific BYG substrate agar plates  
Test Substrate/100ml BYG Treatment Positive result 
Cellulase 1 g carboxy-methyl-cellulose 
(CMC) 
16 min with 0.1% Congo red, 
destain 1M NaCl/flood with 
Bromocresol blue 2min 
Yellow zone 
  
      
Xylanase 
0.1% xylan, 0.025% 
cellobiose 16 min with 0.1% Congo red, 
destain 1M NaCl/flood with 
Bromocresol blue 2min 
Yellow zone 
   
      
Inulinase 1% raftiline 
16 min with 0.1% Congo red, 
destain 1M NaCl/flood with 
Bromocresol blue 2min 
Yellow zone 
   
      
Pectinase 0.5% pectin Flood 1% cetyl-triammonium 
Bromide (CTAB) 40min 
Zone of clearing on 
clouded agar     
Protease 1-2% casein No staining White ppt around 
colonies       
Phytase 2% (w/v) sodium phytate 
Flood 2% cobalt chloride 5min, 
flood with equal volume 6.25% 
ammonium molybdate and 
0.42% ammonium vanadate 




    
Amylase 0.2% soluble starch Flood Gram's iodine Zone of clearing on 


















2.3.4.10. Antibiotic resistance  
The antibiotic resistance profiles of the probiotics against 10 antibiotics were determined 
using the standard Kirby-Bauer disk diffusion method. The following antibiotics discs were 
used: vancomycin (5µg), kanamycin (30µg), cephalothin (30µg), ampicillin (10µg), penicillin 
G (10 units), rifampicin (5µg), streptomycin (10µg), tetracycline (30µg), erythromycin 
(15µg) and chloramphenicol (30µg;Oxoid Ltd, Basingstoke, UK). The probiotic strains were 
grown in MRS-Cys broth for 18 h under anaerobic conditions. The overnight culture was 
adjusted to A600 = 0.25 and 100 µl of this was spread plated onto MRS-Cys agar. Each 
antibiotic was tested in duplicate and each plate was repeated in triplicate.  The plates were 
incubated for 48 h under anaerobic conditions and the diameter of the zone of inhibition 
around each disk was measured.  
2.3.4.11. Tolerance of probiotic strains to antibiotic tylosin 
100µl of a pure overnight culture of the probiotics strains were separately spread plated onto 
MRS-Cys agar plates. An inverted blue eppendorf tip was used to bore holes into this agar 
and the agar plugs were removed. 100µl of various concentrations of tylosin (10, 20, 30 and 
40 mg/l water) were added to these wells, in duplicate and the plates were incubated for 48h 
anaerobically. Each plate was done in triplicate.  
2.3.4.12. Thermotolerance assay  
A single, pure colony of the five probiotic strains were separately inoculated into 5ml MRS-
Cys broth and incubated anaerobically overnight to ensure the cells were in stationary phase. 
The purity of the cultures was tested and the cells collected by centrifugation at 10000 g for 
10 min (Eppendorf, centrifuge 5415 C). The pellets were resuspended in 2 ml PBS and 
incubated at 37°C, 50°C, 60°C and 80°C for 10 min. Serial dilutions were made of the 
control and of the heat treated suspensions and 100 µl was plated separately onto MRS-Cys 
agar. Each treatment was plated in triplicate.   
2.3.4.13. Statistics 
Statistical analysis was performed using the SPSS 11.0 software (SPSS Inc, Chicago, IL, 
USA). Data were subjected to one-way analysis of variance (ANOVA) and the post-hoc test 
as Student-Newman-Keuls (S-N-K) test was used for comparison of the means, where 















2.4. Results and Discussion 
2.4.1. Identification of isolates  
The molecular identification of five potential probiotics isolated from ostrich faeces and 
intestines using the API 50 CHL as well as by the amplification of extracted genomic DNA 
using various primers is shown in Table 2.5. The API 50 CHL strips identified three of the 
five strains as L. plantarum (99.9%) and one as  L. acidophilus with a low certainty of 85.6% 
(Table 2.5). The fifth strain Bp303.3.2 was not identified using the API 50 CHL strips as it 
had been previously identified as belonging to Bifidobacterium spp. The identity of Lr136.2.2 
did not match the identity previously reported as L. reuteri. Previous work on bacterial 
identification using the API system has reported the incorrect identification of lactobacilli 
species as L. acidophilus (Klein et al., 1998; Boyd et al., 2005). In addition, Brolazo et al. 
(2011) found that L. reuteri detected using multiplex PCR, was not detected using the API 
system, suggesting L. reuteri is not on the API database. Although the API system is a rapid 
means of identifying large numbers of samples, this limited database, together with the 
inability to distinguish between closely related species, leaves molecular techniques to be the 
preferred method of identification. 
For future confirmation of identity of isolates the reliability of the Lactobacillus specific 
primers, Lac 16S-f and Lac 16S-r, and the Bifidobacterium-specific primers, lm 26-f and lm 
3-r (Table 2.1) were tested. Both primer sets showed species specificity, giving product sixes 
of approximately 350 bp and 1400 bp respectively, and were sequenced with their respective 
forward primers only (Table 2.5). Sequencing results confirmed the identity of the three L. 
plantarum strains, however, this method of identification correctly identified Lr136.2.2 as L. 
reuteri. Bp303.3.2 was also identitifed as B. pseudolongum subsp. pseeudolongum.  
2.4.1.1. 16S rRNA gene PCR 
The extracted genomic DNA from the potential probiotic strains was used as a template for 
16S rRNA gene PCR using the universal primers F27 and R5 (Table 2.1). The products 
obtained were approximately 1.5 kb and the nucleotide sequences were determined in both 
directions. Lp1.1.2.2, Lp6039.3 and Lp162.2 were identified as Lactobacillus plantarum with 
100% similarity to sequenced L. plantarum (Accession numbers HQ286594.1, FJ763580.1, 















(Accession number HM162424.1) and strain Bp303.3.2 was found to share 99% similarity to 
Bifidobacterium pseudolongum subsp. pseudolongum (Accession number AY174106.1).    
Table 2.5. Preliminary identification of the five isolates 
 
In addition, the sequences obtained from the 16S rRNA genes were used for further analysis 
in the construction of bootstrap neighbour-joining phylogenetic trees (Fig. 2.2). Phylogenetic 
analysis was carried out separately for the Lactobacillus spp. (Fig. 2.2a), as it was for the 
Bifidobacterium spp. (Fig. 2.2b).  
Strain API 50 CHL 16S Lac-
specific 
16S 
Bif-specific 16S ITS mapA 










































Lr136.2.2 L. acidophilus 
(85.6%) 










































The analysis of the selected Lactobacillus spp. clustered as expected, Lp1.1.2.2, Lp6039.3 
and Lp162.2 (all identified as L. plantarum; Table 2.5) grouped closely with L. plantarum 
type strain, and L. paraplantarum (Fig. 2.2a), suggesting the probiotic isolates are very 
closely related to the type strain, and fall into the L. plantarum group of Lactobacillus spp. 
Similarly, Lr136.2.2 (identified as L. reuteri; Table 2.5) also grouped closely to its respective 
type strain, but is not as closely related as the L. plantarum strains are to their type strain. 
Lr136.2.2 fell under the L. reuteri groups of Lactobacillus spp. 
 
Figure 2.2a. Bootstrap consensus neighbour-joining phylogenetic tree using 16S rRNA gene 
sequences from the Lactobacillus species selected for characterisation as well as from type 
strains L. plantarum AJ965482, L. paraplantarum DSM10667, L. brevis M58810, L. 
animalis AB326350, L. ruminis AB326354, L. casei ATCC393, L. rhamnosus JCM1136, L. 
mucosae DSM13345, L. oris DSM4864, L. pontis LTH2587, L. reuteri L23507, L. gasseri 
ATCC33323, L. johnsonii ATCC33200, L. delbrueckii ATCC12315, L. intestinalis 
DSM6629 and L. acidophilus AY773947. Bootstrap values are shown at the nodes and 
represent 5000 iterations.  
The Bifidobacterium spp. strain Bp303.3.2 isolated from ostriches was identified as B. 
pseudolongum subsp. pseudolongum (Table 2.5) and clusters close its type strain and closely 
related B. pseudolongum subsp. globosum. (Fig. 2.2b). Leblond-Bourget et al. (1995) 
reported that the V1, V2 and V3 regions of the 16S rRNA region of Bifidobacterium  have a 
similarity of 82 to 99% and it has been recommended to amplify other regions such as the 
16S-23S intergenic spacer regions for better identification (Felis et al., 2001).  
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Figure 2.2b. Bootstrap consensus neighbour-joining phylogenetic tree using 16S rRNA gene 
sequence from the Bifidobacterium species Bp303.3.2, selected for characterisation, as well 
as from type strains B. adolescentis ATCC 15703, B. ruminatium JCM8222, B. longum 
ATCC15697, B. breve ATCC15700, B. bifidum KCTC3202, B. animalis AB050136, B. 
pseudolongum subsp. globosum JCM5820 and B. pseudolongum subsp. pseudolongum 
ATCC25526. Bootstrap values are shown at the nodes and represent 5000 iterations.  
 
In order to discriminate between strains of the same species, less conserved regions like the 
16S-23S intergenic spacer region (ITS) and the mapA genes were used to confirm the 
identities of the isolates. All the methods used here confirmed the identification of the strains. 
Amplification of the 16S-23S intergenic spacer region (ITS) allowed a method to distinguish 
the probiotic strains from themselves and from a mixed microbial population using the 
fingerprint obtained. This is due to the hypervariable nature of the intergenic region 
compared to the 16S or 23S rRNA genes (Barry et al., 1991). ITS-PCR of the five strains 
used in this study showed the typical fingerprint pattern, reported by Moreira et al. (2005), 
Lactobacillus having three bands, and Bifidobacterium having one (results not shown). The 
differing number of bands correspond to the short, medium and long spacer regions, are due 
to insertions of tRNA-Ala in the medium spacer regions, and tRNA-Ala and tRNA-Ile in the 
long spacer regions. Excision, amplification and sequencing of the small spacer region of the 
Lactobacillus strains allowed for confirmation of the identification of the strains found using 
the 16S rRNA gene (Table 2.5). The advantage of using ITS-PCR is its high discriminating 
power, for example, being able to differentiate between L. casei and L. rhamnosus, not 
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possible using 16S V2-V3 sequences (Tannock et al., 1999). The phylogenetic analysis of the 
probiotic strains showed the intergenic spacer region of Lp162.2 to be most closely related to 
the L. plantarum type strain (Fig. 2.3a). The other L. plantarum strains of ostrich origin were 
also closely related to the type strain.  
 
Figure 2.3a. Bootstrap consensus neighbour-joining phylogenetic tree using 16S-23S 
intergenic rRNA gene sequence from the Lactobacillus species selected for characterisation 
as well as from type strains L. plantarum AJ965482, L. brevis M58810, L. casei ATCC393, 
L. rhamnosus JCM1136, L. mucosae DSM13345, L. panis DSM6035, L. reuteri L23507, L. 
johnsonii ATCC33200 and L. acidophilus AY773947. Bootstrap values are shown at the 
nodes and represent 5000 iterations.  
Similarly, the phylogenetic analysis of Bp303.3.2 showed it to be very similar to its type 
strain as seen in Fig. 2.3b.  
 
Figure 2.3b. Bootstrap consensus neighbour-joining phylogenetic tree using 16S-23S rRNA 
gene sequence from the Bifidobacterium species Bp303.3.2, selected for characterisation, as 
well as from type strains B. adolescentis ATCC 15703, B. breve ATCC15700, B. bifidum 
KCTC3202, B. animalis AB050136, B. pseudolongum subsp. globosum JCM5820 and B. 
pseudolongum subsp. pseudolongum ATCC25526. Bootstrap values are shown at the nodes 
and represent 5000 iterations.  
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Amplification of the mapA gene in the potential probiotic strains using degenerate primers 
gave a product of approximately 400bp for the four lactobacilli strains, but no product for the 
Bifidobacterium Bp303.3.2, suggesting that the sequence of this gene in Bifidobacterium spp. 
is very different to that of Lactobacillus, to which these primers were designed. The primers 
used were degenerate primers designed to the mapA sequences of L. plantarum 423 (Ramiah 
et al., 2007) and L. reuteri NCIB 11951 (Miyoshi et al., 2006). The multiple alignment of this 
gene (data not shown) showed the three L. plantarum strains to be identical in this region and 
Lr136.2.2 to have six mismatches when compared to the L. reuteri type strain.  These 
sequences were therefore no use for the design of unique primers for accurate identification 
of the strains.  
The mapA gene encodes a protein thought to enhance the adhesion of the bacteria to mucin in 
the gut (Rojas et al., 2002). Adhesion to the mucosal layer is an important criteria in selecting 
probiotics (Kun Lee, 2009), and the detection of the mapA gene w uld give an indication as 
to the likelihood of the strain successfully adhering to the gut wall of the ostrich.  
 
2.4.1.2. RAPD  
RAPD analysis has been frequently used for molecular fingerprinting and allows rapid, 
specific, immediate identification of strains (Manan et al., 2009). This technique allowed for 
detection of fed probiotics during the feeding trial. Optimisation of the method was needed as 
the PCR was performed on colonies which had been freshly isolated from faecal samples. 
Bead beating the colonies for 140 s and amplification using Kapa2G Robust Taq (Kapa 
















Figure 2.4. Optimisation of RAPD-PCR using different volumes of template and different 
master mixes using the same freshly isolated colony from a faecal sample, picked from an 
MRS agar plate. Lanes 4, 7, 10 and 13 used 0.5µl template; lanes 5, 8, 11 and 14 used 1 µl 
template and lanes 6, 9, 12 and 15 used 1.5 µl template. Lane: M, λPstI molecular weight 
marker; 1, OPL5 primer only control; 2, PL1 primer only control; 3, no template DNA 
control; 4-15, colony suspension in the above specified volumes, using the master mixes 
indicated above the respective lanes with primers OPL5 and PL1.   
 
The sensitivity of the PCR was determined using genomic DNA of Lp6039.3 at amounts 
ranging from 20 ng to 200 ng using RAPD primers OPL05 and PL1 (Fig. 2.5). This was done 
to estimate at what level the strain would have to be present in the faeces to be detected using 
this method. Although 20 ng of DNA was detected, the best PCR yield was obtained using 
100 ng DNA.  
























Figure 2.5. Sensitivity of RAPD-PCR using Kapa Robust Taq on different amounts of 
template DNA extracted from Lp6039.3.  M. λ DNA digested with PstI; Lane 1. Primer 
OPL05; Lane 2. Primer PL1; Lane 3. No template control; Lane 4. 20 ng DNA; Lane 5. 40 ng 
DNA; Lane 6. 60 ng DNA; Lane 7. 100 ng DNA; Lane 8. 200ng DNA. 
 
Colonies of each probiotic were amplified with Kapa 2G Robust Taq (Kapa Biosystems, 




Figure 2.6. RAPD PCR 
amplification of DNA extracted from 
the five potential probiotic strains 
using Kapa Robust Taq. M. λ DNA 
digested with PstI; Lane 1. Primer 
OPL05 with DNA obtained from 
Lp162.2.2; Lane 2. Primer PL1 with 
DNA obtained from Lp162.2.2; 
Lanes 3-8: Primers OPL05 and PL1 
with: Lane 3. No template control; 
Lane 4. Lp162.2; Lane 5. Lp6039.3; 
Lane 6. Lr136.2.2; Lane 7. Lp1.1.2.2; 
Lane 8. Bp303.3.2.   
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The patterns obtained for the three L. plantarum strains, Lp162.2.2, Lp6039 and Lp1.1.2.2 
are the same, as expected (although the top band in sample Lp6039 is much fainter than for 
Lp162.2.2 and Lp1.1.2.2; Fig. 2.6). L. reuteri and B. pseudolongum subsp. pseudolongum 
give unique fingerprints too. This confirms that this technique can discriminate between 
species but not between the same strains, and is a successful method for the differentiating 
between different Lactobacillus isolated from the ostriches.  
 
2.4.2. Characterisation of isolates 
 
2.4.2.1. Acid and bile tolerance assays 
To confirm that the probiotic strains would survive the acid and bile levels encountered in the 
ostrich gut, in vitro tests were used to monitor the strains survival at different concentrations 
of bile and decreasing pH.   
The growth of the five strains in both acid and bile showed similar trends. The three L. 
plantarum strains showed no decrease in growth in MRS at pH3 when compared to the 
control at pH 6.5 – 6.8. However, they did show reduced growth at pH 1 and 2 (Fig. 2.5). 
Increasing bile concentrations showed the same pattern as the decreasing pH, 2% and 3% bile 
inhibiting the growth of the L. plantarum strains slightly (Fig. 2.7). The L. reuteri and B. 
pseudolongum subsp. pseudolongum showed severely decreased growth in both acid and bile, 
and no growth was seen in the 6 hour time at pH1 and 3% bile. (Fig. 2.7 and 2.8). Acid and 
bile tolerance are considered intrinsic properties of LAB (Ouwehand et al., 2002). 
Bifidobacterium spp. are considered to be less acid tolerant than some Lactobacillus spp. 
(Dunne et al., 1999), however, the effect of bile on the B. pseudolongum in this study is 
surprising. Bile salt hydrolase (BSH) is reported to have been first isolated from 
Bifidobacterium spp., L. acidophilus, L. gasseri, L. johnsonii and some L. plantarum 
(Bergley et al., 2004), and it would therefore be expected that the B. pseudolongum used here 
would be more tolerant to bile. However, Margolles et al. (2002) tested 19 Bifidobacterium 
strains and found the MICs to range from 0.125% to 2%. At 2% bile, the bifidobacteria in this 
study still showed some growth (Fig. 2.8). Stress tolerances to low pH and the presence of 
bile are reported to be strain specific and generalisations regarding the tolerances of species 















GIT have been shown to be more tolerant to acid and bile, and it is common to observe a 
“cross-resistance” to both of these conditions (Noriega et al., 2004). It is believed that these 
tolerances can be either intrinsic or acquired (Margolles et al., 2002; Noriega et al., 2004). 
Margolles et al. (2002) obtained sodium-cholate-resistant Bifidobacterium strains by slowly 
exposing them to gradually increasing concentrations of this compound. Similarly, Collado 
and Sanz (2006) discovered a method of direct selection of acid-tolerant Bifidobacterium spp. 
by exposing human faecal samples to prolonged stressful conditions. These acid-resistant 
strains were also found to tolerate high concentrations of bile salt and NaCl.  Given the 
strain-specific resistance profiles of bacteria and the incomparable results of in-vitro stress 
tests (Bergley et al., 2004), all potential probiotics should be tested, and preferentially in 
conditions closely representing that of the conditions found in the GIT of the animal to be 

















































































































Figure 2.7. Growth of bacterial 
isolates in MRS broth (pH 6.5-6.8) 
and MRS adjusted to pH1, 2 or 3 
using hydrochloric acid. Error bars 
represent the mean ± standard error, 

















2.4.2.2. Measurement of aggregation properties between probiotic and 
pathogens 
The ability of the strains to autoaggregate, as well as coaggregate with pathogenic bacteria 
was evaluated using the in-vitro measure of radioactivity developed by Collado et al. 
(2007a). Aggregation is considered to be an important property of probiotics, enabling them 
to achieve an adequate mass to manifest their beneficial properties (Collado et al., 2007b). 
The ability to co-aggregate with other bacteria may offer probiotics an additional advantage 
over those which do not have this ability, allowing them to persist in the gut rather than being 
easily removed (Collado et al., 2007b). Furthermore, the inhibitor-substances of bacteriocin-
producing LAB, which aggregate with pathogens, may constitute an important host defence 
mechanism against infection (Spencer and Chesson, 1994). The results obtained for the auto- 










































































































Figure 2.8. Growth of bacterial 
isolates in MRS broth supplemented 
with !5, 2% and 3% Ox bile. Error 
bars represent the mean ± standard 















Table 2.6. The results are displayed as the autoaggregation of the probiotic strain, followed 
by the coaggregation results with each of the four pathogens tested  
 
Table 2.6.Aggregation of probiotic strains with pathogens over 20 hours of incubation (%)
Time in Hours 
  0 1 2 4 20 
Lp1.1.2.2 0.0±0.0 4.6±0.4 22.9±3.5 21.5±4.9 57.4±8.0 
 + C.difficile 0.0±0.0 7.4±1.3 19.5 39.6±5.6 61.3±3.5 
 + C.perfringens 0.0±0.0 10.0±0.06 18.8 24.8±0.1 52.3±0.3 
 + E. coli 0.0±0.0 3.8±0.2 10.1 17.6±0.6 53.0±0.5 
 + S. typhimurium 0.0±0.0 3.9±0.1 9.2±0.2 15.2±0.05 49.2±0.2 
Lp6039.3 0.0±0.0 5.0±0.6 18.4±2.3 21.7±4.7 58.2±6.9 
 + C.difficile 0.0±0.0 5.3±0.4 14.9±0.8 27.8±0.6 60.5±0.4 
 + C.perfringens 0.0±0.0 4.4±0.5 11.1±0.4 22.8±0.1 60.8±0.5 
 + E. coli 0.0±0.0 2.9±0.2 9.8±0.3 22.8±0.6 59.7±0.4 
 + S. typhimurium 0.0±0.0  0.0±0.0 4.5±0.2 14.1±0.5 55.2±0.5 
Lp162.2 0.0±0.0 8.0±4.4 13.4±0.7 19.0±3.0 55.4±5.5 
 + C.difficile 0.0±0.0 6.1±0.5 10.0±0.6 19.2±0.6 56.8±0.6 
 + C.perfringens 0.0±0.0 7.5±0.3 11.7±0.3 23.3±0.4 57.1±0.6 
 + E. coli 0.0±0.0 6.4±0.1 10.5±0.4 18.5±0.4 56.5±0.6 
 + S. typhimurium 0.0±0.0 6.3±0.4 9.6±0.2 19.9±0.1 56.6±0.2 
Lr136.2.2 0.0±0.0 4.6±0.1 13.1±1.4 21.4±5.5 60.3±7.8 
 + C.difficile 0.0±0.0 7.4±1.3 19.5±0.1 39.6±5.6 61.3±3.5 
 + C.perfringens 0.0±0.0 10.0±0.1 18.8±0.1 24.8±0.1 52.4±0.3 
 + E. coli 0.0±0.0 3.8±0.2 10.1±0.2 17.6±0.6 53.0±0.5 
 + S. typhimurium 0.0±0.0 3.9±0.1 9.2±0.2 15.2±0.0 49.2±0.2 
Bp303.3.2 0.0±0.0 3.9±0.2 15.9±2.4 21.2±5.5 58.8±7.8 
 + C.difficile 0.0±0.0 1.9±0.2 11.0±0.3 24.5±0.4 59.6±0.9 
 + C.perfringens 0.0±0.0 3.1±0.2 11.1±0.5 22.1±0.2 52.6±0.5 
 + E. coli 0.0±0.0 0.3±0.0 8.0±0.2 23.6±0.2 58.9±0.5 
 + S. typhimurium 0.0±0.0 0.1±0.0 9.0±0.5 22.9±0.5 56.9±0.5 
5 strain mix 0.0±0.0 5.2±1.1 16.6±2.3 25.6±2.6 64.0±3.3 
 + C.difficile 0.0±0.0 3.5±0.3 13.9±0.3 25.4±1.2 54.3±0.8 
 + C.perfringens 0.0±0.0 5.0±0.9 14.8±0.5 24.9±0.4 56.5±0.4 
 + E. coli 0.0±0.0 1.0±0.1 7.8±0.4 17.9±0.4 53.2±0.5 















All the probiotic strains showed the ability to autoaggregate and by four hours of incubation 
showed up to 21.7% aggregation. Probiotic properties are species-specific, and as this is the 
first study characterising probiotics of ostrich origin, there is no available literature for 
comparison. However, Collado et al. (2008) showed a commercial L. plantarum strain to 
autoaggregate up to 21.7% after 2 hr and 63.2% after 20 hr. This is similar to results observed 
in this study. The same work by Collado et al. (2008) showed much lower autoaggregation 
ability by B. lactis, a close relative of B. pseudolongum subsp. pseudolongum, aggregating to 
28.8% by 20 hr. The bifidobacteria strain used here, Bp303.3.2, showed a higher 
autoaggregation by this time reaching 58.8%. The five strain probiotic mix showed similar 
aggregation abilities to the single strains and by 20 hours of incubation showed higher 
aggregation (64%) than any of the single strains. Each probiotic showed ability to 
coaggregate with the four tested pathogens after 20 hours of incubation. However, the 
percentage of coaggregation as well as the time required was demonstrated to be strain-
specific (Table 2.6).   This method of measuring aggregation using radioactive labels has 
been shown to be a reproducible and the most sensitive method when compared to using 
fluorescence and absorbance (Collado et al., 2007b).  
 
2.4.2.3. Adhesion of the probiotic strains to chicken mucous and their 
ability to displace and inhibit pathogens 
Adhesion of probiotics to the mucosal surface of the gut is thought to be a prerequisite for the 
beneficial effects to be exerted, as it prolongs their transit in the gut. It is proposed that 
probiotics and their combinations colonise the gut and form a barrier which prevents 
adhesion of pathogens, mainly by competitive exclusion (Collado et al., 2005, 2006, 2007c, 
2008).  Adhesion is a complex occurrence which may involve both a specific ligand receptor, 
and a non-specific mechanism (Vinderola et al., 2003). Cell surface properties of probiotics, 
such as physiochemical and chemical makeup affect their ability to adhere (Boonaert and 
Rouxhet, 2000). The adhesion of each strain to mucous from different areas of the chicken 
gut was tested (Fig. 2.9). Probiotics are thought to be host-specific and therefore, although it 
was not ideal to use chicken mucous, no ostrich mucous was available at this time. Lp6039.3 
adhesion showed similar values for all regions tested, whereas the other two L. plantarum 
strains, Lp1.1.2.2 and Lp162.2, as well as Lr136.2.2, showed slightly better adhesion to 















strains (Lp6039.3, Lp1.1.2.2 and Lp162.2) and the L. reuteri strain showed highest adhesion 
to colonic mucous, reaching 9.5, 11.5, 13.0 and 10.9% respectively (Fig. 2.9). Conversely, 
Bp303.3.2 showed higher adhesion percentage in the small intestine, reaching 13.5% to the 
mucous from the jejunum (Fig. 2.9). Very little literature is available on the distribution of 
microorganisms in the ostrich GIT, however, in the chicken model, Lactobacilli are found in 
their highest numbers in the caeca (Gabriel et al., 2006). It would be expected that the strict 
anaerobes such as the Bifidobacterium species would be found further down in the gut in the 
more anaerobic environment and the facultative anaerobes to be in the less anaerobic 
environment.  
 
Figure 2.9. Adhesion of the five probiotic strains to chicken intestinal mucous preparations 
from five different intestinal areas. Results are expressed as the percentage of radioactivity 
recovered from immobilized mucous compared to radioactivity added to mucous ( Error bars 














































The adhesion of four pathogens was tested against mucous from the same areas as used for 
the probiotic strains (Fig. 2.10).   
 
Figure 2.10. Adhesion of radiolabeled model pathogen strains C. perfringens, C. difficile, E. 
coli and S. enterica serovar Typhimurium to chicken intestinal mucous preparations from 
different intestinal sections. Results are expressed as the percentage of radioactivity 
recovered from immobilized mucous compared to radioactivity added to mucous. Error bars 
represent the mean ± standard error, n = 3). 
 
In general, the pathogens adhered less successfully than the probiotic strains, ranging from 
1.83% (S. typhimurium and caecum mucous) to 5.70% (C. difficile and duodenum mucous; 
Fig. 2.10). C. perfringens and S. typhimurium have the lowest ability to adhere to mucous 
from all areas of the gut, ranging from 1.98% in caecum to 2.72% in the jejunum, and 1.83% 
in caecum to 2.37% in jejunum, respectively. These results confirm work by Collado et al., 
(2007c) where C. perfringens, and S. typhimurium were found to have similarly low adhesion 
abilities to pig intestinal mucous.  On the other hand, E. coli and C. difficile differ from the 
previous two pathogens showing higher adhesion, again confirming work by Collado et al., 
(2007c) which showed a significant increase in the ability of E. coli to adhere to mucous from 
various areas of the pig intestine and a slight increase in the ability of C. difficile to adhere. 
To eliminate the variable, jejunum mucous was chosen for further mechanism studies as 










































2.4.3. Adhesion mechanisms 
2.4.3.1. Inhibition of pathogen adhesion to intestinal mucous 
The adhesion of selected pathogens was significantly (p < 0.05) inhibited by all probiotic 
strains and their mixes in percentages ranging from 24.5% for the three strain mix against S. 
typhimurium, to 67.0% for Lr136.2.2 against C. difficile (Table 2.7A). In general, the 
probiotic combinations showed better abilities to inhibit the pathogen adhesion (Table 2.7A). 
C. perfringens was most effectively inhibited by the two strain mix (Lr136.2.2 and Lp162.2) 
which inhibited its adhesion by 63.29%, and least effectively by Lr136.2.2 on its own, which 
decreased its adhesion by 31.82%. C. difficile was successfully inhibited by all strains and 
their mixes, most effectively by Lr136.2.2 at 67.03%.  E. coli was most effectively inhibited 
by the two strain mix at 58.84%, followed closely by Bp303.3.2 at 56.93%. It was least 
inhibited at 46.63% by the three strain mix. Finally, the five strain mix inhibited S. 
typhimurium 45.16% and the three strain mix by 24.48%.  Bifidobacteria have been shown to 
inhibit a variety of pathogens (Fujiwara et al, 1999) and our work confirms this (Fig. 2.7A). 
These results show that probiotics which adhere well to mucous are not necessarily 
successful at pathogen inhibition and that inhibition is both probiotic and pathogen strain 
specific, confirming previous work (Collado et al., 2005, 2006, 2007c).  
 
2.4.3.2. Displacement of pathogens adhered to intestinal mucous 
C. perfringens, E. coli and S. typhimurium were all significantly (p < 0.05) displaced by 
single probiotics, as well as the different probiotic mixes (Table 2.7B). In contrast, adhered 
C. difficile was displaced by the mixes but not by single probiotics. C. perfringens was more 
successfully displaced by the single strains than by the probiotic mixes, for example 72.67% 
by Lp162.2 compared to 48.55% by the five strain mix. The single strains appeared to 
enhance the adhesion of C. difficile significantly (p < 0.05), whereas it was significantly (p < 
0.05) displaced by the mixes. E. coli was poorly, but significantly displaced by Lr136.2.2 and 
Lp1.1.2.2 at 5.90% and 9.65% respectively, but well displaced by all probiotic mixes, 
especially the three strain mix at 61.99%. S. typhimurium was significantly displaced by all 
strains and mixes, the least being 18.54% by Lp162.2 and 63.13% by the three strain mix. 
Probiotic strains in combination showed less ability to displace the pathogen adhesion than 















differs with increasing ability of the pathogen to adhere to mucous. C. difficile showed the 
best adhesion to jejunum mucous, and the probiotics alone or as a mixture are unable to 
displace it. E. coli showed the next best adhesion with single probiotics offering very low, 
although significant displacement abilities of this pathogen. Again the mixes are more able to 
displace it. S. typhimurium and C. perfringens follow the same trend, showing weak mucous 
adhesion and easy displacement by probiotics.   
 
2.4.3.3. Competitive exclusion to intestinal mucous 
The single probiotic strains were able to inhibit adhesion (p < 0.05) of all the pathogens to the 
intestinal mucous except Lp6039.3 which could only inhibit E. coli (Table 2.7C).  It was 
unable to compete for adhesion with C. perfringens, C. difficile and S. typhimurium. This 
may suggest that including this strain in the probiotic mix would have a detrimental effect on 
the ability to out-compete pathogens, however, the two and three strain combinations (not 
containing Lp6039.3) are also unable to out-compete the pathogens. The five strain probiotic 
mix was also unable to inhibit adhesion (p < 0.05) of any of the pathogens tested, in fact, all 
the different mixes appear to enhance pathogen adhesion. This may be due to the probiotics 
aggregating together and blocking the necessary cell membrane carbohydrate-binding 
adhesins on their cell surfaces (Malago and Koninkx, 2011), making them unavailable for 
blocking the carbohydrate moieties on the intestinal surface. The pathogens can then bind 
freely. C. perfringens and S. typhimurium were best inhibited by Lp162.2 (24.66% and 
52.55%, respectively), and C. difficile and E. coli by Lr136.2.2 (31.22% and 31.06%, 



















Table 2.7. Adhesion inhibition to intestinal chicken mucous of the tested pathogenic strains by the probiotics, alone and in various combinations. 
Results are shown as mean ± standard deviation. 2 strain mix: equal volumes of Lp1.1.2.2 and Bp303.3.2; 3 strain mix: equal volumes of Lp1.1.2.2, 
Lr136.2.2 and Bp303.3.2 
1
 Adhesion of pathogens in the absence of a probiotic (control) was assigned a value of 0% 
2
 Adhesion of preadhered pathogens following the addition of buffer without probiotics (control) was assigned a value of 0% 
3
 Changes in the adhesion of pathogens in presence of probiotics applied simultaneously with pathogen. Control (pathogen adhesion) was assigned a value of 0% 
A % adhesion inhibition
1
   
Pathogen strain Probiotic strain tested  ANOVA 
  Lp1.1.2.2 Lp6039.3 Lp162.2 Lr136.2.2 Bp303.3.2 5 mix 2 mix 3 mix p-value 
C. perfringens 37.09 ± 10.27 37.97 ± 5.32 38.65 ± 2.75 
31.82 ± 
17.71 39.69 ± 12.19 47.04 ± 9.28 63.29 ± 2.22 38.11 ± 28.60 0.004 
C. difficile 51.16 ± 6.04 51.72  ± 6.41 57.91  ± 7.86 
67.03  ± 
12.74 61.64  ± 0.91 61.98  ±5.77 41.47  ± 2.97 55.05  ± 7.38 0.0001 
E. coli 51.65 ± 15.49 48.76 ± 2.88 53.42 ± 12.05 48.62 ± 5.02 56.93 ± 21.39 47.85 ± .070 58.84 ± 9.00 46.63 ± 16.36 0.001 
S. typhimurium 39.86 ± 7.15 32.77 ±  2.74 36.37 ±  8.36 
34.42 ± 
13.76 41.23 ±  14.64 45.16 ± 2.22 43.19 ±  9.94 24.48 ± 6.31 0.005 
B % pathogen displaced
2
   
Pathogen  Probiotic strain tested  ANOVA 
  Lp1.1.2.2 Lp6039.3 Lp162.2 Lr136.2.2 Bp303.3.2 5 mix 2 mix 3 mix p-value 
C. perfringens 
71.21 ±  
12.54 68.72 ±  14.73 
72.67 ±  
15.65 71.10 ±  18.94 
70.62 ±  
11.51 48.55 ±  4.24 56.58 ±  5.66 49.01 ±  9.17 0.0001 
C. difficile 
 -74.11 ±  
5.80 
 -101.88 ±  
15.03 
 -52.62 ±  
5.46 
 -89.32 ±  
27.32 
 -73.87 ±  
5.46 72.77 ±  12.91 63.24 ±  14.87 68.000 ±  16.46 0.0001 
E. coli 
9.65 ± 
0.49 42.95 ±  21.27 14.05 ± 6.44 5.90 ±  4.81 19.22 ±  2.43 52.20 ±  10.12 58.38 ±  12.97 61.99 ±  17.59 0.0001 
S. typhimurium 
54.59 ±  





















C % reduction of adhesion of pathogen by competition
3
   
Pathogen  Probiotic strain tested  ANOVA 
  Lp1.1.2.2 Lp6039.3 Lp162.2 Lr136.2.2 Bp303.3.2 5 mix 2 mix 3 mix p-value 
C. perfringens 
9.10 ±   
0.86  -61.50 ±   45.61 24.66 ±  4.18 15.89 ±  8.35 19.47 ±  7.98  -60.02 ±  38.24  -47.78 ±  63.89  -64.82 ±  2.03 0.026 
C. difficile 
14.98 ±   
1.45  -19.97 ±   12.69 22.30 ±   5.23 31.22 ±  7.38 45.54 ±  3.64  -36.28 ±  5.15  -99.29 ±  52.64  -62.96 ±  3.70 0.0001 
E. coli 
23.44 ±  
14.83 13.84 ±   7.36 
21.18 ±  
10.62 31.06 ±  5.68 43.10 ±  4.29  -27.33 ±  2.25  -134.76 ±  16.32  -46.01 ±  39.74 0.0001 
S. typhimurium 
32.12 ±  
2.00  -17.00 ±  6.86 52.55 ±  3.50 33.48 ±  9.02 
39.37 ±  















2.4.3.4. Antimicrobial action against selected pathogens 
The widespread ability of LAB and bifidobacteria to produce antimicrobial compounds such 
as organic acids, hydrogen peroxide and bacteriocins, infers an important biological role of 
these products (Versterlund, 2009). The activity of the strains against selected pathogens was 
tested by overlaying a colony of the probiotic with the indicator pathogen. Antimicrobial 
activity was indicated by a zone of inhibition and the area of this zone is represented in Fig. 
2.11.  
 
Figure 2.11. Antimicrobial properties of the probiotic strains measured by the area of the 
zone of inhibition produced against each indicator pathogen strain. Results shown as the 
mean zone of inhibition± standard error, n = 3.  
 
All five strains showed high activity against S. typhimurium, a major pathogen in poultry 
(Gong et al., 2005), but much less activity against the Clostridium spp. particularly C. 
perfringens (Fig. 2.11). The three L. plantarum strains were active against all tested 
pathogens except C. perfringens, and S. aureus where Lp162.2 did not produce a zone of 
inhibition (Fig. 2.11). Lr136.2.2 was however, the only probiotic strain tested here to show 
antimicrobial activity against C. perfringens, considered to be one of the most important 
pathogens in ostrich farming. Bp303.3.2 showed antimicrobial activity against all pathogens 
except C. perfringens, C. botulinum and S. aureus. Its maximum activity was against S. 

















































Further studies on the antimicrobial agents produced here, indicated that the activity was not 
due to bacteriocins as protein fractions did not show zones of clearance when overlaid with 
the indicator strain (data not shown). The production of acid compounds was thought to be 
the active compound as when the supernatant of the respective probiotics was neutralised (pH 
7), no antimicrobial activity was noted (data not shown). Treatment of these supernatants 
with catalase gave no change in activity and it was therefore concluded to not be due to 
hydrogen peroxide. In addition to the pH effect which lactic acid has on the cytoplasm of 
cells (Eschenbach et al., 1989), the acid is reported to collapse the electrochemical proton 
gradient, causing bacteriostasis and finally death of susceptible bacteria (Eklund, 1989).  
 
2.4.3.5. Enzyme assays 
To test the ability of each strain to utilise particular substrates, each isolate was spotted in 
triplicate onto agar containing various substrates and zones of clearance were detected using 
the appropriate staining (Table 2.3). The results are shown in Table 2.8. All strains were able 
to utilise starch, cellulose and protein. None of the probiotics in this study were able to digest 
lipids or inulin. Lr136.2.2 was also unable to utilise phytic acid and Bp303.3.2 was unable to 
degrade xylan, phytic acid, pectin and had very limited ability to degrade cellulose (Table 
2.8). 
Table 2.8. The area of the zones of clearance produced by the isolates on BYG basal medium 
supplemented with specific substrates. The values are the average of three replicates.  
 
The ability to hydrolyse phytic acid is considered important in animal farming as this acid, 
found naturally in plants and seeds, forms metal-phytate complexes (Oh et al., 2004) which 
are indigestible to most animals and may lead to dietary deficiencies. Young farmed birds 
often suffer from soft bones and apparent rickets (Cooper and Gimbi, 1994) and hence 
Enzymes
Lp1.1.2.2 Lp6039.3 Lp162.2 Lr136.2.2 Bp303.3.2
Amylase 15 18.3 12 11.5 42.3
Cellulase 11 17.5 8.3 5.3 1
Inulinase 0 0 0 0 0
Lipase 0 0 0 0 0
Pectinase 11.5 9 10.3 4.5 0
Phytase 5 9.5 11.3 0 0
Protease 21.3 25 5 4.3 11.3
Xylanase 8 7.5 5.3 9.5 0
Isolates

















mineral availability is something which farmers need to address. Phytic acid plays a large 
role in lowering phosphorous absorption, as well as calcium, iron, zinc and magnesium (Oh 
et al., 2003). Very few animals can degrade phytic acid naturally and this can lead to animals 
suffering from nutrient deficiencies (Marounek et al., 2003). Phytic acid hydrolysis is best 
accomplished by the gut microbiota, as the addition of phytases to the feed is expensive and 
unstable (Oh et al., 2004). The three L. plantarum strains included in the probiotic mix 
produced phytase (Table 2.8).    
In addition to these enzyme assays, the API 50CHL strips also gave information on the 
enzymes produced by each isolate (Table 2.9). The API results agree with the results in Table 
2.8 with respect to the inability of all strains to degrade inulin and showed all strains except 
Bp303.3.2 to be able to utilise cellobiose. The API strip showed only Bp303.3.2 to degrade 
starch, whereas the modified BYG plates gave positive results for all strains. This may 
indicate that the substrates used in these different tests vary slightly or that the modified agar 
technique is more sensitive to the APIs.  
The probiotics tested here show a good range of substrate degradation which would be able to 
make more nutrients available for growth and so benefit the ostrich. The multistrain probiotic 
mixture should be more advantageous in this case with some strains being able to digest 

























Table 2.9. Selected API 50CHL results for relevant enzyme activities 
 
 
2.4.3.6. Antibiotic resistance profiles of the strains 
To determine the antibiotic resistance profiles of the five probiotic strains, commercially 
available antibiotic disks (Oxoid) were used and the results are shown in Fig 2.12. In 
addition, the well diffusion assay was used to test various concentration of tylosin and the 
highest concentration tested is shown in Fig. 2.12.  
Test Active ingredient
Lp1.1.2.2 Lp6039.3 Lp162.2 Lr136.2.2 Bp303.3.2
GLY Glycerol - - - - -
ERY Erythritol - - - - -
DARA D-Arabinose - - - - -
LARA L-Arabinose + + + + -
RIB D-Ribose + + + + +
DXYL D-Xylose - - - - -
LXYL L-Xylose - - - - -
ADO D-Adonitol - - - - -
GAL D-Galactose + + + + -
GLU D-Glucose + + + + +
FRU D-Fructose + + + + -
MNE D-Mannose + + + + -
SBE L-Sorbose - - - - -
RHA L-Rhamnose - - - - -
DUL Dulcitol - - - - -
INO Inositol - - - - -
MAN D-Mannitol + + + + -
SOR D-Sorbitol + + + + -
CEL D-Cellobiose + + + + -
MAL D-Maltose + + + + +
LAC D-Lactose + + + + +
SAC D-Saccharose + + + + +
INU Inulin - - - - -
RAF D-Rafinose + + + + -

















Figure 2.12. Antibiotic resistance profiles of 10 selected antibiotics. Results shown as the 
mean zone of inhibition ± standard error (n = 3).  
Only Bp303.3.2 showed a slight sensitivity to vancomycin at 5µg (Fig. 2.12). All the strains 
were resistant to kanamycin and streptomycin and all strains except Bp303.3.2 were sensitive 
to erythromycin. All five strains were most sensitive to ampicillin. Bp303.3.2 showed high 
sensitivity to penicillin G and tetracycline, and Lr136.2.2 showed high sensitivity to 
rifampicin. The strains showed varying sensitivity to the remaining antibiotics tested here 
(Fig. 2.12). In addition, all five strains were shown to be resistant to tylosin at all 
concentrations tested (up to 40mg/litre, data not shown). In this study, tylosin was 
administered to the ostrich chicks at a 20mg/kg feed. It is therefore concluded that this 
concentration would not affect the probiotic strains.  
LAB have been reported to be intrinsically resistant to many antibiotics due to their structure 
and physiology (Donohue, 2009). Temmerman et al. (2003) showed the majority of 

















































found to be resistant to kanamycin (81%), tetracycline (30%), erythromycin (12%) and and 
chloramphenicol (9%). Sullivan and Nord (2006) reported all isolated L. plantarum strains 
from bacteremic patients, to be resistant to vancomycin and Cannon et al. (2005) reported all 
isolated L. plantarum strains to be sensitive to erythromycin and ampicillin. The tetracycline 
resistance gene tet(W) has been isolated from L. reuteri (Kastner et al., 2006). 
Bifidobacterium spp. have been reported to be sensitive to penicillin G and erythromycin 
(Kheadr et al., 2006) and resistant to aminoglycosides (kanamycin and streptomycin) and 
vancomycin. Strain Bp303.3.2 (Bifidobacterium pseudolongum subsp. pseudolongum) was 
indeed sensitive to penicillin G, but resistant to erythromycin (Fig. 2.12). In addition 
Bp303.3.2 was resistant to kanamycin and streptomycin, but slightly sensitive to vancomycin. 
Mayrhofer et al. (2011) showed a B. pseudolongum subsp. pseudolongum of animal origin to 
be sensitive to chloramphenicol and resistant to kanamycin. This highlights the strain-specific 
resistance profiles, as Danielson et al. (2007) reported, showing great variation between 
species. The five gram positive, anaerobic probiotic strains used in this study were all 
resistant to kanamycin and streptomycin (Fig. 2.12). Gram positive anaerobes have been 
shown to be resistant to aminoglycosides (Davis, 1987) given their multiple cationic charges 
in their membrane rendering them impermeable to these antibiotics and this resistance is 
therefore likely to be intrinsic. Determining whether the resistance is intrinsic or acquired is 
important, since genes encoding for antibiotic resistance can be transferred between species 
in the same ecological niche (Kruse and Sorum, 1994). The antibiotic profile of potential 
probiotics must be determined before the product is commercialised to avoid introducing 
strains that carry transferable resistance genes.  
 
2.4.3.7. Thermotolerance assay 
The ability of the probiotics to survive exposure to heat during processing is necessary, 
depending on the technique to be used. Spray drying, for example, uses high temperatures 
and in-vitro examination of heat resistance would indicate the likelihood of the strains 
survival.  The bacteria used here were in stationary phase as it has been previously reported 
that the stage of growth affects the heat resistance of the strain, and that stationary phase cells 
resulted in a higher survival rates after heat treatment (Teixeira et al., 1994). The probiotics 















too few colonies to count for all five strains tested. The results of each strains survival at the 
remaining test temperatures are shown in Figure 2.13.  
 
Figure 2.13. Survival of the selected probiotic strains after 10 min exposure to 37°C, 50°C 
and 60°C. Results shown as the mean ± standard error, n = 3.  
 
The three L. plantarum strains survived equally well at 37°C and 50°C, however incubation 




CFU/ml (Fig. 2.13). 
L. reuteri Lr136.2.2 showed no difference in survival between the three incubation 
temperatures, maintaining a cell count of approximately 10
9 
CFU/ml. Nitisinprasert et al. 
(2000) isolated a thermotolerant L. reuteri strain from the chicken intestine, and other studies 
have isolated thermotolerant L. paraplantarum from the GIT of various animals (Sow et al., 
2005).  The probiotic Bp303.3.2 showed higher temperature sensitivity, decreasing from 10
9 
CFU/ml at 37°C to 10
8 
CFU/ml at 50°C and 10
7
 at 60°C (Fig. 2.13). Lian et al. (2002) also 
showed a decrease in viability for Bifidobacterium spp. after spray drying (1 – 2 log/g dry 
mass reduction), but concluded that after the process, there was still an acceptable number of 
viable cells for probiotic use. All five strains still had an acceptable viability after exposure to 
60°C, having cell counts of around 10
8 
CFU/ml, proving them suitable for processing up to 
60°C. There are a variety of composite carrier matrices available which have been shown to 
improve the survival of bacterial strains under stressful conditions for example, using 
glycerol or skim milk as cryoprotectants (Pascual, et al., 1999), and calcium alginate beads 
(Anal and Singh, 2007). Tests could be performed on the probiotic strains using these 






































The beneficial effects of probiotics are well documented and include the ability of probiotics 
to adhere to the mucosa and outcomplete pathogens, aid in digestion by production of 
desirable enzymes and boost the immune system.  
It is also well known that each strain and their combination should be tested in-vitro as 
probiotic effects are strain-specific. It is therefore vital to correctly identify and rigorously 
characterise each strain before commercialising the probiotic product. This chapter aimed to 
fully characterise five strains, previously isolated from ostrich faeces or the ostrich GIT, 
which were selected for their suitability for inclusion into ostrich chick feed with the 
intention of replacing the use of the growth-promoting antibiotic tylosin.  
With confidence we can say that the five isolates were identified as: Lp1.1.2.2 – L. 
plantarum, Lp6039.3 – L. plantarum, Lp162.2 – L. plantarum, Lr136.2.2 – L. reuteri and 
Bp303.3.2 – B. pseudolongum subsp. pseudolongum.  
The five isolates were shown to successfully adhere to the chicken mucous, a factor 
considered critical for the beneficial effects to be exerted. The single strains, as well as all 
combinations tested could prevent adhesion of four pathogens, C. difficile, C. perfringens, E. 
coli and S. typhimurium, tested here. The single strains were unable to displace pathogenic C. 
difficile, but were able to displace the other three pathogens, whereas the mixes could 
displace all four pathogens. The single strains were able to out-compete the pathogens once 
they had adhered to the mucous, except Lp6039.3 which could not out-compete C. 
perfringens, C. difficile and S. typhimurium. Again, a strain-specific, combination-specific 
pattern is observed.  
The functionality of the five probiotic strains was evident. All five probiotics produced 
antimicrobial compounds against the potential pathogens S. typhimurium and E. coli. Only 
Lr136.2.2 was active against C. perfringens, considered the main pathogen in ostrich 
farming. However, when looking at the adhesion mechanisms above, C. perfringens was 
successfully inhibited, displaced and out-completed by all strains (except Lp6039.3) and 















Given the importance of cellulose as a component of ostrich feed, the production of cellulase 
by all strains is highly beneficial. Although Bp303.3.2 produced low levels of this enzyme, 
the combination of all five strains would produce it in reasonable amounts. Amylase and 
protease were produced by all five strains in different amounts and pectinase and xylanase 
were produced by all except Bp303.3.2. These additional enzymes are thought to contribute 
towards increasing digestion and therefore improving the feed conversion ratios in animals.  
The identification of the strains placed them in the GRAS (generally regarded as safe) 
category of species used for probiotics. The characterisation of these strains showed an 
overall beneficial profile, but highlighted the strain-specific nature of probiotics, highlighting 
the need of thorough identification and characterisation before each potential strain is used in 
feeding trials. The five strains all showed a resistance to tylosin, an antibiotic commonly used 
in animal husbandry, concluding that it did not alter the viability of these probiotics in this 
feeding trial.  The enhancement of properties such as the enzyme production by a multi-strain 
mix is obviously beneficial. However, the effect on adhesion needs to be determined when 
used as a multi-strain mix, as this may alter the probiotic effects beneficially or detrimentally 
compared to single strains.  
The next chapter explores the scale-up production and method of delivery of the five strain 
combination in feeding trials to ostrich chicks. The effect of the probiotics on their faecal and 


















                                                    
CHAPTER 3 
 
 The effect of dietary supplementation with Lactobacillus plantarum, 
Lactobacillus reuteri and Bifidobacterium pseudolongum subsp. pseudolongum 
on the faecal and gut microbial populations using culture-dependent 
techniques 
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Lactobacillus plantarum, Lactobacillus reuteri and Bifidobacterium pseudolongum subsp. 
pseudolongum were investigated in a feeding trial on ostrich chicks. The five strain mixture was 
incorporated into calcium alginate encapsulated beads, which improved their viability. The 
chicks were fed this probiotic mix alone, or in combination with the antibiotic, tylosin, in order 
to elucidate and compare the effect of probiotics on the growth rate and health of the chicks. No 
significant difference was observed between treatments for growth rate or feed conversion ratio, 
however the mortality rate in the probiotic-fed group was noticeably higher than that of the 
groups receiving tylosin. These birds were the only groups to have C. perfringens in the 
duodenal mucosal scrapings. The changes in the culturable microbiota were observed using 
selective growth media for enumeration of total anaerobes, lactic acid bacteria, Bifidobacterium 
spp., Clostridium spp., Salmonella spp. and Enterobacteriaceae. Overall, the faecal samples did 
not show many significant differences in the culturable bacteria between treatments, however, as 
expected, the majority of bacterial counts increased significantly over time for each treatment. At 
week two, treatment E and ET showed higher counts for LAB and Bifidobacterium spp. showing 
the effect of receiving probiotics on these bacterial groups. Treatment E also showed higher 
coliform counts as well as C. perfringens counts at week two, and after this time point the chicks 
in this treatment died. The prevalence of this pathogen decreased over time in treatments 
receiving tylosin, indicating the effectiveness of this antibiotic against this pathogen. The 
mucosal samples showed increasing trends for total bacteria, LAB and Enterobacteriaceae, 
while C. perfringens disappeared by the second slaughter point for all groups except in the colon 
and caecum of treatment ET. Treatments C and CT showed higher LAB, total anaerobes and 
coliform counts than E and ET at slaughter one. Interestingly, only treatment E showed the 
presence of C. perfringens in all areas of the gut tested. C. perfringens is considered to have 




















3.2 Introduction  
 
Agricultural animal farming for human consumption has a main objective: to get the animal to 
slaughter age as fast and as economically as possible. Ostrich farming is not only expensive, but 
also suffers mortality rates of up to 74.8% in the first three months of life (Cloete et al., 2001). 
This mortality is due to stress and pathogenic invasion such as fading chick syndrome and 
enteritis caused by C. perfringens (Shivaprasad, 1993; Huchzermeyer, 2002). Naturally, ostrich 
chicks ingest the parent‟s faeces as a means of obtaining a healthy microbiota which would 
protect them against these invasions by providing the initial inoculum of beneficial bacteria to 
develop their gut microbiota (Cooper et al., 2010), and chicks in open pastures seldom get 
enteritis (Huchzermeyer, 2002). In intensive ostrich farming, the environment into which the 
chicks are born does not allow for this and pathogenic bacteria colonise the gut freely. There is 
therefore, widespread use of antibiotics, such as tylosin, commonly used in animal farming for 
its prophylactic properties as well as for its growth promoting effects (Collier et al., 2003). This 
antibiotic is used in South Africa, particularly in the ostrich farming industry due to the high 
mortality rates of farmed ostrich chicks. In addition, the cost involved in rearing an ostrich chick 
to the slaughter age of nine months, is high when compared to the feed costs alone (Mike Jarvis, 
personal communication). It has been suggested that the slaughter age of the ostriches could be 
brought down to seven months for economic reasons. However, in this case, the birds need to 
reach slaughter weight in less time and an alternative to the use of growth promoting antibiotics 
would need to be found.  
Tylosin is a macrolide antibiotic with broad spectrum activity against Gram positive anaerobes, 
as well as some Gram negatives (Poole et al., 2003). Like other macrolides, tylosin has a 
bacteriostatic effect on susceptible organisms, inhibiting protein synthesis through binding to the 
50S subunit of the bacterial ribosome. It is commonly used as a growth promoter at 
concentrations between 10-40 mg/kg of feed and as medication at concentrations between 20-50 
mg/kg of feed (Tertius Brand, personal communication). In this study it was administered daily 
in the feed at a concentration of 20 mg/kg of feed. Enteric E. coli and Salmonella spp. are 
intrinsically resistant to tylosin (Shryock et al., 1998), therefore, in this study it would be 
primarily targeting pathogenic C. perfringens. When used for promoting growth, its effect on the 















is known to reduce susceptible bacteria and exhibit benefits to the host including inhibition of 
bacterial virulence and enhancement of immune system (Shryock et al., 1998). There is limited 
information on the composition of gastrointestinal microbiota of humans and animals, however, 
both culture-dependent and -independent methods have demonstrated that most gastrointestinal 
bacteria are Gram positive anaerobes (Gueimonde and de los Reyes-Gavilán, 2009). However, 
this study focused on the effect of subinhibitory concentrations of tylosin on the ostrich 
microbiota. The overuse of antibiotics in intensive animal husbandry may lead to the long-term 
development of drug resistant human pathogens (Fey et al., 2000) and has lead the European 
Union to ban the growth promoting use of antibiotics in animal farming. Due to these concerns, 
there is a significant interest in the development of an alternative and sustainable solution to 
improving growth and health of farmed animal species.  
Microbial cultures have shown potential as a replacement to the prophylactic and growth 
promoting use of antibiotics, due to associated benefits such as antimicrobial production and 
competition with pathogens for adhesion sites (Casey et al., 2007; Margolles et al., 2009). 
Probiotics have shown great promise in this scope, being used in humans (Collado, 2009) as well 
as farm and domesticated animals (Lim and Tan, 2009).  Previous research has shown probiotics 
to be most effective when isolated from the host they are to be used in (Rinkinen et al., 2003) 
and therefore, in this study, five potential probiotic strains were isolated from wild and farmed 
ostrich faeces and gut scrapings. Three Lactobacillus plantarum, one Lactobacillus reuteri and 
one Bifidobacterium pseudolongum subsp. pseudolongum, showed potential in initial probiotic 
screening assays (Chapter 2). Lactobacillus spp. and Bifidobacterium spp. are constituents of 
most animal intestinal microbiota and are some of the most commonly used probiotic strains due 
to their proposed benefits (Margolles et al., 2009). These benefits include increasing body weight 
gain and egg quality in layer chickens (Nahashon et al., 1994) and increasing body weight gain 
and survival rates of piglets (Abe et al., 1995). However, considerable strain-to-strain variation is 
seen among these species and it is therefore important to screen each potential probiotic before 
inclusion in a dietary supplement.  
Prebiotics are nondigestible food ingredients which selectively stimulate the proliferation of 
resident beneficial bacteria in the gut, especially Bifidobacterium, by 10-100 fold (Boehm and 















to as a synbiotic. There is increasing scientific evidence of synbiotics aiding young animals to 
increase their growth performance (Patterson and Burkholder, 2003; Fleige, 2007). Some 
prebiotics also offer protection against cell injury during processing like freeze drying 
(Crittenden, 2009). In this study, raftilose 
®
P95, a commercial fructooligosaccharide (FOS) 
product containing a mixture of oligofructose, glucose, fructose and sucrose, was used as both a 
prebiotic as well as a cryoprotectant. FOS has been shown to have good prebiotic properties in 
numerous human feeding trials (Boehm and Stahl, 2003; Bouhnik et al., 2006) and has been 
shown to elicit a response in the bifidobacteria and lactobacilli populations in luminal and 
mucosal samples (Suzuki et al., 2006).    
 
For the probiotics to have the desired effect, they have to be delivered to their site of action in 
sufficient quantities (Lee, 2009). The dosage administered is dependent on several factors: 
 Type of probiotic used 
o Lactobacilli, bifidobacteria, yeast, and/ or combination, 
o Each needs to be separately studied, 
 Daily dose 
o As yet, there is not a systematic study on the effective dosage required for specific 
applications, 
o Needs to be sufficient, but not excessive as this can lead to side effects such as 
diarrhea, 
 Daily frequency of administration 
o Probiotics which do not adhere well to the mucosa, or are degraded by the harsh 
GIT conditions may have to be administered more frequently than more 
successful probiotics,  
 Timing of administration 
o There is no information on this, but it is thought that between meals is optimal for 
exposure of the strains to receptor sites as food may dilute the probiotic, 


















 Duration of administration 
o This depends on the disorder being treated, 
 Method of delivery 
o Appears to have minimal effect on probiotic efficacy, 
 Viability 
o Depends on the mechanism of the probiotic effect, 
o Each probiotic/combination needs to be evaluated respectively. 
 
Probiotic treatment has had positive reports (Jin et al., 1998b; Kabir et al., 2004; Gil De Los 
Santos et al., 2005) as well as negative effects in broilers (Watkins and Kratzer, 1984; 
Priyankarage et al., 2003). However, it is difficult to compare studies of probiotics as their 
efficacy depends on many factors, including the environmental and stress status of the animal 
(Patterson and Burkholder, 2003). In a previous investigation, a five strain probiotic combination 
was found to be effective at increasing growth performance of chickens, as well as improving 
digestive tract function at a concentration 10
8 
cfu/kg feed (Mountzouris et al., 2010). However, 
they suggested a probiotic concentration of >10
9 
cfu/kg of feed for beneficial modulation of the 
chicken caecal microbiota. Given the sensitivities of ostrich chicks, the probiotic mix in this 
study was administered at 10
8 
cfu/kg feed. Mountzouris et al. (2007) also demonstrated that a 
five-bacterial species competitive exclusion probiotic product for broilers was effective for 
promoting growth and modulating caecal microbiota composition and metabolic activity. In 
addition, the same probiotic mix was effective at reducing Salmonella Enteritidis in Salmonella 
Enteritidis-challenged broilers (Mountzouris et al., 2009). Furthermore, Mountzouris et al. 




cfu/kg of feed 
resulted in a beneficially altered caecal microbiota.  
 
Although probiotics have been incorporated into fermented food products like yoghurt for 
decades (Capela et al., 2005), including them into a wider range of food and maintaining their 
viability over a longer shelf life is a challenge. The five probiotics used in this study are 
considered to be strict anaerobes, and therefore protection from oxygen was critical for securing 
their viability following long- to medium-term storage. The temperature of the ostrich pens was 















probiotics were given to the ostriches with the food in the morning and left in the pens during the 
day. As mentioned above, it is thought to be optimal to administer the probiotics in the water so 
as not to get any interference from food particles. In this case, however, had the probiotics been 
mixed with the drinking water, and left all day, it was suspected they would sink to the bottom of 
the drinking tank. The different strategies tested here for successful administration of probiotics 
to the chicks included freeze drying the probiotic combination in skim milk and raftilose
®
P95, 
encapsulation of the probiotic mix in calcium alginate beads, and immersing these beads into 
cocoa butter, and finally vacuum impregnation into the ostrich feed.  
 
Culture-dependent techniques such as plating on selective agar have been used traditionally for 
enumeration of bacterial groups. This method is cheap, easy and quick and offers high 
taxonomical discrimination (Vaz-Moreira et al., 2011). It also gives information on viability of 
the strains which culture-independent methods do not. This is particularly useful in this study 
where it is important to know the effect of the production processes on the viability of the 
probiotics that are to be tested.   
 
3.2.1 Aims and objectives of this study 
The main objective of this study was to formulate a probiotic mix that could successfully replace 
the use of growth promoting tylosin and prevent invasion by common pathogens. These factors 
are critical to the long-term growth and success of the currently-depressed local ostrich farming 
industry. In this chapter we investigate different modes of probiotic delivery to the chicks and 
carry out a pilot feeding tr al on a commercial ostrich farm with the aims of monitoring the 
effects of probiotics and tylosin on the mortality rates and feed conversion ratios of the chicks. 
Once this feeding trial had shown no detrimental effects for the probiotic mix (Juste-Poinepen, 
2008; du Toit, unpublished), a larger feeding trial was carried out at Elsenberg Agricultural 
Centre (Stellenbosch, South Africa).  
 
3.3 Materials and Methods 
 
3.3.1 Bacterial strains and growth conditions  
Five selected strains of ostrich origin (Chapter 2) were included in the probiotic mix: L. 















L. reuteri 136.2.2 (Lr136.2.2) and B. pseudolongum subsp. pseudolongum 303.3.2 (Bp303.3.2). 
All bacterial strains were cultured anaerobically, as described in Chapter 2.  
For enumeration of bacterial populations in faecal samples, the following selective media and 
conditions were used: De Man Rogosa Sharpe (MRS) agar (Merck) according to De Man et al. 
(1960), supplemented with 0.05% cysteine hydrochloride (Sigma Aldrich) and 15g/l 
bacteriological agar (Merck) for total lactic acid bacteria, Brain Heart Infusion (BHI) agar 
(Bacto) supplemented with 0.05% cysteine hydrochloride (Sigma Aldrich) and 15g/l 
bacteriological agar (Merck) for total anaerobes, Beerens agar ((Beerens, 1990) containing in g/l: 
Columbia agar (Oxoid) 39.0; glucose 5.0; cysteine hydrochloride 0.5; agar 1.5; propionic acid 
5.0 ml) for total Bifidobacterium, Tryptose Sulphite Cycloserine (TSC) agar (46g/l Perfringens 
agar base (Oxoid), 2 vials/l TSC supplement (Oxiod)) for isolation of Clostridium perfringens, 
Salmonella Shigella (SS) agar (Merck) for detection of Salmonella and Shigella, and McConkey 
agar (Merck) for detection of Enterobacteriaceae. MRS, BHI, Beerens and TSC were incubated 
anaerobically at 37°C for 48 h, and the SS and McConkey were incubated aerobically at 37°C for 
24 h. Cell numbers were recorded after incubating the plates for the desired period and viability 
recorded as log colony forming units (cfu)/g faeces. 
 
3.3.2 Development of method of delivery of probiotic strains to ostrich chicks  
3.3.2.1 Freeze drying of probiotics for addition to ostrich feed 
A single colony of each of the probiotic strains was inoculated separately into 5 ml MRS broth 
supplemented with 0.05% cysteine (MRS-Cys) and cultured under anaerobic conditions for 18 h. 
This culture was checked for purity using a Gram stain and 1 ml of this was inoculated into 500 
ml MRS-Cys broth and grown as above. The cells were harvested by centrifugation at 10,000 
rpm for 10 min at 4°C (Beckman Coulter J2-21 M/E), washed twice in 1x PBS and resuspended 
in 100 ml 5% (w/v) skim milk, 5% (w/v) raftilose 
®
P95. The strains were freeze dried separately 
to test the viability of the single strains after processing, as well as mixed together in equal 
volumes before being freeze dried to ensure overall survival of the mix. The suspensions were 
shelled in an ethanol bath in a drying flask for 2 h and then freeze dried (Balzers-Pirani gauge 
TiG 030) at 10 mbar for approximately 48 h. The freeze dried product was transferred to a sterile 
Sterilin tube and maintained at 4°C in a dessicator. Cell viability of the freeze dried probiotics 















was suspended in 1x PBS and was serially diluted in 1x PBS and 100 µl of the suspension was 
spread onto MRS-Cys solid growth media. The cell numbers were determined after incubating 
the plates at 37°C for 48 h under anaerobic conditions and viability determined as cfu/g of freeze 
dried product. 
 
3.3.2.2 Calcium alginate encapsulation of culture  
Bacterial strains were grown in 500 ml MRS-Cys for 18 h under anaerobic conditions. The cells 
were collected by centrifugation at 10,000 rpm for 10 min, washed twice in 1x PBS and 
resuspended in 50 ml sterile 5% milk, 5% raftilose. The five suspensions were combined and 
added to 250 ml 3.6% sodium alginate and mixed thoroughly. This mixture was poured into a 
sterile customized funnel and dripped through a blue eppendorf tip into 0.1M CaCl2 with stirring. 
The alginate beads, approximately 2-3mm in diameter, were left to harden in this solution for 45 
min, and then transferred to 0.85% sterile saline solution for a further 20 min. The beads were 
finally rinsed in sterile water for 10 min, air dried and stored at 4°C. To test viability of 
encapsulated probiotics, three alginate beads were resuspended in 1.5 ml 0.1 M sodium citrate 
(pH 6.0) using a Mini-Beadbeater-1 (Biospec Products, Oklahoma, U.S.A) for 1 min. This step 
released the bacteria from the alginate by sequestering the calcium ions which cause the alginate 
to gel. The viable probiotic cells were quantified by spread plating on MRS agar with anaerobic 
incubation at 37°C for 48 h. Different bead sizes were tested using a yellow eppendorf tip, 
resulting in beads of approximately 1 mm in diameter, a cut-tip blue eppendorf tip, giving beads 
of about 4 mm diameter, and also beads were allowed to drop directly out of the nozzle of the 
funnel (4 mm wide) giving beads approximately 4-5mm in diameter.  
3.3.2.3 Cocoa butter encapsulation  
Bacterial strains were grown as previously described (Chapter 2) and encapsulated in alginate as 
described above (section 3.3.2.2). Commercially available cocoa butter was heated to 100°C and 
allowed to cool to approximately 40°C in a water bath. Alginate encapsulated probiotic beads (1 
mm in diameter) were added to a final concentration of approximately 10
9 
cfu/ml cocoa butter 
and mixed, while the temperature was maintained at 40°C. This mixture was poured into sterile 
plastic petri dishes, hardened at 4°C, cut into 1 cm
3 
blocks and stored at 4°C. Viability of cells 
encapsulated in this manner was determined by plate counts on MRS agar. A block of cocoa 















incubated at 40°C for 15 min, prior to plating on MRS solid media, to aid in the release of 
encapsulated probiotic cells from the cocoa butter mixture and was incubated for 48 h at 37°C in 
an anaerobic chamber.  
 
3.3.2.4 Incorporation of probiotics into ostrich feed by vacuum impregnation 
The strains were grown as previously described (section 3.3.1). The cells were collected by 
centrifugation (10,000 rpm for 5 min), washed twice in 1x PBS, and resuspended in 5 ml of a 
sterile solution of 5% skim milk and 5% raftilose 
®
P95.  This solution was impregnated into the 
ostrich feed using vacuum impregnation technology to a final concentration of approximately 1 x 
10
8 
culturable cells/g feed. 50 g ostrich feed was placed in a glass jar sealed with a rubber seal 
and clamp. A vacuum pump drew a vacuum of 80 kPa inside the glass jar and 5 ml of the 
bacterial suspension was drawn into the vacuum jar and thoroughly mixed by shaking the jar. 
During this intake of bacterial suspension, the pressure inside the vessel was decreased to 
50 kPA where it was maintained for 5 min. Thereafter the vacuum was slowly decreased to 
atmospheric pressure and the impregnated ostrich feed was emptied onto clean Whatman 3MM 
paper to dry for 18 h at 22°C.  To test the viability of the probiotics after impregnation, 1 g of 
feed was added to 10 ml sterile water and left overnight at 4°C. Serial dilutions of this were 
made and spread-plated, in triplicate, onto MRS agar and the cell numbers calculated after 
incubation for 48 h at 37°C as cfu/g of feed. The impregnated feed was stored at 4°C. 
 
3.3.3 RAPD 
Colonies used for RAPD analysis were cultured from faecal samples from ostrich chicks in both 
feeding trials. Ten colonies were randomly selected from MRS-Cys agar and suspended in 1 ml 
sterile water containing 0.1 mm zirconia/silica beads. This was subsequently bead beaten at 
4,800 oscillations/min for 140 s. This was left at 4ºC for 10 min and the supernatant used as PCR 
template, using primers OPL5 and PL1 (Chapter 2). RAPD PCR reactions and conditions 
employed are as described in Chapter 2.  
 
3.3.4 Pilot-scale ostrich feeding trial   
A pilot feeding trial was carried out at Tier Vlei commercial ostrich farm in Carnarvon, South 















mix was used, as described below and administered as calcium alginate encapsulated beads. As 
this feeding trial was carried out on a commercial farm, the antibiotics oxytetrachloride and 
colimix were administered on an “as and when needed” basis, dependent on the development of 
illness at a concentration recommended by the veterinarian. The five probiotic strains used were 
found to be resistant to both of these antibiotics. Faecal samples were cultured on MRS, BHI and 
Beerens agars and 10 colonies from MRS agar were selected for analysis using RAPD. BHI 
plates were incubated both aerobically and anaerobically, and randomly selected colonies were 
gram stained and tested for catalase (Maehly and Chance, 1954) activity. The ostrich chicks were 
weighed in crates in batches of ten on a large-scale scale and the weights recorded every two 
weeks, to reduce the stress of handling the chicks, and feed conversion ratios were calculated as 
described below (section 3.3.5.1). Total DNA was extracted from faecal samples using ZR Fecal 
DNA Kit (Zymo Research, C.A., U.S.A.) according to the manufacturers‟ protocol and the 
diversity of total bacteria, Lactobacillus and Bifidobacterium was analysed using DGGE (data 
not shown).  
 
3.3.5 Large-scale feeding trial  
3.3.5.1 Administration and doses of probiotics  
This trial was carried out at Elsenburg Agricultural Centre (Stellenbosch, South Africa). Three 
day old ostrich chicks from Oudtshoorn and Darling (South Africa) were weighed, tagged and 
randomly allocated to probiotic (E) or control (C; no probiotic treatment) pens (n=17). Each 
group was done in triplicate (three pens for probiotic treatment and three pens for control groups) 
and the pens were arranged so that similar treatments were not situated in neighbouring pens 
(Fig. 3.1). Another set of pens were allocated for probiotic and control groups also receiving the 
antibiotic tylosin (ET and CT) at a concentration of 20 mg/kg of feed daily. All chicks had 
unlimited access to food and water. The pelleted feed was formulated and mixed by Elsenburg 
Agricultural Centre and consisted of (w/w): 50% maize meal, 10% lucern meal, 20% soya 
oilcake meal, 13% full fat soya meal, 1% oil, 2% feedlime, 1% monocalciumphosphate, 0.5% 
salt and 0.5% vitamin and mineral mixture. The pens had cement floors overlaid with rubber 
matting and were separated by low concrete walls. The ambient temperature was kept between 
25-30ºC and the chicks had controlled access to the outdoors from two weeks of age. These 















treatments. One alginate bead containing the probiotic mixture was fed to each chick in the 
treatment groups, and this was counted as day one of the trial. The chicks were weighed 
separately in a crate on an industrial sized scale on day one and weekly hereafter, and the 
average weights per treatment were calculated. This was done more frequently than in the pilot 
feeding trial as weighing every two weeks was found to be too broad a time difference. On day 
seven another alginate bead was fed to each chick. The average viability of one bead was 
calculated to be 1.84 x 10
8 
cfu/bead. In order to ensure that from day 14 each chick received at 
least 1 x 10
8 
bacteria, 500 mg of alginate beads were mixed in with the normal ostrich feed daily.  
The control group received normal feed pellets. Treatment ceased after nine weeks. Weekly, the 
average mass of food eaten by the ostrich chicks was divided by the average weight gain of each  
treatment to get the feed conversion ratio. Mortality rates were recorded and birds that died were 
sent to a veterinarian for postmortem analysis. At weeks two and five a total of 12 ostrich chicks 
(one from each pen) were euthanized by severing of the spinal cord and the digestive tract 
dissected. Mucosal scrapings from the duodenum, colon and caecum were immediately put into 
1 x PBS and frozen at -20°C. 
 
Figure 3.1 The layout of the feeding trial showing the numbers of ostrich chicks per feeding 
treatment. The treatments were divided into three (n=17) and the pens were arranged so as not to 
have the same treatments adjacent to each other. Treatments: E, probiotic mix; ET, probiotic mix 


















3.3.5.2 Faecal sample collection 
Anaerobic travel swabs (In vitro diagnosticum, Oxoid) were used to collect excreta on day zero 
since the quantity of faeces generated by five day old ostrich chicks is not sufficient to be 
collected. From day seven onwards, six faecal samples were collected in sterile faecal collection 
tubes (Lasec, South Africa) and three of these were swabbed with the anaerobic travel swabs for 
anaerobic storage and later analysis of anaerobic bacteria. Samples were rapidly transported to 
the laboratory and samples were immediately frozen at -80°C until analysed or fixed in 
paraformaldehyde and frozen for later FISH analysis (Chapter 5). The travel swabs were used for 
selective culturing, as described below. 
 
3.3.5.3 Microbiological analysis of ostrich chick faecal samples using culture techniques  
Faecal matter from anaerobic travel swabs was suspended in 1 ml sterile pre-reduced PBS under 
anaerobic conditions. Five faecal samples were pooled per pen and plated in duplicate onto the 
various selective agar under the conditions described above in section 3.3.1.   
 
3.3.5.4 Microbiological analysis of ostrich chick mucosal samples using culture techniques 
Homogenised scrapings from the colon, caecum and duodenum were serially diluted in 0.9 ml 
sterile pre-reduced 1x PBS under anaerobic conditions and spread plated onto the selective agars 
as described above. 
 
3.3.5.5 Statistical analysis 
The effects of the addition of probiotic and tylosin to the ostrich diet on the culturable numbers 
of chosen bacterial groups were analysed using the two-way analyses of variance (ANOVA). 
Stata statistical program (version 11.0) was used to perform post hoc Kruskal-Wallis analysis. 





















3.4 Results and Discussion 
 
3.4.1 Development of method of delivery of probiotic strains to ostrich chicks  
The relative survival of probiotic bacteria during processing, storage and passage through the 
gastrointestinal tract may limit their usefulness in food applications (Lahtinen et al., 2007). 
However, several attempts have been made to increase survival of probiotic microorganisms 
using encapsulation techniques. Of these, freeze drying, lipid-based encapsulation, feed 
impregnation and alginate encapsulation were investigated in this study. 
 
3.4.1.1 Freeze drying 
Water activity is an important factor to consider when wanting to extend the shelf-life of a 
quiescent, dried probiotic product (Crittenden, 2009). As water activity and moisture levels 
increase, survival of the probiotic decreases. Drying of microorganisms is one of the most 
common methods of preservation (Carvalho et al., 2004) and is frequently used for the 
preservation of large quantities of probiotic bacteria (Carvalho et al., 2004; Capela et al., 2005; 
Bolla et al., 2011; Salgado et al., 2011). In this study, all five probiotic strains maintained a high 
degree of viability after being freeze dried and processed separately (data not shown), as well as 
when they were freeze dried together in a skim milk and raftilose 
®
P95 solution (Fig. 3.2). 
Probiotic bacteria differ in their ability to survive freeze-drying, perhaps due to differences in 
surface area of the microorganism, variations in cell wall and membrane composition, sensitivity 
to process oxygen and temperature exposure, and/or water activity and changes in solute 
concentration (Carvalho et al., 2004). Cryoprotectants are often used during freeze drying 
processes to improve a bacteria‟s ability to survive this treatment and increase its shelf life, and 
include sugars, such as lactose or sucrose, monosodium glutamate and ascorbate in a milk or 
water base (Bigret and Mäyrä-Mäkinen, 2004). These can be added to the growth media or to the 
mix to be freeze dried. The protective effects provided by carbohydrates during freeze-drying is 
well documented and is thought to be due to their ability to raise the glass-phase transition 
temperature, enabling the cells to reach the glassy phase without nucleating intracellular ice 
(Fowler and Toner, 2005). Alternatively, prebiotics such as fructooligosaccharides (FOS) have 
been shown to improve viability of Bifidobacterium spp. in skim milk when included in the 















storage (Shin et al., 2000). Raftilose 
®
P95 was found to increase the viability of a mix of freeze 
dried probiotic strains, including L. rhamnosus, L. casei, L. acidophilus and B. infantis, over four 
weeks of storage at 4ºC (Capela et al., 2005). Skim milk proteins have also been shown to 
prevent cellular injury by stabilizing cell membrane constituents thus making it an effective 
cryoprotectant (Castro et al., 1995). In addition, milk proteins may form a protective layer on the 
surface of cell wall proteins, while the calcium in milk enhances survival following dehydration 
(King and Su, 1993). 
 
Although the freeze dried probiotic mix displayed good viability after 25 days of storage at 4ºC 
(Fig. 3.2), this method was not used as the mode of probiotic preparation and delivery in these 
ostrich feeding trials. The reasons for not making use of freeze dried probiotics for this feeding 
trial included the small processing capacity of freeze drying probi tic cultures, together with 
difficulties in on site application of the dried final product. Although freeze dried probiotic 
strains can be incorporated into dry feed pellets (Timmerman et al., 2006) it is time consuming 
and expensive as the probiotics need to be co-extruded and prepared with formulated feed.   
 
Figure 3.2 Viability of the five strain probiotic mix over 25 days after freeze drying in 5% skim 
milk and 5% raftilose 
®
P95 (♦), encapsulation in calcium alginate (■), vacuum impregnation into 
the feed pellets (▲) and entrapping the calcium alginate beads into cocoa butter (■). All 

































3.4.1.2 Calcium alginate encapsulation  
Another more widely used method of immobilization of probiotics is entrapment in calcium 
alginate beads (Sheu and Marshall, 1993; Sultana et al., 2000; Krasaekoopt et al., 2004). In this 
study, this method maintains the initial viability of the probiotic mix over 25 days at 4ºC (Fig. 
3.2). Furthermore, this method is relatively simple, low cost and non-toxic. It involves packaging 
the cells into a shell material, such as sodium alginate, which offers them protection from 
unfavorable environments, but permits diffusion of nutrients into and out of the matrix and, 
thereby enables the probiotic cells to maintain long-term viability (Talwalkar and Kailasapathy, 
2004). 
 
Encapsulation has been shown to reduce cell injury or cell loss (Rao et al., 1989) and to stabilise 
cells, enhancing their viability and stability in fermented milks and in the gastrointestinal tract 
(Kailasapathy, 2003). It has been shown to increase the survival of lactobacilli in frozen food-
stuffs (Sheu and Marshall, 1993), in unfavorable conditions such as gastric juice (pH 1.2; Ross et 
al., 2008), and to slow the decline in viable L. acidophilus and Bifidobacterium spp. cells during 
storage in yoghurt, when compared to free cells (Sultana et al., 2000). In comparison to freeze 
dried probiotics, the shelf life is enhanced as it is when freeze dried, but storage at 4ºC is not 
necessary (Capela et al., 2006). Of the delivery mechanisms studied here, calcium alginate 
encapsulation of the probiotic mix was the best alternative to overcome the problem of poor 
stability, survival in the GIT as well as practical issues around delivery to chicks, and was the 
method used in this feeding trial.  
 
3.4.1.3 Cocoa butter encapsulation 
The cocoa butter encapsulated calcium alginate beads provided a good matrix for protecting the 
probiotic beads, maintaining the viability of the strains sufficiently over 25 days (Fig. 3.2). 
Encapsulation of cells in cocoa butter has been shown to increase culturability of two 
Bifidobacterium longum strains during storage and to extend the viability of the bacteria as 
compared to non-encapsulated strains (Lahtinen et al., 2007). The improved culturability 
observed with cocoa butter encapsulated strains is thought to be due to protection offered by the 
lipid matrix against storage stress such as blocking exposure of cells to water and associated 
stress factors such as H
+ 















stresses is matrix encapsulation, rather than „true‟ encapsulation as some cells are attached to the 
surface of the lipid particles and are thus exposed to the stress factors. Some amount of bacterial 
shedding of cells from the matrix may also occur. In this study, the probiotic strains were first 
encapsulated in calcium alginate beads after being mixed with the cryoprotectants, skim milk and 
raftilose 
®
P95, and then embedded in the cocoa butter, thus preventing surface exposure of some 
bacteria to the stress factors. They also had the protection of the cryoprotectants, known to avoid 
damage caused during processing and further extend shelf life (Fowler and Toner, 2005). Due to 
the low melting temperature (approximately 37°C) of cocoa butter, the probiotic microorganisms 
entrapped in this matrix would be released at human body temperature (Lahtinen et al., 2007), 
and similarly in this case at ostrich body temperature. Although the cocoa butter was a good 
option for maintaining probiotic viability, it was not a viable option in this case due to its low 
melting temperature and the high temperatures experienced on the ostrich farms, sometimes 
reaching temperatures above 45°C. Handling of the cocoa butter cubes was also complicated.  
 
3.4.1.4 Vacuum impregnation 
Vacuum impregnation of fruit and vegetables has been shown to be a viable method for 
incorporation of functional foods such as probiotics into food matrices, providing new product 
categories and new commercial opportunities (Alzamora et al., 2005; Huddy, 2010). In this 
study, vacuum impregnation of the probiotic mix into ostrich feed was a successful means of 
incorporating the probiotics into food, the viability of the strains remaining above 10
6 
cfu/g feed 
over 25 days storage at 4ºC (Fig. 3.2). However, after day 10, a substantial decrease was seen in 
viability. For this reason, as well as the suitability of the calcium alginate beads, this method was 
not used to administer the probiotics to the chicks.  
 
3.4.2 Pilot feeding trial (Carnarvon, Karoo)  
The pilot feeding trial in Carnarvon was carried out to test the delivery, safety and success of the 
five strain probiotic mix. Delivery of the probiotic mix via the calcium alginate bead proved 
successful and easy. Total anaerobes and lactic acid bacteria increased in the probiotic treated 
birds compared to the controls (data not shown). Although DGGE analysis of faecal samples 
using universal, Lactobacillus- and Bifidobacterium-specific primers showed no significant 















improved, growth rates increased and mortality rates decreased, for birds receiving the probiotic 
mix.  
 
The pilot feeding trial was carried out on a commercial ostrich farm and it was therefore difficult 
to interfere with the normal running of the farm including dosage of antibiotics (oxytetrachloride 
and colimix) and a commercially available probiotic mix (Protexin). However, the outcome of 
this feeding trial showed that chicks receiving the five strain probiotic mix increased their weight 
gain, improved their feed conversion ratios and decreased the mortality rates when compared to 
the control group (Juste-Poinepen, 2008; du Toit, unpublished). Therefore, the mix was chosen 
for further assessment in the following feeding trial, carried out on an experimental research 
farm, under conditions which were more controlled.  
 
3.4.3 Feeding trial (Elsenburg) 
 
3.4.3.1 RAPD analysis of faecal samples  
RAPD analysis was evaluated here as a possible method for detecting the fed bacterial strains in 
the faecal samples. The pathogens obtained for the five probiotic strains are shown in Chapter 2. 
Faecal samples were cultured on MRS agar and, 10 colonies were selected and amplified with 
Lactobacillus-specific RAPD primers (Fig. 3.3). The pattern, indicating the presence of the 
included L. plantarum strains, is seen in the probiotic group (lanes 9, 11, 12 and 15, 17, 19, 20, 
22, 31 and 33) and not in the control group at the same time point (Fig. 3.4). The RAPD 
fingerprints for the probiotic fed group show a more diverse range of patterns in comparison to 
the control group, which mainly shows only one or two bands per lane. With the maturing gut, 
the microbial diversity in the gut changes (Barnes et al., 1972), and accompanying this, a change 
in RAPD fingerprints obtained would be expected. However, a more intense and diverse range 
would be expected for the probiotic group as found by Fuentes et al. (2008), who reported an 
increased diversity and presence of certain Lactobacillus in the gut and faecal samples of mice 

















Figure 3.3 RAPD analysis of colonies picked from MRS agar obtained from faecal matter of 
ostrich chicks receiving the probiotic mix at week two of the feeding trial, amplified with 
Lactobacillus-specific primers OPL-05 and PL1. Lanes: M, λ-DNA digested with PstI; 1, OPL-
05 primer only; 2, PL1 primer only; 3, no DNA control; 4-13, probiotic treatment pen 1; 14-23, 
probiotic treatment pen 2; 24-33, probiotic pen 3.  
 
RAPD PCR enabled rapid genotyping of the microbial biodiversity found in ostrich faecal 
samples and gave a positive identification of the fed L. plantarum strains, however, for an initial 
screen for the presence of the administered probiotic mix, based on fingerprints, it has been 
reported to have low resolution (Martín-Platero et al., 2009). In addition, this method provides 
limited information on the ostrich gut microbiota as only those culturable on MRS were studied. 
For these reasons, this method was not continued in this study.  
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Figure 3.4 RAPD analysis of colonies picked from MRS agar obtained from faecal matter of 
ostrich chicks in the control group at week two of the feeding trial, amplified with Lactobacillus-
specific primers OPL-05 and PL1. Lanes: M, λ-DNA digested with PstI; 1, no DNA control; 2-
11, control group pen 1; 12-21, control group pen 2; 22-31, probiotic pen 3; last lane, overflow 
from lane 31.  
 
3.4.3 Ostrich chick growth and mortality rates  
During the feeding trial, the ostrich chick‟s weights were recorded (Fig. 3.5), as well as FCR 
(Fig. 3.6) and mortality rates (Table 3.1). On a weekly basis, each chick was weighed separately 
and the average weight for each treatment calculated to establish whether the probiotics had 
enhanced the growth rate of ostrich chicks in comparison to the control group and to the tylosin-
treated chicks. Improved growth rate in poultry, following dietary probiotic supplementation, is a 
commonly reported effect (Nahashon et al., 1994; Abe et al., 1995; Jin et al., 1998a; Jin et al., 
1998b; Timmerman et al., 2006; Thanh et al., 2009; Mountzouris et al., 2010; Mountzouris et 
al., 2011; Thu et al., 2011). In the pilot trial, this specific probiotic mix was shown to 
significantly (p<0.05) increase the weight gain of ostrich chicks in comparison to birds fed a 
control diet (data not shown). In the large-scale feeding trial at Elsenberg, the weights of the 
chicks did not show any differences (Fig. 3.5) until week three where treatment C showed a 
higher, but not statistically different mean weight than the remaining three treatments, which 
were all comparable. 
M 1 2 3 4 5 6 7 8 9
M
19
20 21 22 23 24 25 26 27
10 11 12 13 14 15 16 17 18


























Figure 3.5 Average weights of ostrich chicks in each treatment group E (■), ET (□), C (■) and 
CT (■). Error bars represent the mean ± standard error (n=51). 
 
By week four, the control bird‟s weights were lower than that of the ostriches receiving the 
treatments ET and CT, and group E had all died. This suggests that the probiotic mix was not as 
effective as we had anticipated at increasing ostrich growth rates at an early stage, as previously 
reported (data not shown), and that the antibiotic tylosin may initially retard ostrich chick 
growth. Unfortunately, the majority of control group, C died after four weeks, leaving too few 
chicks for statistical analysis for comparison of weight gain. Groups ET and CT increased from 
week four at a comparable rate reaching approximately 12 kg by week nine. Mushi et al. (1998) 
reported weight loss in the first seven days after hatching due to the use of nutrients from the egg 
yolk, followed by an average weight gain of 1.3 kg per week for ostrich chicks not receiving any 
feed supplements under intensive farming methods up to 12 weeks. In this study, the chicks did 
not show such a rapid weight gain until week five, where the birds receiving treatments ET and 
CT displayed overall weight gains of 1.3 and 1.2 kg/week, respectively. This suggests that 
tylosin is not an effective weight enhancer in ostrich chicks, given that the ostrich chicks‟ weight 
gain reported by Mushi et al. (1998) was higher despite not receiving tylosin. Glatz and Miao 







































72. This study shows the body weight increasing in accordance with this for treatments ET and 
CT.  
 
A feed conversion ratio is a measure of an animal‟s efficiency in converting feed into body mass, 
and is defined as the amount of feed consumed to produce one kg of weight gain (de Verdal et 
al., 2011). The lower the FCR, the more efficiently the animal is converting the food eaten into 
weight gained. Initially, treatment E had the lowest FCR, however the four treatments did not 
differ significantly (p>0.05) at week one (Fig. 3.6). The control group decreased more rapidly to 
below treatment E by week two and maintained the lowest FCR until week four, at the ideal 
value of 1.4 (www.ostrichesonline.com). From week four onwards, treatments ET and CT 
maintained similarly low FCRs, reaching 1.4 by week six, and by week eight, treatment ET had 
an FCR of 0.96 and CT 1.45. No significant differences between FCR‟s were observed between 
these four treatments. Kreibich and Sommer (1995) reported ostrich chicks under six months old 
to have a FCR of 1.4 to 1.6, which is similar to the reported ideal ostrich FCR of 1.5 
(www.ostrichesonline.com). Mountzouris et al. (2007) showed that antibiotic treatment of broiler 
chickens significantly reduced their FCR compared to the control, where as probiotic treatment 
reduced the FCR but not significantly when compared to the control. The average FCR of 
commercially raised broilers up to two months of age is reported to be approximately 2 
(Williams, 1994; Mountzouris et al., 2007; FAO, 2010), showing that ostriches have a better 
FCR than commercially raised poultry. Tylosin treated poultry chicks showed very efficient 
FCRs and, although the use of growth promoting antibiotics is banned, tylosin is a well 
documented growth promoter (Collier et al., 2003). It is not possible to draw any significant 
conclusions on the effect the probiotic mix had on the FCR of ostrich chicks as treatment E died 


















Figure 3.6 Feed conversion ratio of ostrich chicks in treatment groups E (♦), ET (■), C (▲) 
and CT (x). Error bars represent the mean ± standard error (n = 51). 
 
The mortality rates of ostrich chicks receiving treatments E and C followed similar patterns, as 
did ET and CT (Table 3.1). This suggests that tylosin has a profound effect on reducing ostrich 
chick mortality rates, and is evident during the first week of the trial, where treatments E and C 
had mortality rates of 33 and 31%, respectively, in comparison to treatments ET and CT with 
mortality rates of 16 and 22%, respectively (Table 3.1). The mortality rate within treatments E 
and C increased comparably, although the rate was faster for treatment E than for treatments C, 
reaching approximately 92% in week four in comparison to 61% for treatment C. At this time 
point, both treatments ET and CT showed mortality rates of 39.2%. Treatment E and C did not 
show 100% mortality rate, as birds taken for slaughters were not considered for this data. From 
week four onwards, mortality rates for treatment C increased rapidly, while treatment ET and CT 
gradually increased and by week nine 51% of treatment ET had died while 45% of treatment CT 
had died. This shows that the probiotic treatment alone has a negative effect on the survival of 
the chicks, while the combination of probiotics and tylosin shows similar results to group CT. 

































Table 3.1. Cumulative percentage mortality of ostrich chicks in each treatment group 




E ET C CT 
During week1 33.3 15.7 31.4 21.6 
 week 2 47.1 23.5 43.1 25.5 
 week 3 60.8 31.4 54.9 29.4 
 week 4 92.2 39.2 60.8 39.2 
 week 5 - 47.1 88.2 41.2 
 week 6 - 49.0 92.2 41.2 
 week 7 - 49.0 - 43.1 
 week 8 - 51.0 - 43.1 
 week 9  - 51.0  - 45.1 
 
 
Probiotics are thought to reduce host mortality rates via competitive exclusion of pathogenic 
microorganisms, thereby preventing the colonization and proliferation of enteric pathogens 
within the host‟s digestive tract (Timmerman et al., 2006). However, inconsistent mortality rates 
were observed in trials when broiler chickens were fed Lactobacillus preparations (Watkins and 
Kratzer, 1984; Jin et al., 1998a, b and 2000; Zulkifli et al., 2000). Ostrich farming suffers from 
particularly high mortality rates, not only from pathogens, but as a result of handling and 
transportation associated stresses, starvation, leg problems, navel and yolk sac infections, and 
poor ventilation in the pens which can result in high ammonium levels which influences the 
health of chicks (Glatz and Miao, 2008). Glatz and Miao (2008) also suggest that low digestive 
enzyme activity in young ostrich chicks may contribute to high mortality rates. Probiotic 
microorganisms are also considered to contribute to the health of the host by production of 
supplemental digestive enzymes (Ziaei-Nejad et al., 2006). The five probiotic strains used in this 
study were shown to produce zones of clearing on carboxy-methyl-cellulose solid media 
(cellulase test) and xylan solid media (xylanase test; Chapter 2), as well as a positive test for 
cellobiose using the API strip (Chapter 2). Furthermore, diet plays an important role in the health 
of young ostrich chicks. At six weeks old an ostrich chick is able to digest 66 and 38% of dietary 















young ostrich chicks can only utilize 6.5% of ingested fibre (Angel, 1993) and high fibre feeds 
can cause intestinal obstructions. The diet fed in this study contained high fibre, with 50% maize 
meal and 10% lucerne meal. Given the low usage of fibre at this age, this may have contributed 
to the high mortality rates observed here, including treatments ET and CT. In addition, Sato et al. 
(1994) found obstructions such as maize, lucerne or hay, in the proventriculus and gizzard to be 
the cause of death in ostrich chicks in their study. Suffocation due to over-stocking in the pens is 
yet another common reason for mortality. In Zimbabwe, the space requirement for day old chicks 
is 0.16 m
2
/chick increasing by 10% per week (Hallam, 1992). The pens used in this study were 4 
m
2
 and contained 17 chicks per pen (0.24 m
2
/chick). Although this is adequate initially, the pens 
remained the same throughout the feeding trial, and by week two the pens would have been 
smaller than the recommended size. Overcrowding of young ostrich chicks can lead to stress and 
physical abnormalities, such as leg deformities. During the course of the feeding trials the chicks 
were handled by humans regularly, initially when being fed the probiotic encapsulated bead, and 
thereafter when being weighed. This has been reported to cause stress and result in high 
mortalities in ostrich chicks (Hicks, 1992).  
 
3.4.3.4 Microbiological analysis of ostrich chick faecal samples  
In this study, conventional microbiological techniques, using selective solid growth media, were 
used to analyse the microbial composition of faecal (Fig. 3.7 and Table 3.2) and gut mucosal 
samples (Table 3.3). Fuller (1989) described probiotics to beneficially improve the host‟s 
microbial intestinal balance. Ingesting probiotics should result in the development of a healthy 
microbiota which excludes pathogens (Pascual et al., 1999) and favours the colonisation by 
beneficial bacteria, generally enhancing the gut health. In this analysis, p < 0.05 was used for 
statistical significance, but as the sample size here was so small (n = 9), the confidence interval 
was increased to p < 0.1.  
 
MRS agar favours the growth of lactic acid bacteria, and the presence of sodium acetate in this 
medium suppresses the growth of competing bacteria. When comparing the LAB counts between 
the treatments at given time points, weeks two and nine showed significant differences (p = 0.06 
and 0.1, respectively; Table 3.2a). The graphical display (Figure 3.7A) shows treatment E and 















than CT. When comparing the treatments over time, a significant difference is observed for 
treatments C, ET and CT (p = 0.07, 0.03 and 0.02, respectively; Table 3.2b), and perhaps this is 
due to the decrease for these treatments from week two to week four. Hereafter, treatments ET 
and CT gradually increase again. This trend is interesting as all three treatments show this 
decrease in LAB by week four, just after the death of all chicks in treatment E. This could 
indicate that the LAB population was affected by an event such as diarrhea, for example, which 
was detrimental to the chicks in E but the other three treatments were able to survive. Previous 
work by Collier et al. (2003) showed tylosin to increase the lactobacilli counts significantly; 
however this is only seen at weeks two and nine, although the probiotic mix contains two 
different species of Lactobacillus which would be expected to increase their numbers in the 
ostrich gut. The combination of probiotics and tylosin does however show a higher final LAB 
count than that of the chicks only receiving tylosin. Mountzouris et al. (2007) found that feeding 
a probiotic mix including two Lactobacillus strains and a Bifidobacterium to broiler chickens 
increased the numbers of lactobacilli, bifidobacteria and Gram positive cocci compared to the 
control and antibiotic treated birds. It is important to note here that the five probiotics used in this 
study were shown to tolerate tylosin at the level used in the feeding trial (Chapter 2).   
 
BHI agar is an enriched non-selective media used for cultivation of most anaerobic bacteria and 
other fastidious organisms. The total anaerobe counts found in the four treatments showed 
significant differences between them at week four (p = 0.1; Table 3.2a) and week seven (p = 
0.08), and visual analysis of the graph (Fig. 3.7B) indicates that treatment ET has higher 
numbers of anaerobes than C and CT at both time points, indicating a role of the probiotics. Due 
to the lack of specificity with culturing on selective agar, it is unknown whether these anaerobes 
are beneficial or potential pathogens. Treatment CT is the only group showing a significant 
difference over time (p = 0.07; Table 3.2b) and this is possibly due to the dip seen in anaerobes 
at week four and seven. Again, the overview of the data trends show treatment E increasing 
while the other three remain constant in the first two weeks, again suggesting the probiotic mix 
alone increases the total anaerobes initially. Hereafter, treatment ET shows the highest 
prevalence of this bacterial group. Tylosin appears not to have an effect on the total anaerobes. In 
the development of the microbiota, it is expected to see an increase of anaerobic bacteria as the 














































































































E Figure 3.7. Culturable bacterial counts on 
selective solid growth media cultivated from 
ostrich faecal samples during the feeding trial 
where ostriches were fed a control (C■) diet 
supplemented with tylosin (CT ■) or the five 
strain probiotic mix (E ■) supplemented with 
tylosin (ET  ■), grown on MRS agar (A), BHI 
agar (B), McConkey agar (C), SS agar (D) and 
TSC agar (E). Error bars represent the mean  
the standard error (n = 3). Absence of error 
bars indicates that data was available from 







































This is not seen here but may be due to the methods of enumeration used. Although the faecal 
samples were transferred rapidly to the anaerobic travel swabs, they were exposed to the air 
before being collected. This may have an effect on the culturable numbers of anaerobes. 
 
Table 3.2. P-values obtained by performing the Kruskal-Wallis statistical test on the plate 
counts obtained on the selective growth media used for (a) between treatments at a certain time 
point and (b) over time (11 weeks) for each treatment.  
 
McConkey‟s agar contains bile salts and crystal violet dye to inhibit the growth of most gram 
positive bacteria, but selecting for E. coli, Enterobacter and Klebsiella. This group of bacteria 
showed a significant difference at week two between the treatments (Table 3.2a), the control 
group C being significantly lower (p = 0.05) than the other three treatments (Fig. 3.7C). 
Treatments E and C (p = 0.08; Table 3.2b) and CT (p = 0.07) differed over time in prevalence of 
Enterobacteriaceae. Treatment E showed an increase in prevalence of this bacterial group, and C 
and CT a decrease. Both treatments ET and CT do not fluctuate much over the trial suggesting 
that tylosin and probiotic treatment do not affect this bacterial population. Adhesion studies with 
this probiotic mix showed it to be able to inhibit and displace E. coli but unable to out compete it 
(Chapter 2). Shryock et al. (1998) reported an intrinsic resistance of both E. coli and Salmonella 
spp. to tylosin, which appears to be the case in this study too.  
 
SS agar is used for the selection of pathogenic enteric bacilli, especially Salmonella. Salmonella 
spp. did not differ significantly between treatments (Table 3.2a), however, treatment C changed 
significantly over time (p = 0.08; Table 3.2b), decreasing steadily (Fig. 3.7D). All treatments 
remained stable up to week two,  however, at week four, the three remaining treatments showed 
a reduced number of Salmonella spp. and by week seven it was found to be below the limit of 
detection in treatments ET and C, indicating that it was present below the detection limit. Tylosin 
Agar
Time MRS BHI McConkeys SS TSC
Day 0 0.22 0.88 0.46 0.67 0.76
Week 1 0.74 0.25 0.46 0.43 0.50
Week 2 0.06 0.22 0.05 0.20 0.76
Week 4 0.48 0.10 0.17 0.67 0.12
Week 7 0.32 0.08 0.56 N/A 0.37
Week 9 0.10 0.46 0.95 N/A 0.28
Week 11 0.21 0.87 0.28 N/A 0.38
Agar
Treatment MRS BHI McConkeys SS TSC
E 0.59 0.19 0.08 0.30 0.59
ET 0.03 0.47 0.98 0.60 0.03
C 0.07 0.16 0.08 0.08 0.10

















alone (CT) is not effective as this treatment still has Salmonella spp. present at week nine, 
although there appears to be a technical problem at week seven and nine as this bacterial group 
was only detected on one of the duplicate agar plates, hence the absence of error bars, and the 
other two groups were not represented at all (Figure 3.7D), again suggesting it was present below 
the limit of detection. An intrinsic resistance of Salmonella spp. to tylosin was reported by 
Shryock et al. (1998). Again the adhesion data reported in Chapter 2 shows the probiotic mix to 
be able to inhibit and displace Salmonella typhimurium but unable to out compete it. 
 
TSC media is used for the quantification of C. perfringens and is characterised by the 
development of black colonies due to the reaction of hydrogen sulphide produced by C. 
perfringens, and the ferric salt present in the media. The numbers of C. perfringens did not show 
any significant differences between treatments. However, over time, treatments ET and CT 
differed significantly (p = 0.03 and 0.01, respectively) as did treatment C (p = 0.1), all groups 
decreasing over time, except treatment C which showed a peak at week nine (Fig. 3.7E). This 
agrees with previous work by Gérard et al. (2008) where Clostridium spp. titres decreased over 
time in broiler chickens supplemented with probiotics and those not supplemented. C. 
perfringens appears to be more constantly controlled when antibiotics are ingested and by week 
11, the combination of probiotic and tylosin (ET) seems more effective at lowering this 
pathogens count than treatment CT. The postmortem performed on chicks from all treatments 
which died were reported to show intestinal lesions similar to those caused by C. perfringens. 
When comparing groups C and CT it can be seen the CT counts for C. perfringens are always 
higher than the C group, except for week 9, showing that tylosin is not as effective against 
C. perfringens as previously reported (Collier et al., 2003; Martel et al., 2004). This is not the 
trend seen in group ET over 11 weeks. The counts for ET decreased by 10
5
 cfu/g, again 
confirming the effectiveness of the five strain probiotic mix and tylosin combination against this 
pathogen. Adhesion studies (Chapter 2) showed that the single probiotics as well as the five 
strain combination were able to inhibit and displace C. perfringens, explaining the decrease in 


















The data obtained from the Beerens agar plates was not included in this study due to uneven 
growth and contamination. This was unfavorable as the abundance of bifidobacteria are often 
used as biomarkers for the efficacy of pre and probiotics (Apajalahti et al., 2006) and in this 
study would have given useful information on the effectiveness of B. pseudolongum subsp. 
pseudolongum as a probiotic for use in ostrich chicks. The lack of data from Beerens agar plates 
may have been due to medium composition and the fact that some bifidobacteria are more 
difficult to culture than others (Martinaeu, 1999).  
 
The chicks in treatment E died after week two. The selected culturing of faecal samples from 
these chicks did not expose any significant indications as to the cause of death. At week two, 
treatment E shows the highest numbers of all three pathogenic groups, although these differences 
are not significant. Treatment CT showed similar numbers to E on SS agar at week two. The 
postmortems indicated death was likely due to C. perfringens lesions in the guts of these chicks, 
but perhaps it was a combination of reasons, given that the chicks in this treatment suffered 
continually from diarrhea, and that Salmonella spp. and E. coli are important contributors to this 
disorder. The diarrhea would cause weakness and general bad health of these chicks, and 
together with the C. perfringens, may have caused the death of the chicks in this treatment.   
 
The production of antimicrobial compounds by lactobacilli active against pathogens such as E. 
coli, Clostridium and Salmonella spp. is well documented (Naaber et al., 2004, Coconnier-Polter 
et al., 2005, Bernbom et al., 2006). The cumulative antimicrobial effect of the strains used in this 
probiotic mix showed strong activity against S. typhimurium and E. coli, but weak activity 
against C. perfringens indicator strains (see Chapter 2). This data was obtained testing each 
isolate separately. In combination these five strains may act differently against these pathogens 
in vivo.  Treatment ET did successfully reduce the C. perfringens counts on TSC agar compared 
to CT, and perhaps this is due to production of antimicrobials by the probiotic mix.  
 
3.4.3.5 Microbiological analysis of ostrich chick mucosal samples  
To compare the culturable counts of the chosen bacterial groups found in the faecal samples and 















agar as above. Statistical tests showed any significant changes in the certain areas of the gut for 
each bacterial group over time.  
MRS agar detected LAB in all sections of the gut tested (Table 3.3). Some of these groups of 
bacteria are facultative anaerobes and are therefore expected to be present in all sections of the 
gut. Between the two slaughter times, significant increases were noted in the caecum of 
treatment ET (p = 0.05), in the colon of treatment C (p = 0.04) and in the duodenum of treatment 
CT (p = 0.001; Table 3.3). The probiotics fed in this study were shown to adhere well to all 
sections of the gut mucosa (Chapter 2) and would have been expected to cause an increase in 
LAB in all sections of the gut tested here.  
 
Table 3.3. Culturable bacterial counts on selective solid growth media, (MRS, BHI, McConkeys 
and TSC) cultivated from ostrich gut mucosal samples during the feeding trial where ostriches 
were fed a control (C) diet supplemented with tylosin (CT) or the 5 strain probiotic mix (E) 
supplemented with tylosin (ET), in three different gut locations: duodenum (duo), colon (col) 
and caecum (caec). Statistical analysis between the two slaughter points (slaughter 1 (S1) at 
week 2; slaughter 2 (S2) at week 5) displayed any significant differences between the two time 
points (p<0.05).  
Treatment/gut 
region 
MRS BHI TSC McConkeys 
S1 S2 p value S1 S2 p value S1 S2 p value S1 S2 p value  
Eduo 5.92 
 
  4.51 
 
  4.04 
 





  4.73 
 
  3.72 
 





  5.08 
 
  4.19 
 
  5.99 
 
  
ET duo 5.13 7.64 0.33 5.79 7.24 0.01 0.00 0.00   0.00 7.56 
 ETcol 5.00 7.40 0.16 5.37 7.20 0.001 0.00 3.26 
 
6.13 7.26 0.03 
ETcaec 4.98 7.18 0.05 5.03 7.25 0.02 3.78 3.63 0.43 6.16 7.18 0.05 
Cduo 7.13 7.42 0.46 7.54 7.14 0.01 0.00 0.00   6.40 7.36 0.08 
Ccol 7.38 7.62 0.04 6.51 7.63 0.001 4.51 0.00 
 
7.74 7.61 0.19 
Ccaec 7.08 7.49 0.28 6.64 7.70 0.02 0.00 0.00   8.23 7.44 0.03 
CTduo 6.55 7.22 0.001 6.27 6.51 0.23 0.00 0.00   6.19 6.55 0.04 
CTcol 7.39 7.51 0.41 7.39 7.52 0.15 5.53 0.00 
 
7.45 7.55 0.62 
CTcaec 7.18 7.54 0.30 7.13 7.57 0.02 4.46 0.00 
 
3.19 7.50 0.001 
 
As expected, the total anaerobe counts show significant increases for most regions of the gut 
between the two slaughters (Table 3.3). In treatment ET and C, this was evident in all gut regions 
(duodenum p = 0.01; colon p = 0.001; caecum p = 0.02) in both cases, and in the caecum of 
treatment CT (p = 0.02). This decrease was expected in most animals as there are more 















more abundant (Mead and Adams, 1975). It may also be due to the velocity of digesta flow being 
higher in the duodenum than in the distal gut and the commensal anaerobes being “washed-out” 
(Tannock, 1995). The probiotics fed in this study were shown to adhere well to mucous from all 
sections of the gut mucosa (Chapter 2) suggesting a reason why treatment ET showed significant 
increases for anaerobes in all sections of the gut, compared to treatment C which showed a 
decrease in the duodenum and treatment CT which showed no significant change in the 
duodenum.  
The culturable counts on McConkeys agar show significant increases for treatment ET in all 
sections of the gut tested, treatment C in the duodenum, and treatment CT in the duodenum and 
caecum (Table 3.3). Treatment C showed a significant decrease in the caecum as expected as the 
caecum would harbour a higher prevalence of strict anaerobes and the duodenum more 
facultative anaerobes (Mead and Adams, 1975). The increases of coliforms seen for treatments 
ET and CT in the colon and caecum is surprising. The digest flow rate in the caecum and colon is 
slower than in the duodenum, and it could therefore be possible that these increases are observed 
because the culturable facultative microbes found on McConkeys agar were being passed though 
the colon and caecum, not actually resident there. However, Mead and Adams (1975) reported 
facultative anaerobes to predominate in the caeca of chickens for the first two to three days post-
hatching, and to be present throughout the life of the bird. Barnes et al. (1972) reported high 
level of enterococci, lactobacilli and coliforms in the caeca of chickens.  
At slaughter one, TSC agar showed C. perfringens to be present in all regions of the gut in 
treatment E, but was only present in the colon in treatment C and CT, and in the caecum in 
treatment ET and CT (Table 3.3). Only treatment E showed the presence of this pathogen in the 
duodenum. This may be significant as by the second slaughter, chicks in treatment E had died 
and the pathogen was only detected in treatment ET, in the colon and caecum where it had 
increased to 10
3 
cfu/g mucosa. This implies again that the probiotic mix encouraged the 
colonisation of the gut by this pathogen. It also shows tylosin‟s role in C. perfringens control, 















Interestingly, there was a lack of growth on SS agar for the mucosal scrapings at both slaughter 
times (week two and week five), indicating that Salmonella spp. were not likely to be involved in 
the mortality seen in this trial.  
 
In the chicken model, the alimentary canal is reported to be sterile on hatching, but is rapidly 
colonised by bacteria from the mother and the surrounding environment (Amit-Romach et al., 
2004). Previous studies have shown a high prevalence of anaerobic bacteria capable of 
decomposing uric acid in the caecal microbiota of broiler chicks within a few hours of hatching 
(Mead and Adams, 1975). During the first four days post-hatch, streptococci and enterobacteria 
colonise the small intestine and caecum. After the first week, lactobacilli predominate in the 
small intestine, and the caecum is colonized mainly by anaerobes such as Bacteroides, with 
lower numbers of facultative aerobes (Lev and Briggs, 1956; Mead and Adams, 1975). An adult 
chicken‟s caecal microbial community takes 30 days to mature, being dominated by obligate 
anaerobes such as bifidobacteria and bacteroides (Barnes et al., 1972). The culture-dependent 
approach to investigate microbial diversity adopted in this chapter, did not allow for species-
specific enumeration of the ostrich chick microbiota, but it can be seen that LAB, anaerobes and 
E. coli are present in substantial numbers throughout the gut of the ostrich chick by week five 
(slaughter time two; Table 3.3).  
 
The comparison between culturable bacteria from faecal and gut mucosal 
scrapings from three different areas of the ostrich GIT  
To highlight the differences observed in culturable bacteria between the faecal samples and gut 
scrapings of different areas of the ostrich GIT, the bacterial counts obtained on the various 
selective media at week two, four, five and seven were compared (Table 3.4). Week two and five 
are the time points for slaughter one and two, respectively. As there were no faecal counts 
available at week five, week four and seven faecal counts were used for the comparison.  
At the first slaughter point (week two), the faecal counts for all bacterial groups tested were 
higher than those found in any region of the gut mucosal scrapings, except on McConkeys agar 















faecal samples (Table 3.4). By the second slaughter (week five), the coliform numbers on 
McConkeys showed a similar prevalence between faecal and mucosal samples.    
Although the numbers of LAB were higher in the faecal samples at week two for all the groups, 
by the second slaughter (week five), total LAB counts for faecal and gut samples were similar, 
indicating that the microbiota had stabilised by this time. No C. perfringens were detected in 
treatment C and CT mucosal samples, although it was present in the faecal samples. Treatment 
ET showed similar counts for this pathogen between faecal and mucosal samples, but none were 
detected in the duodenum, as mentioned previously. The faecal samples showed a high 
abundance of Salmonella species at week two (approximately 10
6 
cfu/g faecal sample; Fig. 
3.7D), but no growth was observed on SS agar for any of the gut mucosal samples at either of the 
slaughter points. By week seven, only treatment CT still showed the presence of this pathogen in 
the faecal samples. This could suggest that Salmonella was not able to colonise the gut by 
adhering to the mucosa. Instead, it was passed out in the faeces, suggesting that it was inhibited 
or out-competed for binding sites in the gut by the probiotics and commensal bacteria.  
Differences between the culturable counts in the faecal samples compared to the mucosal 
samples could be due to the adhesion properties of the bacterial groups tested, some adhering 
less well than others, and being easily washed off (Zhu et al., 2002). Zhu et al. (2002) also report 
a consistent difference in microscopic examination of mucosal scrapings and caecal contents, the 
latter having higher bacterial counts. Zoetendal et al. (2002) have reported similar findings 
describing significant differences between bacterial communities recovered from human faeces 
as compared to mucosa-associated communities. Other studies have shown that there are no 
significant differences in the detected bacterial numbers in faeces and mucosal samples 
(Wallace, 2008). Another possible explanation for the difference is the difficulty associated with 
culturing of anaerobic bacteria. The exposure of the faecal samples to oxygen before culturing 
would assumedly have an effect on the viable and culturable anaerobes detected. Corthier et al. 
(1996) reported that faecal samples exposed to the air for one hour resulted in killing of the 















Table 3.4. The comparison between ostrich faecal and gut mucosal samples culturable bacterial counts on selective solid growth 
media, (MRS, BHI, TSC, McConkeys and SS) during the feeding trial where ostriches were fed a control (C) diet supplemented with 
tylosin (CT) or the 5 strain probiotic mix (E) supplemented with tylosin (ET), in three different gut locations: duodenum (duo), colon 
(col) and caecum (caec). The faecal counts closest to the slaughter one (at week two) and slaughter two (at week five) time points 
were compared (week two, week four and week seven).   
Treatment/region 
MRS BHI TSC McConkeys SS 
W2 W4 W5 W7 W2 W4 W5 W7 W2 W4 W5 W7 W2 W4 W5 W7 W2 W4 W5 W7 
S1   S2   S1   S2   S1   S2   S1   S2   S1   S2   
E faecal 9.30 
  
  9.19 
  
  7.03 
  
  8.08 
  





  4.51 
  
  4.04 
  
  0.00 
  
  




  4.73 
  
  3.72 
  
  5.23 
  
  




  5.08 
  
  4.19 
  
  5.99 
  
  
   
  
ET faecal 9.04 7.19 
 
7.74 8.73 8.42 
 
9.08 5.85 3.82 
 
4.76 7.49 6.91 
 
7.73 6.22 6.07 
 
  
ET duo 5.13 
 
7.64   5.79 
 
7.24   0.00 
 
0.00   0.00 
 
7.56   




7.40   5.37 
 
7.20   0.00 
 
3.26   6.13 
 
7.26   




7.18   5.03 
 
7.25   3.78 
 
3.63   6.16 
 
7.18   
   
  
C faecal 7.64 6.40 
 
8.03 8.20 7.17 
 
7.97 5.61 3.08 
 
4.67 6.69 6.36 
 





7.42   7.54 
 
7.14   0.00 
 
0.00   6.40 
 
7.36   




7.62   6.51 
 
7.63   4.51 
 
0.00   7.74 
 
7.61   




7.49   6.64 
 
7.70   0.00 
 
0.00   8.23 
 
7.44   
   
  
CT faecal 8.56 6.60 
 
7.71 8.33 7.85 
 
7.78 5.93 5.44 
 
5.00 7.78 6.88 
 





7.22   6.27 
 
6.51   0.00 
 
0.00   6.19 
 
6.55   




7.51   7.39 
 
7.52   5.53 
 
0.00   7.45 
 
7.55   
   
  



















Delivery of the mixture of probiotic strains to the ostrich chicks by encapsulation in calcium 
alginate beads was shown to be quickest, easiest and most effective means of maintaining cell 
viability during processing and storage. Furthermore, the ease of administering the beads to the 
chicks offered another distinct advantage over the other methods investigated in this study.  
 
Probiotic supplementation had no significant effects on weight gain and/or feed conversion 
ratios, and the previously observed growth promoting properties of tylosin were not observed in 
this study due to the lack of a control comparison. In addition, the mortality rates for ostriches 
fed only the probiotic-supplemented diet were highest, in comparison to those receiving the 
control diets, which suggest that a component of the probiotic mix or the five strain combination 
may have encouraged pathogenesis in the ostriches. These birds were the only group to have C. 
perfringens in the duodenal mucosal scrapings. Adhesion studies on this mixture of putative 
probiotic strains showed that it was able to inhibit and displace the pathogens, C. perfringens, 
C. difficile, E. coli and S. typhimurium, but was not able to out compete them for adhesion sites 
in the mucosal membrane in the gut. This suggests that one of the above-mentioned pathogens 
was present in the feed or ostrich pens from the start of the trial. As the pens were open to the 
environment, it was impossible to control the presence of pathogens in the pens. Although the 
pens were regularly washed, it was impossible to prevent the introduction of a pathogen from the 
outside via rodents, or the spread of a pathogen already present in some of the faeces throughout 
the whole pen. In addition, the pens receiving probiotics were adjacent to those not receiving 
probiotics, all in the same shed, and therefore the possibility of the spread of probiotics by 
aerosols or workers cannot be eliminated. A feeding trial using different combinations of the 
probiotic strains or the use of single strains would confirm whether this five strain combination 
was encouraging pathogenesis in the ostrich gut.  
 
The microbiota of the ostrich chick‟s faecal and gut samples were analysed using a culture-
dependent approach in this chapter. At week two the faecal samples showed treatments E and ET 
to have significantly higher LAB counts, as expected as they were receiving probiotic 
supplementation MRS allows for the growth of potential pathogens such as Staphylococcus and 















(www.condolabs.com). Week four showed treatment C to harbour significantly fewer anaerobes 
than ET and CT. After this time point, treatment C died, suggesting this reduction in anaerobes 
was linked to a pathogen present. It is interesting to note that the pathogen, C. perfringens 
decreases significantly for treatments CT and ET over time, indicating that the bacteriostatic 
effect of tylosin was sufficient to prevent mortality in these groups. The post-mortems showed C. 
perfringens lesions to be prevalent and therefore this pathogen could have been responsible for 
the death of these chicks. However, there was a clear effect on the C. perfringens population on 
the different areas of the gut, being found by slaughter two in the anaerobic environments of the 
caecum and the colon, only in treatment ET. The bacteriostatic effect of tylosin on this pathogen 
was clearly seen in the caecum of chicks in treatment ET where the levels of the pathogen did 
not change. Faecal samples showed consistently higher counts for C. perfringens than the 
mucosal counts, indicating that this pathogen is being constantly passed through the gut of the 
chicks and that it appears to be resistant to tylosin.   
 
The method of bacteriological culture is biased, since many selective culture media are not 
absolutely selective. Furthermore, these media do not equally support the growth of the different 
species comprising a population, and not all bacteria are presently cultiviable (Penders et al., 
2006). Non-culturable organisms include those for which the specific growth requirements are 
not available; slow-growing organisms out-competed in the presence of fast-growing 
microorganisms and injured organisms, which cannot withstand the stressful conditions imposed 
by laboratory-based cultivation (Vaz-Moreira et al., 2011). Although culture-dependent 
techniques have been commonly used to study the gut microbiota of various animals (Pieper et 
al., 2006; Mountzouris et al., 2007; Rehman et al., 2007; Vaz-Moreira et al., 2011), ideally both 
culture-dependent and culture-independent methods should be used together for comparable 
analyses. In the following chapters, culture-independent, molecular based techniques, such as 



















Molecular analysis of the microbial diversity of the ostrich 
gastrointestinal tract using denaturing gradient gel electrophoresis 
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The ostrich farming industry is plagued by high chick mortality rates up to three months of 
age. A healthy gut microbiota is thought to play an important role in the competitive 
exclusion (CE) of pathogens, and an in-depth understanding of the microbial diversity in the 
intestines of newly-hatched chicks, as well as  the effect of in-feed probiotics, may lead to the 
development of possible CE candidates to reduce pathogen invasion of the gastrointestinal 
tract. Since culture-dependent microbial techniques have their drawbacks, DGGE based 
molecular analysis was undertaken of the total bacteria and Bifidobacterium and 
Lactobacillus populations in faecal samples from ostrich chicks under three months old. 
Newly-hatched chicks were fed a control diet (C) or a diet supplemented with the antibiotic 
tylosin (CT), probiotics (E) or probiotics and tylosin (ET). The microbial community 
diversities present in faecal samples from the ostrich chicks in each group were analysed by 
calculating the Shannon-Wiener diversity index and major bands were excised from the 
DGGEs and their nucleotide sequence determined.  Feeding of probiotics alone had no effect 
on the total bacteria or Lactobacillus spp. populations, but clustering of probiotic treated 
chicks was seen with regard to the Bifidobacterium spp. populations. When probiotics were 
fed together with tylosin, no changes were seen in the diversity of the total bacterial 
population or the Bifidobacterium spp., however, a significant decrease in diversity of the 
Lactobacillus spp. population was observed. The early death of treatment E may have been 
due to the strain and dose combination of the probiotics used or the immature status of newly-
hatched chicks’ GIT. No bands correlated to the C. perfringens included in the reference 
ladder of the DGGE representing total bacteria althoughthe death of both  group E and the 
control group  was thought to be due to C. perfringens due to the lesions found in the gut 
during the post-mortem. Tylosin was able to maintain the chicks in a healthy state up until the 
end of the feeding trial at nine weeks.  
 
4.2. Introduction 
Although culture based techniques, such as those used in the previous chapter, provide the 
first insight into the complexity of the animal GIT, these methods only allow for detection of 
culturable bacteria, they are time consuming and the results are dependent on the selectivity 















nucleic acid sequence similarities, such as denaturing gradient gel electrophoresis (DGGE) 
and fluorescent in-situ hybridisation (FISH), overcome some of these limitations and are 
useful in the detection of uncultivated bacteria (Harmsen et al., 2000). Even the richest 
culture medium is not able to support the growth of the majority of microbes isolated from 
the GIT of humans and animals due to exclusive growth requirements, resulting in a gross 
underestimation of microbial diversity and numbers (Apajalahti and Kettunen, 2006).  
DGGE is a method which has been widely used in mutation analysis, and has also been 
successfully used to provide a rapid survey of microbial communities. It is based on the 
separation of PCR products according to the melting behaviour of the different amplicons 
(Nikolausz et al., 2005). Fischer and Lerman (1980) suggested that the separation of these 
DNA fragments was not dependent on the length of the fragment, but that the DNA molecule 
partially dissociates due to the increasing concentration of denaturants (urea and formamide) 
at high temperatures (ie the melting behaviour is sequence dependent). This partially-melted 
DNA fragment is now retarded in its movements through the polyacrylamide matrix. They 
also suggested that a double stranded DNA molecule migrates through the polyacrylamide 
gel until its least stable region is melted, indicating that base-pair changes in the melting 
domain significantly alter the overall mobility of the molecule. In addition, a 40 base pair 
GC-rich “clamp” is included into one of the two primer sequences, which is then 
incorporated into each amplicon generated during the PCR. This clamp avoids single-
stranded DNA strands migrating out of the gel by preventing total denaturation of the DNA 
molecule and allows optimal resolution of fragments in the denaturing gradient (Myers et al., 
1985; Muyzer et al., 1993).   
In PCR-DGGE, primers are used to amplify target DNA fragments (usually the 16S rRNA 
genes) from a mixed template (faecal matter in this case) resulting in amplicons of the same 
size, but containing different sequences. The benefits of using the rRNA genes include that 
they are present in the genome of all organisms and have a highly conserved structure, 
comprised of both conserved and variable sequence regions. The conserved regions provide a 
base for primer design and annealing, and the variable regions provide a possibility for 
molecular separation using DGGE. In this study, universal, Lactobacillus- and 
Bifidobacterium-specific primers were used. The use of these specific primers gives an 
indication of the Bifidobacterium and Lactobacillus species present in the ostrich gut. These 
lactic acid bacteria are thought to be important indicators of gut health and are thought to 















variable V3 region of the 16S rRNA genes of all eubacteria, Univ-341-f and Univ-515-r, 
were used to get an overall view of all the different species of bacteria present in the ostrich 
GIT. This is extremely useful in getting a profile of bacteria present, including new and 
unusual species. Muyzer et al., (1993) estimated that any target DNA present at 1% or more 
of the total bacterial pool can be detected.  To improve the specificity and yield, one can use 
genus- and group-specific primers to isolate and characterise a certain group present. To 
detect the lactobacilli present in the faecal samples, the Lactobacillus species-specific primer, 
Lab-0677-r, also targeting the V3 region of the 16S rRNA gene was used in combination with 
Univ-341-f. The Bifidobacterium were detected using Bifidobacterium species-specific 
primers, Bif-164-f and Bif-662-r. These primers target the V2 and V4 variable regions, 
respectively (Langendijk et al., 1995) and have been shown to be specific for the genus 
Bifidobacterium (Satokari et al., 2001). These PCR products are then separated in a sequence 
dependent manner by DGGE on a chemical denaturing gel (usually formamide and urea) 
resulting in a fingerprint, representative of the various species present in the sample. Muyzer 
et al. (1993) were first to apply PCR-DGGE to the field of microbial ecology, pioneering the 
use of rRNA genes for characterisation of a microbial community.  
4.2.1. Aims and objectives of this study 
The aims of this chapter are to evaluate the diversity of the microbiota in the faeces of ostrich 
chicks, examined in chapter three, using universal primers, Bifidobacterium and 
Lactobacillus group-specific primers and evaluating the effect of the administration of 
probiotics and/or the antibiotic tylosin on these communities and their diversity. In addition, 
the detection of the probiotic in the faeces of the test group would indicate successful passage 
though the GIT, surviving the harsh conditions and maintaining the integrity of their nucleic 
acid so as to be detected by DGGE.  
 
4.3. Materials and Methods 
4.3.1. Faecal sample collection and DNA extraction 
Fresh faecal samples were collected in sterile containers and kept on ice while on route to the 
laboratory where they were immediately transferred to a freezer at -20 ºC. Total genomic 















(Inqaba Biotec) according to the manufacturers’ protocol with the exception that 5 samples 
per pen were combined to get a better description of the diversity (Zhou et al., 2007) and 
faecal samples were bead beaten for 140 sec (as described in Chapter 2) prior to extracting 
the total DNA. For the reference ladder, DNA was extracted from the probiotic strains and 
type strains, as described above. The PCR products obtained from the DNA extracted from 
the faecal samples of birds from each pen were run separately for statistical analysis of the 
diversity indices. For comparison between treatments, the pooled samples from each of three 
pens were combined to give one lane representing a treatment group (see feeding trial layout 
in chapter 3). 
4.3.2. DGGE analysis of bacterial diversity 
The DNA was subjected to two rounds of PCR targeting the 16S rRNA gene using the 
following primer sets (Table 4.1; 4.2): 
 Total bacteria: Univ-341-f and Univ-515-r, followed by Univ-341-f-GC and Univ-515-r 
 Lactobacillus specific: Univ-341-f and Lab-0677-r, followed by Univ-341GC-f and Univ 
515-r 
 Bifidobacterium specific: Bif 164-f and Bif 662-r, followed by Univ-341-f-GC and Univ 
515-r 
The PCR reaction mix (50 µl) contained: 25 µl of 2 x Fermentas master mix, 12.5 pmol of 
each primer, bovine serum albumen (0.6 µg/µl final concentration), 200 ng of genomic DNA 
(first round) or 1 µl first round PCR product (second round) and nuclease free sterile water 
(Fermentas).  
 
Table 4.1. Primers used in the nested PCR reactions for analysis with DGGE 
Primer name Sequence (5’ – 3’) Reference 
Univ-341-f cct acg gga ggc agc ag Muyzer et al., 1993 
Univ-341-f-GC cgc ccg ccg cgc gcg gcg ggc ggg 
gcg ggggcacgg ggg g-tcc tac ggg 
agg cag cag 
 
Muyzer et al., 1993 
Univ-515-r atc gta tta ccg cgg ctg ctg gca Lane, 1991 
Lab-0677-r cac cgc tac aca tgg ag Heilig et al., 2002 
Bif-164-f ggg tgg taa tgc cgg atg Langendijk et al., 1995 































The product of the second PCR was analysed by DGGE using the DCode Universal Mutation 
Detection system (BioRad, California), and separated on polyacrylamide gels containing 8% 
(vol/vol) polyacrylamide (37.5:1 acrylamide-bisacrylamide) and 50 X TAE buffer (2M Tris 
Base, 1M Acetic acid, 50mM EDTA, pH8, and water). A denaturing gradient was formed 
with deionised formamide (Sigma) and urea (Sigma-Aldrich). A 100% denaturant was 
defined as 7M urea and 40% v/v deionized formamide. Gels were poured into a 160 x 160 x 1 
mm parallel gel sandwich using a manual gradient former (Bio-Rad, CA). A denaturing 
gradient of 45 – 65% was used for the separation of total bacteria using the universal primers, 
45 – 55 % for Lactobacillus spp. using the Lac primers and a gradient of 55 – 65% was used 
for the separation of Bifidobacterium spp. For analysis, 10 µl of each PCR product was 
loaded and electrophoresis was carried out for 18 h in 1 X TAE buffer. A pre-run voltage of 
180V was maintained for 10 min and hereafter the voltage was kept constant at 62V as was 
the temperature, at 60ºC. Gels were stained in ethidium bromide as per manufacturer’s 
instructions (Bio-Rad) and viewed and photographed the using Gel Doc system (BioRad, 
CA). This procedure was carried out at least twice to ensure reproducible results. 
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4.3.3. Excision of DNA fragments and sequence analysis 
Dominant DNA fragments were excised as described by Omar and Ampe (2000) with some 
modifications. Briefly, after taking the photograph, the gels were restained with ethidium 
bromide for 30 min and destained for 5 min in 25 ml of 1x TAE. DNA bands were cut out 
aseptically using surgical blades, added to sterile nuclease free water, and left to elute at 4 C 
for 18h.   
DNA obtained from excised DGGE fragments was amplified with primers Univ-341-f-GC 
and Univ-515-r as described previously. The PCR products were subjected to DGGE again as 
described above, to ascertain the position and purity of the bands. Thereafter, the DNA from 
the excised band was reamplified using Uni-431-f and Univ-515-r and purified using the 
Biospin PCR purification kit (Bioflux) and the concentrations of purified PCR products were 
determined spectrophotometrically using a Nanodrop instrument (Nanodrop Technologies). 
The pure PCR products were ligated into the pTZ57R/T vector (Fermentas) and transformed 
into E. coli DH5α. Colony PCR was used to confirm the presence of the correct construct and 
one to three of these transformed E. coli cells were sequenced using the M13-f primer.  
Plasmid extraction and determination of the nucleotide sequence data was done by Macrogen 
Inc., Seoul, Korea. Further sequence analysis and editing was carried out using the DNAman 
software programme (Lynnon Biosoft, version 4.13). The closest match of the partial 16S 
rRNA gene was determined by searching the GenBank and NCBI databases using the 
BLAST algorithm (Altschul et al., 1997). A similarity of 97% or more to the 16S rRNA gene 
sequences of type strains was used as a basis for identification. 
4.3.4. Cluster analysis 
The relationship of the DGGE banding patterns of the two population groups was determined 
by a clustering algorithm using Quantity-One (Biorad, CA). This programme assesses 
distances migrated by each band through the gel and compares lanes using a pairwise 
comparison to calculate a Dice similarity coefficient between each pair based on the number 
of bands common to both lanes. Dendrograms were constructed using an unweighted pair 
group method with arithmetic averages (UPGMA).  
The images were analysed for the number of bands per samples (absence versus presence) 
















4.3.5. Shannon-Wiener diversity index 
The microbial diversity of the faecal samples was determined by calculating the Shannon-
Wiener diversity index, H’ (Ledder et al., 2007). This was calculated using the following 
formula: 
                                                 H’ = - ∑ (Pi) (loge Pi) 
where Pi is the importance probability of the bands in the gel lane. The importance 
probability Pi was calculated as 
                                                Pi = ni / N                      
where ni  is the height of a band peak and N  is the sum of all band peaks in the densitometric 
curve. Since the data was not normally distributed, nonparametric analysis was done 
manually using a Mann-Whitney U test (when comparing two cases) or the Kruskal-Wallis 
one way analysis test (when comparing more than three cases). p ≤ 0.05 was interpreted as 
being statistically significant. 
 
4.4. Results and Discussion 
4.4.1. DNA extraction and PCR amplification 
The Zymo Genomic Extraction Kit (Inqaba Biotec) together with bead-beating resulted in 
high DNA yields, ranging from 200- 500ng/µl from 200mg starting material. Inhibitors from 
the faecal material as well as the DNA extraction kit present in the PCR are thought to 
interfere with the amplification process. To avoid this, BSA was added to the PCR reaction 
mix as it has previously shown to improve the PCR product yield and specificity. BSA 
stabilises the Taq DNA polymerase as well as interacts with any inhibitory compounds 
(Nagai et al., 1998). The quality of the DGGE gels of ostrich faecal matter was found to not 
be as good as those obtained from human subjects (Reid, personal communication), perhaps 
reflecting the higher levels of PCR inhibitors due to the plant material in the ostrich feed.  
4.4.2. Choice of PCR primer pairs and the generation of reference ladders 
Total bacteria in the faecal samples were detected using the Univ-341-f and Univ-515-r 















in this study. The type strains used (L. plantarum ATCC 700211
T
; L. reuteri ATCC 23272
T
; 
and B. pseudolongum subsp. pseudolongum ATCC 25526
T
) were found to migrate to the 
same position as the respective probiotic strains (Fig. 4.1A) and therefore, only the probiotic 
strains were included in the reference ladder here. In addition, Clostridium perfringens ATCC 
13124
T
 was added (Fig 4.1A) as it was considered to be one of the main pathogens involved 
in ostrich chick mortality in this study and including it in the reference ladder would allow for 
rapid visual confirmation of its presence in the faecal samples. Three L. plantarum strains 
were used in the probiotic mix (Lp6039.3, Lp1.1.2.2 and Lp162.2), and, as expected, 
migrated to the same position on the denaturing gel. The other two probiotic strains, 
Lr136.2.2 (L. reuteri) and Bp303.3.2 (B. pseudolongum subsp. pseudolongum), as well as C. 
perfringens, showed good separation and were used in combination as the reference ladder 
(Fig 4.1A).  
The primer combination Univ-341-f and Lab-0677-r detected all Lactobacillus reference 
strains used here (Fig. 4.1B). Previous work by Magwira (2008) showed that using a 
denaturing gradient of 45-55% resulted in the best separation of the highest number of 
Lactobacillus species using these primers. 
The reference ladder used with these primers included the three L. plantarum strains and the 
L. reuteri included in the probiotic mix, as well as L. brevis ATCC 14869
T
; L. gasseri ATCC 
33323
T
; and L. pentosus ATCC 8041
T
. The latter two strains were found to migrate to the 
same position as L. plantarum but L. gasseri migrated to a specific position, as did L. reuteri.  
 
The reference ladder used with the Bifidobacterium-specific primers used here, Bif-164-f and 
Bif-662-r included B. adolescentis ATCC 15703
T





,   B. pseudolongum subsp. pseudolongum ATCC 25526
T
, (Fig. 
4.1C). Kullin (2010) found that a denaturing gradient of 55-65% was best for separation of 
species using these primers. All of these type strains co-migrated with the exception of B. 
longum, which migrated to a specific position above the rest. Previous authors have shown 
this set of primers to be specific to a broad range of species from the genus Bifidobacterium 
(Langendijk et al., 1995; Kok et al., 1996; Satokari et al., 2001). However, the strains used to 
test the specificity of these primers have only been of human origin. The specificity has been 
shown to be the case here too with all sequences being returned as belonging to this genus as 















4.4.3. DGGE analysis of PCR products generated from ostrich chick faecal 
samples 
The DGGE gels were run with two intentions. The first was to analyse the banding 
similarities using the programme Quantity-One (Bio-Rad, CA) to show the clustering of the 
different treatments. In this case, only two treatments per gel could be compared in a single 
gel. For this analysis, the faecal samples from the three different pens were pooled (ie 15 
faecal samples combined per lane). The second aim was to compare the microbial diversity in 
treatment groups statistically, by keeping the three pens per treatment separate so as to get 
three Shannon-Wiener diversity (H’) values per group and be able to verify any significant 
differences observed between them. For this, five faecal samples from each pen were pooled 
to minimise the degree of variation between the samples (Zhou et al., 2007). This was a 
preliminary study, focusing on the major bacterial groups and any differences associated with 
them over the course of the feeding trial.  
 
Figure 4.1. DGGE analysis of 16S rRNA gene PCR products from genomic DNA of probiotic and 
type strains, 1 X TAE, 62V for 18 hours and a constant temperature of 60ºC. A. Universal primers, a 
gradient of 45-65%, lanes: M, reference ladder of the five probiotic strains and C. perfringens; 1, 
Lp1.1.2.2; 2, Lp6039.3; 3, Lp162.2; 4, Lr136.2.2; 5, Bp303.3.2; 6, C. perfringens ATCC 13124. B. 
Lactobacillus-specific primers, a gradient of 45-55%, lanes: M, reference ladder of the four 
Lactobacillus probiotic strains and L. brevis ATCC14869T; 1, Lp1.1.2.2; 2, Lp6039.3; 3, Lp162.2; 4, 
Lr136.2.2; 5, L. brevis ATCC 14869T; 6, L. gasseri ATCC 33323T; 7, L. pentosus ATCC 8041T. C. 
Bifidobacterium-specific primers, a gradient of 55-65%, Lanes: M, reference ladder of the five 
Bifidobacterium strains; 1, Bp303.3.2; 2, B. pseudolongum subsp. pseudolongum ATCC 25526T; 3, B. 
adolescentis ATCC 15703T; 4, B. lactis DSM 10140T; 5, B. longum NCIMB 702259T.   DGGE analysis 
of PCR products generated from ostrich chick faecal samples 
A B C

































4.4.4. DGGE analysis of total bacteria, Bifidobacterium and Lactobacillus 
diversity in ostrich chicks 
In order to compare microbial diversity between the treatments, faecal samples from the three 
replicate pens were combined, resulting in one lane per treatment per time point being 
analysed per gel. As expected, variation in band frequency as well as intensity was observed 
both between treatments and between time points of a single treatment.  
The primers used in this study showed good sensitivity and specificity, detecting all the 
respective strains used (Fig. 4.1). Although the reference ladder could be compared to the 
unknown bands in the faecal samples in a visual examination of DGGE profiles (Tannock, 
2002), co-migration of different species to the same banding position in the gel is common 
(Green et al., 2010). It is therefore more useful and reliable to excise the bands of interest and 
sequence them directly to accurately profile a microbial community. Moreover, the great 
bacterial richness observed using the universal primers, makes this method of visual analysis 
difficult. In addition to the dominant bands seen, some less dominant bands were also 
present. These may represent bacterial species present in fewer numbers or may highlight one 
of the problems associated with DGGE: PCR bias where some species are preferentially 
amplified over others (Ishii and Fukui, 2001). There were also some indistinct bands 
observed, which can lead to an overestimation of diversity. These could be due to the high 
diversity of bacteria in the faecal samples which are present in varying proportions, 
artifactual bands due to formation of secondary product during the PCR reaction (Janse et al., 
2004), sequence heterogeneities of rRNA genes (Nübel et al., 1996) or heteroduplexes which 
generally remain high up in the gel due to their lower melting temperatures (Satokari et al., 
2001). 
In our studies, examples of co-migration of different species are given below. In the 
Lactobacillus-specific DGGE of faecal samples, Weissella confuse (band six), Weissella 
paramesenteroides (band nine) and L. plantarum (band 14), migrated to the same positions as 
reference strains L. plantarum, L. brevis and L. reuteri, respectively (Fig. 4.3A and C). 
Interestingly, the Bifidobacterium-specific DGGE of faecal samples did show some 
correspondence. B. adolescentis (band one) and B. pseudolongum subsp. pseudolongum 
(band 14) aligned to the cluster in the reference ladder containing B. pseudolongum subsp. 
pseudolongum, B. adolescentis and B. animalis subsp. lactis (Fig. 4.4A and D). However, 















identity, do not. For example, although bands nine and 14 were both identified as B. 
pseudolongum subsp. pseudolongum, and form a prominent band throughout treatments ET 
and CT, they do not migrate to the position corresponding to the type strain in the reference 
ladder.  
DGGE of faecal samples from ostrich chicks from all treatments showed a consistent 
microbial diversity throughout, with major bands occurring in all or most of the samples run 
on a gel. Nevertheless, unique minor banding patterns were observed between treatments and 
time points. The universal and Lactobacillus populations appear to be quite diverse when 
comparing the number of bands; however, the Bifidobacterium group seems less diverse with 
fewer than four species in most cases.  
 
4.4.5. Cluster analysis 
To examine if there was any relationship between the observed banding patterns and the 
treatments given to the chicks, the faecal samples were analysed and displayed as 
dendrograms created with Quantity-One (Fig. 4.2, 4.3 and 4.4). For this, the DGGE gels were 
run with one lane per treatment (15 faecal samples combined).  
4.4.5.1. Universal primers for total bacteria  
The effect of feeding the five strain probiotic mix on the ostrich microbiota was evaluated by 
comparing group E (receiving the probiotics) to the control group C (Fig. 4.2A). The initial 
time points of both treatments cluster together, as expected, as do the week one and two time 
points of treatment E. This indicates that the probiotics resulted in a distinct difference in 
total bacteria in the first two weeks compared to the control group. Interestingly, treatment C 
showed more intense bands than E, for example band 23 (Anaerostipes butyraticus), band 24 
(Turicibacter sanguinis) and band 26 (Akkermansia muciniphila, section 3.4.8.1). T. 
sanguinis is a possible pathogen and it is clearly less present in treatment E than C. Due to 
the early death of chicks in these treatments, it was not possible to analyse these two groups 
further. 
The effect of tylosin on the microbial diversity of group fed probiotics was also tested by 
comparing the probiotic group E to the group fed probiotics and tylosin, ET (Fig. 4.2B). 















grouping according to treatment is seen hereafter. This suggests that the probiotic mix alters 
the microbial community and that tylosin causes a further alteration. The probiotic strains 
were found to tolerate the level of tylosin administered to the chicks for its growth promoting 
properties (Chapter 3). Band 11, excised from a lane representing treatment E, was identified 
as the pathogen Klebsiella pneumoniae and does not appear to be present in treatment ET, 
perhaps due to its sensitivity to tylosin. An indication of the probiotics effect on E. coli is 
visible, with band nine (identified as E. coli KO11, 100%) present in E day zero and ET day 
zero fading out over the next two time points for both treatments. As an intrinsic resistance of 
E. coli to tylosin has been reported (Suchodolski et al., 2009), it can be assumed this 
disappearance of this pathogen is due to the probiotic mix. Indeed, the adhesion assays in 
chapter two showed the probiotic mix to be capable of inhibiting and displacing E. coli. 
Tanikawa et al. (2010) reported an interesting difference between the times occupied in the 
caeca of two E. coli strains, highlighting the transition state of the microbiota. No bands 
corresponding to the C. perfringens included in the reference ladder were observed for any 
treatments (Fig. 4.2).  
Tylosin’s effect on the diversity of the control group was tested (Fig. 4.2C). The initial time 
points cluster together, and hereafter no clustering according to treatment is seen. Week one 
clusters together for both treatments, as do week two, suggesting tylosin does not affect the 
autochthonous microbiota. Interestingly, most bands are more intense in treatment C than CT, 
perhaps indicating an effect of tylosin in reducing the quantity of certain bacteria in the gut. 
This is interesting as Collier et al., (2003a) showed a significant decrease in total bacteria in 
the ileum of pigs treated with tylosin after two weeks, but that by week four, the tylosin-
treated total bacteria cou ts did not differ from the controls. They suggested this was due to 
the replacement of tylosin-susceptible strains with tylosin-resistant strains. Perhaps this 
would have been the case in this study too. Knothe (1977) showed that extended 
subtherapeautic use of tylosin resulted in tylosin-resistance and cross-resistance to other 
macrolides, lincosamidines and streptogramines. Bands two and three (Clostridium 
clostridioforme and Lachnospiraceae, respectively) are present in both treatments and 
increase gradually over time, the later time points showing them both to be more prevalent 
than at day zero.  
When comparing the effect of probiotics on groups treated with tylosin over a longer time 
period (ET vs CT; Fig. 4.2D), no clustering according to treatment is seen. However, 















later colonisers (week four to week nine) clustering together. Both treatments show band 18 
and 21 (both identified as Akkermansia muciniphila) present initially abundantly, but fading 
out after week two, suggesting sensitivity to tylosin.  In contrast, bands 19 and 22 (Roseburia 
intestinalis and Bacteroides dorei, respectively) seem to be established in both treatments 
after two weeks, and may represent the development of the normal microbiota. The lack of 
clustering according to treatment indicates that the probiotics do not have an effect on groups 
treated with tylosin and that both treatments develop similar microbiota with time. Collier et 
al. (2003a) also found that the use of tylosin resulted in similar pig ileal microbiota between 
individuals throughout tylosin treatment and by day 21, tylosin treated pigs were 
indistinguishable from the control pigs in terms of microbial homogeneity. 
Klarin et al. (2008) showed that feeding L. plantarum 299v together with an antibiotic, to 
patients with antibiotic-associated diarrhoea and Clostridium difficile-associated disease, 
decreased colonisation by C. difficile compared to the control group only receiving the 
antibiotic. The combination also increased the proportion of lactobacilli compared to the 
control group which showed a decrease for this taxon. Other enteric bacteria increased 
similarly in both groups. They also found that the control group showed a more varied 
diversity than in the treatment group, but that this variety included potential pathogens. In this 
current study, the diversity of eubacteria in ostrich chicks seemed to mature at the same rate 
in both treatments, indicated by the same common bands. The relatively low number of bands 
could indicate that a number of species are falling below the 1% threshold (10
12 
bacteria/g). 
An alternative possibility for the low number of bands is that the diversity of total bacteria in 










































































   
Figure 4.2 (A, B, C and D). DGGE and cluster analysis of total bacteria using universal primers Univ-341-f and Univ-515-r. A. The effect of probiotics on the normal 
microbiota. B. The effect of tylosin on the micrbiota of chicks receiving probiotics. C. The effect of tylosin on the normal microbiota of chicks. D. The effect of probiotics on chicks 
receiving tylosin. Universal 16S r RNA gene primers were used to amplify total bacteria isolated from faecal samples provided by groups given probiotics and tylosin (ET), only 
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Figure 4.3 (A, B, C and D). DGGE and cluster analysis of Lactobacillus using lactobacilli-specific primers Univ-341-f and Lab-0667-r. A. The effect of probiotics on the normal 
microbiota. B. The effect of tylosin on the microbiota of chicks receiving probiotics (no bands were excised from this gel). C. The effect of tylosin on the normal microbiota of chicks. 
D. The effect of probiotics on chicks receiving tylosin. 16S rRNA gene primers were used to amplify Lactobacillus isolated from faecal samples provided by groups given probiotics 
and tylosin (ET), only tylosin (CT), only probiotics (E) and the control group (C). PCR products were separated on 45 – 55% DGGE.  Lane M is the mixed strain reference ladder. 
Excised bands are circled and numbered. 
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Figure 4.4 (A, B, C and D). DGGE and cluster analysis of Bifidobacterium using bifidobacteria-specific primers Bif-164-f and Bif-662-r. A. The effect of probiotics on the 
normal microbiota B. The effect of tylosin on the microbiota of chicks receiving probiotics. C. The effect of tylosin on the normal microbiota of chicks. D. The effect of probiotics on 
chicks receiving tylosin. 16S r RNA gene primers were used to amplify Bifidobacterium isolated from faecal samples provided by groups given probiotics and tylosin (ET), only 
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4.4.5.2. Lactobacillus-specific primers  
The DGGE comparing the probiotic treatment E and control group C with respect to the 
lactobacilli present shows clustering of the treatments (Fig. 4.3A), showing that the probiotic 
mix alters the normal microbiota of the ostrich chicks in the first two weeks after hatching, as 
seen with the universal primers. The specific effect may be due to band ten (Lactobacillus 
bifermentans), present in treatment E at both week one and two, but absent in treatment C. 
Aside from this, the DGGE fingerprints of treatment E and C show similar trends, with 
Aerococcus urinaeequi (band 11) disappearing in both groups after week two and L. curvatus 
(band seven) appearing in both groups at week one and two. The probiotic mix administered 
to the chicks in this study did alter the microbiota, agreeing with the numerous studies 
showing that the inclusion of Lactobacillus in a probiotic feed additive affects lactobacilli 
numbers, which significantly increase in treated animals compared to controls (Pollmann et 
al., 1980a; Pollmann et al., 1980b; Jonsson and Olsson, 1985; Jenny et al., 1991; 
Mountzouris et al., 2010). 
The chicks fed probiotics (E) and those fed probiotics and tylosin (ET) did not show 
clustering according to treatment (Fig. 4.3B). E day zero and ET day zero grouped together, 
as expected. These two treatments showed similar DGGE fingerprints, with treatment E 
differing only with the presence of the band previously identified as Lactobacillus 
bifermentans (Fig. 4.3A). This band was present in the control group, and not in treatment 
ET, and may be a tylosin sensitive, commensal Lactobacillus of the ostrich GIT. The 
lactobacilli included in the probiotic mix were shown to tolerate tylosin at the dose 
administered in this feeding trial, and this is seen in the similarity between fingerprints of 
these two treatments.   
Group C showed no grouping of control groups, according to treatment or time (Fig. 4.3C). 
There is no clustering of initial time points which is unexpected. This could be due to band 14 
(Lactobacillus plantarum), present in C day zero, but not in CT day zero, band 19 (Weissella 
paramesenteroides) present in CT day zero and absent in C day zero, or to band 18 
(Weissella paramesenteroides) which only appears in C at week one, and is in CT from day 
zero onwards. This initial difference in gut communities may reflect the random inter-
individual differences between birds. It may also be due to the origin of the chicks as they 















No clustering is seen when comparing the effect of tylosin on probiotic-fed (ET) and control 
(CT) groups over a longer time frame, with regards to Lactobacillus spp., and day zero 
samples did not group together, although they are closely related (Fig. 4.3D). Again, this is 
unexpected. Overall, the clustering is not clear and it can be concluded that feeding probiotics 
to chicks receiving tylosin did not appear to alter the Lactobacillus diversity of the gut 
compared to birds only receiving the antibiotic. Band 21 (Leuconostoc pseudomesenteroides/ 
Weissella confuse) is present, constantly, for both of these treatments and is therefore 
considered insensitive to tylosin. Treatment CT at week seven and ET at week nine cluster 
together, probably due to the appearance of band 25 (L. johnsonii/Aerococcus urinaeequi) at 
these respective time points, indicating this strains tolerance to tylosin. Band 22 (Weissella 
paramesenteroides) and 23 (Pediococcus pentosaceus) are both present initially in treatments 
ET and CT, but decrease gradually, not detected by week seven.  
4.4.5.3. Bifidobacterium-specific primers 
Regarding the Bifidobacterium population, the probiotic mix did not appear to have an effect 
when compared to the control, as no specific grouping of treatments were seen (Fig. 4.4A; 
Table 4.5). Day zero of these treatments did not cluster together, possibly due to the 
appearance of band four (Bifidobacterium animalis subsp. lactis) in C day zero, but not in E 
day zero. Interestingly, this band appears in treatment E by week one. Band one 
(Bifidobacterium ruminantium) was present throughout for both treatments except in the 
control by week two. Although B. pseudolongum subsp. pseudolongum was detected in both 
these treatments (bands two, six and seven), treatment C week 2 showed a much more intense 
band (band seven) compared to treatment E and the earlier time points of treatment C. This 
suggests that this strain develops naturally in the maturing GIT, and is its colonisation is 
unaffected by the ingestion of probiotics which are thought to increase the presence of 
bifidobacteria in the gut. This lack of grouping of treatments shows that the probiotic 
treatment does not have an effect on the Bifidobacterium spp. diversity when compared to the 
control, in ostrich chicks. Harmsen et al. (2002) fed B. longum to healthy human volunteers 
and found, using DGGE and fluorescent in-situ hybridisation, that this probiotic had no effect 
on the gut Bifidobacterium populations. In contrast, Mountzouris et al. (2010) found that 
feeding broilers a probiotic mix containing B. animalis increased the Bifidobacterium spp. 















Again, the initial time points do not cluster together when testing the effect of tylosin on the 
bifidobacterial community for the groups receiving probiotics (E vs ET; Fig. 4.4B; Table 
4.5). Week one of treatments E and ET cluster together and then each treatment at week two 
clusters with their respective day zeros. This could be another example of the tylosin-
sensitive strains being replaced by the tylosin-resistant strains by week two, as previously 
reported by Collier et al. (2003b). However, the fingerprints obtained for these samples show 
an increase in diversity with time, the banding becoming more diverse, indicating that the 
probiotics increase the diversity of Bifidobacterium in the faecal samples. 
The use of tylosin on the control groups (C and CT) appeared to have an effect on the 
autochthonous Bifidobacterium spp. population, with CT clustering together but group C only 
showed grouping of day zero and week one, while week two clustered close to CT day zero 
(Fig. 4.4C; Table 4.5). The initial time points are clearly different too, with band 15 
(Bifidobacterium animalis subsp. lactis) present in C day zero and not in CT day zero, and 
band 18 (B. pseudolongum subsp. pseudolongum) present in CT day zero and not in the 
control, initially. Day zero and week one from both treatments clustered together, indicating 
that initially tylosin does make a difference to the Bifidobacterium spp.   
In the comparison of treatments ET and CT over nine weeks, group ET and CT did not show 
clear clustering (Fig. 4.4D; Table 4.5). The initial time points did not cluster together either 
due to the presence of the band in ET day zero, aligning with band 12 (B. pseudolongum 
subsp. pseudolongum) and its absence in CT day zero. The band corresponding to B. 
pseudolongum subsp. pseudolongum is present in all samples except, ET week one, which 
also contains B. pseudolongum subsp. pseudolongum but which migrated to a unique position 
on the gel. The lack of clustering seen here shows that administration of probiotics to groups 
receiving tylosin had no effect on the diversity of the Bifidobacterium spp. population or that 




















4.4.6. Band richness 
Since each band in DGGE is likely to represent a phylogenetically distinct population, an 
estimation on the species number can be based on the total number of bands in the profile. 
This measure of diversity is very similar to the Shannon-Wiener index, however the 
Shannon-Wiener has the added level of measurement, including not only the number of bands 
per lane, but also their proportions. The bacterial richness was calculated for each treatment 
time point for total bacteria, Lactobacillus and Bifidobacterium populations (Fig. 4.5A-C).   
 
4.4.6.1. Universal primers for total bacteria  
Treatment E showed an increase in band richness in comparison to the control group, which 
showed a constant decrease in bacterial richness (Fig. 4.5A). This is unexpected as the 
diversity of the gut microbiome is expected to increase with age, thus providing a more solid 
competitive exclusion barrier to invading pathogens. It can be seen that feeding the five strain 
probiotic mix alone does increase microbial diversity when studying the total bacteria, but 
this increase seen here did not protect the chicks from an early death either, suggesting that 




























































Figure 4.5(A, B and C). Bacterial band richness 
values for total bacteria (A), lactobacilli (B) and 
bifidobacteria (C) over time obtained from 
DGGE analysis of faecal samples from ostrich 
chicks fed a five strain probiotic mix (E), 
probiotics and tylosin (ET), control diet (C) and 















potential pathogens. Tylosin seems to have a varying effect on the band richness for both ET 
and CT, and this may be due to tylosin-sensitive strains being replaced by tylosin-resistant 
strains repetitively.  
4.4.6.2. Lactobacillus-specific primers  
With regard to the Lactobacillus population (Fig. 4.5B), all treatments increased in richness 
in the first two weeks, except treatment C which decreased sharply at week two. This is 
interesting and suggests that feeding tylosin alone (group CT) increases the lactobacilli 
population in the gut. However, from week two onwards, treatment ET shows a greater 
Lactobacillus richness than treatment CT suggesting that the feeding of probiotics did 
increase the Lactobacillus richness. This agrees with previous work (Pollmann et al., 1980a; 
Pollmann et al., 1980b; Jonsson and Olsson, 1985; Jenny et al., 1991; Mountzouris et al., 
2010) showing that in-feed Lactobacillus probiotics increases the diversity of this bacterial 
group in the gut.   
4.4.6.3. Bifidobacterium-specific primers 
Treatments E and ET follow the same trend, decreasing by week one and then increasing 
again by week two (Fig. 4.5C). Treatment ET decreases steadily hereafter, suggesting tylosin 
has a detrimental effect on the richness of the Bifidobacterium population. Groups C and CT 
gradually increase until week two, thereafter CT decreases, finally increasing slightly by 
week nine.  
 
4.4.7. Statistical analysis of microbial diversity using the Shannon-Wiener index 
(H’) 
For the statistical analysis, the five faecal samples collected from each pen were pooled but 
the three replicates of each treatment pen were run separately on the DGGE to obtain three H’ 
values on which to perform statistics (gels not shown). The H’ is a more sensitive method of 
measuring bacterial diversity as it considers the intensity of each band which it includes. The 
Kruskal-Wallis test was used when comparing all four treatments over the feeding trial 
period. This was only possible in the first two weeks, as thereafter birds undergoing 
treatments E and C died. The Kruskal-Wallis test is a non-parametric test used to assess the 















three or more groups. To compare the remaining two treatments, ET and CT, the Mann-
Whitney U test was used. This is a non-parametric statistical hypothesis test used to assess 
two independent samples.  
4.4.7.1. Diversity of the total bacteria found in the faecal samples over time 
Group E had all died after week two and it was therefore only possible to analyse the H’ 
values for all four groups up to this time point. The Kruskal-Wallis test showed only 
treatment ET having a significant difference in diversity (p = 0.05), increasing from day zero 
to week two suggesting that feeding tylosin together with probiotics increases the diversity of 
the total bacteria over two weeks (Fig. 4.6A(i)). If the confidence interval is dropped to 90 % 
(as n is small), treatment CT shows a significant decrease in total bacterial diversity from day 
zero to week one (p = 0.097).  
The Mann-Whitney U test between treatments ET and CT over the full duration of the 
feeding trial (nine weeks) showed no significant differences for either group (Fig. 4.6A(ii)). 
This differs from the results above using the Kruskal-Wallis test where ET showed a 
significant increase in H’ and is most likely due to the fact that the Mann-Whitney U test is 
biologically more stringent than the Kruskal-Wallis test. Shimada et al. (2010) found that 
addition of tylosin at 1.67mg/L to an anaerobic batch reactor had no effect on total bacteria in 
the first 50 days.  
4.4.7.2. Diversity of the total bacteria found in the faecal samples between 
treatments 
The Kruskal-Wallis test showed no significant difference between the four treatments at day 
zero or at week two, but a significant difference (p = 0.044) was seen at week one, group ET 



















This shows that the antibiotic-probiotic mix has an effect on the microbial diversity as soon 
as one week. However, when the Mann-Whitney U test was done on H’ values from 
treatments CT and ET at all time points (day 0 to week 9), no significant differences were 
seen between these groups at any time point (Fig. 4.6A(ii)). Again this is most likely due to 
the stringency of the Mann-Whitney U test.  
4.4.7.3. Diversity of the Lactobacillus found in the faecal samples over time 
The Kruskal-Wallis statistical analysis only showed a significant increase in lactobacilli 
diversity for treatment C over the two week time frame (p = 0.05; Fig. 4.6B(i)). The other 
treatments have no effect on the diversity of this taxon. At 90 % confidence interval, group 
CT showed a significant increase in lactobacilli diversity from day zero to week two (p = 










E1 1.67 1.56 1.82
0.37E2 2.06 1.57 2.41
E3 1.79 1.71 1.48
C1 1.71 1.72 2.09
0.26C2 1.75 1.31 1.52
C3 1.89 1.52 2.05
ET1 1.75 1.90 2.33
0.05ET2 1.75 1.91 1.95
ET3 1.77 1.91 2.03
CT1 2.02 1.35 2.38
0.097CT2 2.06 1.34 2.07
CT3 2.13 1.37 1.79










E1 1.84 1.93 1.59
1.00E2 1.98 1.09 1.82
E3 1.57 1.76 1.94
C1 1.27 1.33 2.31
0.05C2 0.68 1.64 2.36
C3 0.69 1.25 2.14
ET1 1.91 1.91 1.81
0.37ET2 0.65 1.86 2.20
ET3 1.49 1.56 2.15
CT1 1.44 1.35 2.17
0.10CT2 1.68 1.92 2.12
CT3 1.45 0.49 2.14










E1 0.68 0.84 1.12
0.10E2 1.40 0.78 1.51
E3 0.55 0.43 0.89
C1 0.00 0.48 0.85
0.76C2 0.22 0.82 0.78
C3 0.68 0.00 0.00
ET1 0.00 0.79 0.69
0.37ET2 0.29 0.19 0.66
ET3 0.43 0.64 0.63
CT1 1.51 0.19 0.42
0.72CT2 0.00 0.30 0.63
CT3 1.06 0.90 0.70
p value * 0.28 0.86 0.08
Time point
Pen Day 0 Week 1 Week 2 Week 4 Week 7 Week 9
p value 
**
ET1 1.75 1.90 2.33 1.82 1.66 2.02
0.21ET2 1.75 1.91 1.95 2.11 2.11 1.53
ET3 1.77 1.91 2.03 2.02 1.96 1.47
CT1 2.02 1.35 2.38 1.95 2.05 1.59
0.15CT2 2.06 1.34 2.07 2.03 2.16 1.75
CT3 2.13 1.37 1.79 2.13 1.36 1.58
p value 
* 0.05 0.05 0.83 0.51 0.83 0.51
Time point
Pen Day 0 Week 1 Week 2 Week 4 Week 7 Week 9
p value 
**
ET1 1.91 1.91 1.81 0.83 1.09 1.50
0.05ET2 0.65 1.86 2.20 1.21 0.34 1.11
ET3 1.49 1.56 2.15 1.35 0.14 1.18
CT1 1.44 1.35 2.17 1.59 0.39 1.12
0.07CT2 1.68 1.92 2.12 1.55 0.57 1.61
CT3 1.45 0.49 2.14 0.17 0.32 1.55
p value 
* 0.83 0.51 0.83 0.51 0.83 0.28
Time point
Pen Day 0 Week 1 Week 2 Week 4 Week 7 Week 9
p value 
**
ET1 0.00 0.79 0.69 0.73 0.73 0.91
0.06ET2 0.29 0.19 0.66 0.69 0.74 0.89
ET3 0.43 0.64 0.63 0.64 0.60 0.94
CT1 1.51 0.19 0.42 0.85 0.58 0.75
0.89CT2 0.00 0.30 0.63 0.56 0.74 0.80
CT3 1.06 0.90 0.70 0.77 0.63 0.16
p value * 0.38 0.83 0.51 0.51 0.51 0.05
A(i) B(i) C(i)
A(ii) B(ii) C(ii)
Figure 4.6. The Shannon-Wiener diversity indices calculated from DGGE banding patterns 
from the three different primer sets: A, Eubacteria primers Univ-341-f and Univ 515-r; B, 
Lactobacillus-specific Univ-341-f and Lab-0667-r; C, Bifidobacterium-specific Bif 164-f and 
Bif-662-r. The Kruskal Wallis test (i) was used to statistically differentiate between all four 
treatments, and the Mann-Whitney U test (ii) was used to test between two treatments. P value 
















Collier et al. (2003a, b) where tylosin was shown to enrich Lactobacillus spp. in both 
chickens and pigs.  
Again the Mann-Whitney U test showed different results, showing group ET to have a 
significant increase in lactobacilli diversity (p = 0.05) from day zero to week two (Fig. 
4.6B(ii)). Hereafter, the H’ decreased again. The confidence interval of 90 % also shows 
treatment CT to have a significant increase in this phylum from day zero to week two, 
confirming the above results.  
4.4.7.4. Diversity of the Lactobacillus found in the faecal samples between 
treatments 
No significant differences were observed between the treatments at any of the time points 
using either the Kruskal-Wallis or Mann-Whitney U test (Fig. 4.6B(i) and (ii)). This implies 
that none of the treatments altered the lactobacilli diversity profiles in the ostrich gut even 
though Lactobacillus were included in the probiotic mix. However, at 90 % confidence 
interval, group E has a significantly lower H’ value (p = 0.1) than the other three treatments 
using the Kruskal-Wallis test.   
4.4.7.5. Diversity of the Bifidobacterium found in the faecal samples over 
time 
Neither of the statistical tests used here showed any significant differences in Bifidobacterium 
diversity over time for any of the treatments (Fig. 4.6C (i) and (ii)). This may suggest that the 
Bifidobacterium population is acquired among farmed ostrich chicks as soon as they hatch 
and becomes well established so that exogenous Bifidobacterium do not survive the 
conditions and competition of the endogenous microbiota. When the confidence level is 
altered to 90 % however, group E showed a significant increase from day zero to week two (p 
= 0.1) using the Kruskal-Wallis test, and the Mann-Whitney U test showed the 
Bifidobacterium diversity in group ET to increase significantly (p = 0.06) over the course of 


















4.4.7.6. Diversity of the Bifidobacterium found in the faecal samples 
between treatments 
Using the Kruskal-Wallis test of significance, no differences were seen between any of the 
treatments (Fig. 4.6C(i)). However, at the 90 % confidence interval, week two showed 
treatment E to have a significantly higher Bifidobacterium H’ than the other three treatments 
(p = 0.08). This suggests a positive role for this probiotic mix in the diversity of the 
Bifidobacterium population.  
The Mann-Whitney U test however did show a significant increase in Bifidobacterium 
diversity at week nine for group ET compared to group CT (p = 0.05; Fig. 4.6C(ii)). This 
infers that feeding the combination of tylosin and probiotics increases the diversity of the 
Bifidobacterium population, but only after nine weeks.  
4.4.8. Sequence analysis 
Chosen dominant bands from all treatment groups were excised from the DGGE gel and re-
amplified using Univ-341-f and Univ-515-r, and the PCR purified products were sequenced. 
This approach showed mixed DGGE bands were present due to co-migration. Therefore, the 
PCR purified products were cloned into the pTZ57R/T vector and three random clones were 
selected for sequencing.  
4.4.8.1. Universal primers 
The primer combination used in this section is specific to all eubacteria. Figure 4.2 shows the 
bands which were excised and sequenced. The majority of cloned bands were identified as 
uncultured bacteria as the primary hit using BLAST searches, suggesting that most of the 
amplified bacterial DNA isolated from the ostrich gut have not previously been identified to 
species level in the database. To get an indication of actual bacteria present, the sequences 
from this study returned as uncultured were further used to search for the closest culturable 















Table 4.3. The closest relatives of the amplicons excised from DGGE gels using the universal primers. The 
results are based on BLAST searches. 
Treatment Band  16S rRNA gene  
% 
similarity Accession  
  Number sequence identification   Number 
E day 0 8a,b Clostridium hathewayi 100 NR_036928.1 
  8c Clostridium ramosum 96 AB595128.1 
E day 0 9a, c E. coli KO11 99 CP002516.1 
  9b Klebsiella oxytoca 100 HQ694732.1 
E week 1 10a, b Akkermansia muciniphila ATCC BAA-835 98 CP001071.1 
E week 1 11a, b Klebsiella pneumoniae 342 99 CP000964.1 
E week 1 23a Anaerostipes butyraticus 97 AB616134.1 
  23b Ruminococcus albus 7 95 CP002403.1 
  23c Odoribacter splanchnicus 94 AB547649.1 
E week 1 24a Turicibacter sanguinis strain PC909 97 HQ428099.1 
  24b  Clostridium sp. MK12  98 AB275141.1 
  24c Clostridiales bacterium 94 HQ452851.1 
E week 2 12a Eubacterium xylanophilum  97 L34628.1 
  12b Clostridiales bacterium 95 HQ452852.1 
ET day 0 15a, b, c Clostridium ramosum 98 AB595128.1 
ET day 0 16a, b, c Uncultured Lachnospiraceae bacterium 99 EF708581.1 
ET day 0 17a Anaerostipes butyraticus  100 AB616134.1 
ET week 1 18a, b Akkermansia muciniphila ATCC BAA-835 89 CP001071.1 
  18c Clostridium ramosum 96 AB595128.1 
ET week 1 13a Clostridium ramosum 98 AB595128.1 
  13b Oscillibacter valericigenes  99 AB238598.1 
  13c Coprobacillus cateniformis 100 GU811876.1 
ET week 2 14a, b, c Dethiosulfovibrio acidaminovorans 92 NR_029034.1 
ET week 2 19a, b, c Roseburia intestinalis strain DSM 94 HM007565.1 
ET week 2 20a Clostridium sp. MK12 98 AB275141.1 
  20b Lactobacillus sp. DI71 87 AB290831.1 
  20c Akkermansia muciniphila ATCC BAA-835 96 CP001071.1 
C day 0 1a B. subtilis BSn5 100 CP002468.1 
  1b Uncultured bacterium clone from 93 EU468485.1 
    okapi faeces     
C day 0 25a Escherichia coli O157:H7 EDL933 99 AE005174.2 
  25b Enterobacter sp. KN/03/24 100 HQ235641.1 
  25c Acinetobacter sp. CNE 4 100 FR749854.1 
C week 1 26a Akkermansia muciniphila ATCC BAA-835 97 CP001071.1 
  26b Rumen bacterium NK4B114 from rumen of sheep 95 GU324414.1 
C week 1 2a Clostridium clostridioforme 99 HM008264.1 
  2b Anaeroplasma bactoclasticum 92 M25049.1 
C week 1 3a Lachnospiraceae bacterium 96 AF550610.1 
C week 1 4a Anaerostipes butyraticus 95 AB616134.1 
  4b Pediococcus pentosaceus 100 HQ834496.1 
  4c Lachnospiraceae bacterium 95 EU728787.1 
C week 2 5a Odoribacter splanchnicus 94 AB547649.1 
  5b Uncultured bacterium clone from 97 EU779235.1 
    Trancaspian Urial feces     
C week 2 6a, b Clostridiales bacterium from 95 HQ452851.1 
    chicken caecum     
CT week 2 21a, b, c Akkermansia muciniphila ATCC BAA-835 98 CP001071.1 
CT week 7 22a, b Bacteroides dorei strain F4071 100 FJ460592.1 
 
If no species names were found, the result was recorded as “uncultured”. Using the 97% or 















identified to the species level. This data was obtained from limited sequencing of major 
bands from DGGE and is therefore not a comprehensive indication of the microbiota found in 
ostrich chicks. Six phyla were identified as representatives of the bacterial groups present in 
this study from the clones identified by nucleotide sequence analysis, the majority belonging 
to the Firmicutes.   
When looking at the effect of the treatment on the distribution of total bacteria, all groups 
show a great diversity, including species from various phyla. The Firmicutes were the major 
phylum found in all treatments, with 15 out of the 25 excised bands belonging to this phylum 
(Table 4.3). In addition, Akkermansia muciniphila was detected in all four treatment groups, 
from as early as week one, showing it is an early coloniser and possibly a common 
commensal. It also appears to be resistant to tylosin. Birds from treatment E harboured the 
pathogenic Klebsiella pneumoniae which causes ostrich chick fading syndrome and 
Klebsiella oxytoca, also a potential pathogen. On the other hand, birds from treatment C 
harboured pathogenic Escherichia coli O157:H7 and Acinetobacter sp. Although the 
Acinetobacter band appears to be present in treatment E too, it was not positively identified 
using sequencing and so cannot be confirmed.  Lachnospiraceae spp. is frequently detected 
in C but not in E, highlighting another effect of the probiotic mix. Sequencing results do not 
differ significantly for groups receiving probiotics compared to those receiving both 
probiotics and tylosin. One difference is that treatment ET appeared to have fewer pathogens 
such as Klebsiella and tylosin seems to favour Clostridium, especially cluster XVIII and 
XIVa strains.  
4.4.8.1.1. Phylum Firmicutes 
 
The Firmicutes represented the majority of the sequences identified in this study using the 
universal primers (Table 4.3). Of these most belonged to the Class Clostridium.  Of the 25 
bands sequenced, 14 were identified as members of the Clostridium group. This finding 
agrees with Matsui et al. (2010b), who in a metagenomics study screened a 16S rRNA gene 
clone library obtained from caecal digesta of adult ostriches and found the Firmicutes to 
dominate the sequences obtained from the ostrich caeca (51% of the total number of 
sequences) and of these most were from the class Clostridium (Clostridium leptum and 















Firmicutes to be the main component of the microbiota of broiler chickens, followed by 
Bacteroidetes (Apajalahti and Kettunen, 2006).  
This is in contrast to previous work by Lu et al. (2008) where they showed this genus to be 
present in avian faeces at only 11%. However, Apajalahti et al. (2004) and Dumonceaux et 
al. (2006) showed the chicken caeca to be dominated by the Clostridiales order, followed by 
Lactobacillales and Bacteroidales. Matsui et al., (2010a) confirmed this, showing 
Clostridium clusters XIVa and XIV to be dominant in the ostrich caeca. Our current study 
found the Clostridiales being most frequently detected, the majority being members of 
Clostridium cluster XIVa (C. coccoides) and XIV (C. leptum), both lineages containing many 
butyrate producers. Clostridium hathewayi (cluster XIVa) and C. ramosum (cluster XVIII) 
were the most common, being found in treatments E, C and ET. Treatment C at week one 
also contained Clostridium clostridioforme (cluster XIVa). Tylosin has been shown to be 
effective in decreasing the genus Clostridium (Shimada et al., 2010) and it is therefore 
interesting to find this genus represented at such an extent in treatment ET.  
 
4.4.8.1.2. Butyrate producing bacteria  
 
Butyrate-producing bacterial strains are considered important in the maintenance of a healthy 
gut via butyrate production, maintenance of luminal pH by consumption of lactate or the anti-
inflammatory effect of some of these strains (Sokol et al., 2008; Guilloteau et al., 2010). 
Ostriches have been shown to be particularly dependent on these bacteria. Swart et al. 
(1993b) showed that volatile fatty acids such as butyrate, propionate and acetate, from hemi-
cellulose and cellulose fermentation, are responsible for about 76% of the metabolizable 
energy in a growing ostrich chick, especially acetate, and that propionate and butyrate were 
only present in small amounts in the hindgut. Swart et al. (1993b) also suggested that in 
ostriches, similar to other animals, butyrate is absorbed preferentially over propionate which 
in turn is absorbed faster than acetate. So although acetate is the predominant VFA in the 
ostrich gut, butyrate is the most readily absorbed.  
 
Butyrate-producing strains are well represented in the ostrich gut and most of the Clostridium 
identified in this study are butyrate producers and belong to clusters XIVa and IV. The major 
species identified from the DGGE analysis was Anaerostipes butyraticus (band six), a novel 















caeca (Eeckhaut et al, 2010). This species was detected in treatments E, ET and C and is 
therefore considered resistant to tylosin at the concentration used here. Roseburia intestinalis 
(band 19), which is a dominant band in the DGGE in weeks four to seven, is an important 
butyrate producer isolated from many animals including the caecal contents of broiler 
chickens (Eeckhaut et al., 2011). It is very similar genomically to Eubacterium rectale, both 
part of the Clostridium cluster XIVa, and in addition to butyrate, it also produces lactate and 
formate and utilizes acetate. R. intestinalis was also shown to degrade cellobiose as well as 
arabinose, fructose, maltose, raffinose, sucrose, xylose and starch (Duncan et al., 2002). 
Oscillibacter valericigenes (band 13) is found in Clostridium cluster IV and has been shown 
to be a valerate-producing anaerobic bacteria, producing butyrate and valeric acid from D-
xylose (Iino et al., 2007).  
 
4.4.8.1.3. Fibre digesting bacteria 
Fibre digesting bacteria are also important in terms of their function in ostrich digestion. An 
interesting difference between the well-characterised poultry model we use and the ostrich is 
that chickens do not digest plant fibre, especially not cellulose, to any significant extent 
(Swart et al., 2003a). This is most likely due to the short retention time in the chicken gut, 
compared to the long (40 hour) transit time in the ostrich. Ostriches are capable of digesting 
hemicellulose (68% of that ingested) and cellulose (38% of that ingested) very efficiently and 
this is presumably due to microbial digestion as well as the highly developed hindgut. Van 
Gylswyk et al. (1998) isolated five fibrolytic bacteria from ostrich faeces, two of which were 
identified as Propionibacterium acnes (97%) and Ruminococcus flavefaciens (97%). Matsui 
et al. (2010) also detected an uncultivated Fibrobacter in fresh ostrich faeces.  
In Table 4.3, a number of fibre-digesting bacterial strains have been identified. Eubacterium 
xylanophilum (97%), part of Clostridium cluster IV, is a novel fibre digesting bacteria, 
utilising cellobiose and xylan and producing formic, acetic and butyric acids. Ruminococcus 
albus, a member of the Family Lachnospiraceae, a member of Clostridium cluster IV, was 
also detected in treatment E (band 23) but the similarity was only 95%. Although R. albus 
was only detected in one clone, the corresponding band appears to be present in all lanes 
across the gel in the DGGE with treatments E and C. This phylotype is a major fibrolytic 
bacteria in the rumen of ruminants (Koike and Kobayashi, 2001). However, in a study by 
Matsui et al. (2010), where a specific primer was used for this phylotype, no R. albus was 















a member of Lachnospiraceae (96%; Accession number AF550610.1), which is 
phylongenetically close to clones RA-01 and RA-02 previously isolated from ostrich faeces, 
belonging to Clostridium cluster XIVa (Matsui et al., 2010). Lachnospiraceae have also been 
isolated from the pig intestines (NCBI, Accession number AY587806). More importantly, 
Matsui et al. (2010) found several operational taxonomic units (OTU’s) isolated from ostrich 
faeces, which when sequenced, clustered closely with Ruminococcus flavefaciens and 
Lachnospiraceae bacterium. These two bacteria are closely related and R. flavefaciens has 
been isolated from ostrich faeces previously (van Gylswyk et al., 1998) and is thought to be a 
major fibrolytic bacterium in the large intestine of the ostrich. Tanikawa et al. (2011) found 
uncultured Lachnospiraceae to be the main Firmicute present in the caeca of chicks. Leng et 
al. (2010) detected this bacterial genus using DGGE in the rumen of Indian Gayals and 
reported it is also commonly found in the rumen of cattle and is able to degrade pectin, 
phenolyic compounds and quercetin.  
4.4.8.1.4. Potential pathogenic bacteria 
Proteobacteria were found to account for 20.8% of the total bacteria in the chicken caeca 
(Zhu et al., 2002). Tanikawa et al. (2011) also found Proteobacteria to be one of the main 
phyla present in chick caeca in the first two weeks of life, especially E. coli, and Klebsiella 
pneumonia was also detected. However, Apajalahti and Kettunen (2006) found this phylum 
only as a minorityin chicken caeca.   
E. coli was detected in treatments E and C. Aside from commensal E. coli, there are also 
pathogenic strains of E. coli which cause colibacillosis in chickens (Rodriguez-Siek et al., 
2005) and pigs (Chin and Chapman, 2009) and leads to major economic loss in the farming 
industry. The E. coli detected in treatment C (band 25) shows 99% similarity to E. coli 
O157:H7, a strain posing a major threat to public health, causing haemorrhagic colitis which 
can be fatal (Perna et al., 2001). It is known that stress can lead to intestinal dysbiosis, and 
has lead to the presumption in avian pathology that this aids the penetration of E. coli into the 
blood stream from the gut mucosa, causing septicaemia (Herráez et al., 2005). Ostriches are 
extremely sensitive to stress. On the other hand, E. coli K011 detected in treatment E (band 
nine) is non-pathogenic and is most likely a commensal of the ostrich gut, capable of utilising 
cellobiose, xylose and arabinose (Dien et al., 2000). These two strains appear to migrate to 
the same position on the DGGE gel, just below the reference ladder strain Lr136.2.2 and the 
band seems to be present in treatment ET also. This is not surprising as E. coli is intrinsically 















2009) and pigs (Smith, 2009) when fed tylosin. In an anaerobic continuous fermentation 
culture of chicken microbiota, Poole et al. (2003) showed tylosin to facilitate the persistence 
of pathogenic E. coli O157:H7.    
 
Klebsiella pneumonia (band 11) was detected in treatment E. This species has previously 
been isolated from ostrich chicks and was shown to cause ostrich chick fading syndrome 
(OCFS) (Terzich and Vanhooser, 1993). OCFS is characterised by depression, anorexia and 
death three to five days after onset of clinical signs in ostrich chicks less than three weeks 
old. Klebsiella oxytoca (band nine), a cellulose degrader (Wood, 1997) and cause of 
antibiotic-associated hemorrhagic colitis in humans (Högenauer et al., 2006) was also present 
in treatment E at day zero. Both of the above species have been isolated from ostrich cloaca 
and oropharynx previously (Melville et al., 2004), K. pneumonia reaching as high as 32% in 
the oropharynx, and K. oxytoca present at 2% in both locations.  
Band 25 shows 100% similarity to Enterobacter sp. isolated from human urine and 
Acinetobacter sp. (100%), an opportunistic pathogen.  Both of these Classes have been 
isolated previously from ostrich eggs, in a study related to ostrich embryo death (Cabassi et 
al., 2004).  
Anaeroplasma bactoclasticum (band two), a species belonging to Anaeroplasma, a genus of 
the Mollicutes, was detected in group C. Although mycoplasma are rife in South African 
ostrich farming and most ostrich mycoplasma related illnesses are due to species found in the 
poultry industry (Verwoed, 2000), only three ostrich specific mycoplasmas have been 
isolated, to date which cause respiratory disease (Botes et al., 2005). These isolates, Ms01, 
Ms02 and Ms03 (accession numbers DQ223545, DQ223546 and DQ223547, respectively) all 
fall into the Hominis group of mycoplasma, whereas the Anaeroplasma bactoclasticum 
isolated in this study falls under the Anaeroplasma group, separating it too from the most 
common poultry mycoplasma.  
4.4.8.1.5. Phylum Verrucomicrobia 
This phylum, represented by the species Akkermansia muciniphila only, makes up 13% of the 
sequences from ostrich faeces identified from the gels using total bacteria primers, and was 
found in samples from all treatments. It was therefore assumed to be resistant to tylosin. In 
comparison, Matsui et al. (2010b) found this phylum to be present in ostrich caecal contents 















gorillas. A. muciniphila is capable of using mucin as its sole carbon and nitrogen source 
(Derrien et al., 2004). The exact relationship between mucin-degraders and the host remains 
unknown. Mucins are the main constituents of mucus which provides the protective barrier 
against pathogens. Degradation of this mucus layer can therefore lead to reduced protection 
which can in turn become pathological (Sonoyama et al., 2009). However, van Passel et al. 
(2011) showed that A. muciniphila colonises the gut of humans early and is found less 
abundantly in humans with gut disease, suggesting it may be a good biomarker for a healthy 
gut. Since mucins are highly sulphated acidic monopolysaccharides, their degradation by gut 
microbes release sulphate, encouraging sulphate-reducing microbes such as Dethiosulfovibrio 
acidaminovorans (Gibson et al., 1988), also detected in this study. 
4.4.8.1.6. Phylum Bacteroidetes 
Matsui et al. (2010b) found Bacteroidetes to be the second most dominant phylum present in 
ostrich faeces at 39%. However, Zhu et al. (2002) found that in broiler chickens, the 
Bacteroides group only represented 1.9% of total bacteria detected using TGGE. Lu et al. 
(2009) reported that this phylum is generally very low in avian faecal samples such as the 
waterfowl, having only 7.1%. In comparison, the turkey harbours Bacteroidetes in abundance 
(Scupham et al., 2007), as do humans. Only one DGGE band was identified as Bacteroides 
species, which is surprising given that Bacteroides are thought to have essential roles in the 
degradation and fermentation of organic material in the colon (Salyers, 1995). Sonnenburg et 
al. (2005) showed that Bacteroidetes are able to detect, bind, degrade and import 
carbohydrates, providing substrates to a myriad of bacteria, including the butyrate producers. 
Bacteroides dorei (band 22), a species isolated from human faeces and found to ferment 
xylose (Bakir et al., 2006), has not been isolated in avian faeces before. This is interesting as 
Bacteroidales populations studied in animal and human faeces was shown to be host-specific 
and show host-specific distributions to such an extent that it was possible to design a host-
specific marker, a useful addition to the microbial source tracking toolbox (Mieszkin et al., 
2009). 
4.4.8.1.7. Lactobacillus-specific primers 
The bands which were excised and sequenced are shown in Fig. 4.3. The specificity of the 
Lactobacillus primers for the lactic acid group is confirmed by the sequencing results as the 
identities of the different bands were Lactobacillus, Leuconostoc, Weissella, Pediococcus and 
Aerococcus as expected (Heilig et al., 2002; Table 4.4). Low similarities were also obtained 















(Woese et al., 1980). A. bactoclasticum (Accession number M25049.1) was detected at week 
one with both the Lactobacillus-specific and the universal primers in treatment C (table 4.3). 
Of the 20 bands excised, the majority of sequences were identified at Weisella (52% of the 
total number of sequences) and only six bands corresponding to Lactobacillus species and the 
rest were made up of Pediococcus, Leuconostoc and Aerococcus. Again, some excised bands 
showed identity to more than one species, indicating co-migration. These primers resulted in 
good sequences with high similarities, above the 97% threshold.  
On closer examination of the sequence identities of major bands present in DGGE analysis of 
the faecal samples, it can be seen that neither the administered probiotic strain nor tylosin had 
a profound effect on the LAB diversity of the ostrich chicks. None of the Lactobacillus 
strains included in the probiotic mix were detected in the faecal samples of the groups 
receiving probiotics, and no distinct species grouping was noted according to treatment. 
Although bands six and 13 both aligned with the L. plantarum found in the reference ladder 
on the DGGE, they were identified as Weissella confusa. The L. plantarum strain which was 
detected in treatment C on day zero, where no probiotics were fed, shows an exact sequence 
match to Lp1.1.2.2 (the L. plantarum included in the probiotic mix). This may suggest that 
this strain is a normal member of the ostrich flora, acquired immediately after hatching. It is 
interesting to see that the band corresponding to this bacterium migrates to the same position 
























Table 4.4. The closest relatives of the amplicons excised from DGGE gels using Lactobacillus-specific primers. 
The results are based on BLAST searches. 
Treatment Band  16S rRNA gene  
% 
similarity Accession  
  Number sequence identification   Number 
E day 0 6a, b, c Weissella confusa 100 AM117179.1 
E week 1 7a, b Lactobacillus bifermentans 98 AB289045.1 
  7c Lactobacillus curvatus strain NM33-2 100 HM218173.1 
E week 2 9a, b Weissella paramesenteroides strain FMA246 100 HQ721270.1 
E week 2 10a, b, c Lactobacillus bifermentans 98 AB289045.1 
C day 0 13a Weissella confusa 100 AM117179.1 
C day 0 14a, b, c Lactobacillus plantarum strain P1N 99 GU372710.1 
C week 1 15a, b, c Weissella paramesenteroides strain FMA246 100 HQ721270.1 
C week 1 16a, b, c Pediococcus pentosaceus strain SC1 99 HQ834496.1 
C week 1 11a, c Anaeroplasma bactoclasticum 93 M25049.1 
  11b Aerococcus urinaeequi strain 11LS3 98 HQ284933.1 
C week 2 12a Weissella paramesenteroides strain FMA246 100 HQ721270.1 
C week 2 17a Weissella paramesenteroides strain FMA246 98 HQ721270.1 
  17b Lactobacillus bobalius 99 AB626063.1 
C week 2 18a Pediococcus dextrinicus 99 FM877685.1 
  18b, c Weissella paramesenteroides strain FMA246 100 HQ721270.1 
ET day 0 21a, c  Leuconostoc pseudomesenteroides 100 AB572039.1 
  21b Weissella confusa 100 AM117179.1 
ET week 1 22a, b, c Weissella paramesenteroides strain FMA246 98 HQ721270.1 
ET week 1 23a Weissella confusa 99 AM117179.1 
  23b, c Pediococcus pentosaceus strain SC1 99 HQ834496.1 
ET week 2 24a Weissella paramesenteroides strain YSY-M4 100 GU223367.1 
  24b, c Pediococcus pentosaceus strain SC1 99 HQ834496.1 
ET week 9 25a Lactobacillus johnsonii strain Sun 100 HQ641209.1 
  25b Aerococcus urinaeequi strain 11LS3 100 HQ284933.1 
CT day 0 19a, b Weissella paramesenteroides strain FMA246 100 HQ721270.1 
CT day 0 20a Lactobacillus sp. SXVIII11(2011) 97 HQ728335.1 
  20b Pediococcus dextrinicus 99 FM877685.1 
CT week 1 26a Pediococcus argentinicus 98 AM709786.1 
  26b Pediococcus pentosaceus strain SC1 100 HQ834496.1 
  26c Lactobacillus curvatus strain NM33-2 100 HM218173.1 
 
The LAB distribution in the ostrich gut between treatments appears to be homogenous. 
Weissella paramesenteroides is detected in all treatments and is therefore appears to be a 
common commensal member of the ostrich gut, which is resistant to tylosin used in this 
study. The Lactobacillus strains which were detected include L. bifermentans and L. curvatus 
in treatment E, while treatment C contained L. plantarum and L. bobalius, and group ET had 















Pediococcus pentosaceus, and ET is also the only treatment harbouring Leuconostoc 
pseudomesenteroides although the corresponding band seems to be present throughout in ET 
and CT.  
4.4.8.2. Bifidobacterium-specific primers 
The specificity of the Bifidobacterium-specific primer set was seen from the sequencing 
results in Table 4.5, with only Bifidobacterium being detected, showing high sequence 
similarities to the species in the database, again all above the 97% threshold. The range of 
Bifidobacterium present was very limited, only four species being reported, B. pseudolongum 
subsp. pseudolongum being the most common (55% of clones). 
The next most common strain was B. animalis, with subspecies animalis and lactis present. 
B. ruminatium and B. adolescentis were found to occur only in E day zero. B. pseudolongum 
subsp. pseudolongum was the strain incorporated into the probiotic mix and was not found at 
day zero except in treatment ET. It did, however, occur, in the faecal samples from all 
treatments, indicating it may be a commensal member of the ostrich GIT. Faecal samples 
from day zero showed a high Bifidobacterium diversity with B. pseudolongum subsp. 
pseudolongum, B. ruminatium, B. adolescentis and B. animalis present. This variety 
decreased by week two to mainly B. pseudolongum subsp. pseudolongum with few B. 
animalis. Treatment C and ET showed three species present, B. pseudolongum subsp. 
pseudolongum, B. animalis subsp. animalis and B. animalis subsp. lactis. Treatment CT only 
showed the presence of B. pseudolongum subsp. pseudolongum. Petersson et al. (2009) 
showed that feeding pigs Bifidobacterium spp. resulted in more Bifidobacterium-related 
DGGE bands. This is not so in this study where feeding the ostrich chicks a probiotic mix 
including B. pseudolongum subsp. pseudolongum did not result in any significant differences 
when compared to the control treatments. Vasquez et al. (2009) found a similar low 
Bifidobacterium diversity in the caecal contents of 36 rats, all harbouring one dominant 


















Table 4.5. The closest relatives of the amplicons excised from DGGE gels using Bifidobacterium-specific 
primers. The results are based on BLAST searches. 
Treatment Band  16S rRNA gene  
% 
similarity Accession  
  Number sequence identification   Number 
E day 0 1a Bifidobacterium ruminantium strain KCTC 3425  100 GU361831.1 
  1b Bifidobacterium adolescentis strain LCR4 99 HQ259739.1 
E week 1 2a Bifidobacterium pseudolongum subsp. pseudolongum 98 AB507147.1 
E week 2 3a, b Bifidobacterium animalis subsp. lactis 99 HQ293104.1 
E week 2 16a, c Bifidobacterium animalis subsp. lactis strain NWL83 99 HQ293104.1 
  16b Bifidobacterium pseudolongum subsp. pseudolongum 99 AB507147.1 
C day 0 15a, b, c Bifidobacterium animalis subsp. lactis strain NWL81 99 HQ293104.1 
C week 1 4a Bifidobacterium animalis subsp. lactis 100 HQ293104.1 
  4b Bifidobacterium pseudolongum subsp. pseudolongum 100 AB507147.1 
C week 1 5a Bifidobacterium animalis subsp. animalis 98 GQ913435.1 
C week 1 6a Bifidobacterium pseudolongum subsp. pseudolongum  100 AB507147.1 
  6b Bifidobacterium pseudolongum subsp. pseudolongum 100 GU361829.1 
C week 1 17a, b Bifidobacterium pseudolongum subsp. pseudolongum 100 AB507147.1 
C week 2 18a, b, c Bifidobacterium pseudolongum subsp. pseudolongum 99 AB507147.1 
C week 2 7a, b Bifidobacterium pseudolongum subsp. pseudolongum 100 GU361829.1 
ET day 0 9a Bifidobacterium pseudolongum subsp. pseudolongum 100 AB507147.1 
ET week 1 10a Bifidobacterium pseudolongum subsp. pseudolongum 100 AB507147.1 
  10b, c 
Bifidobacterium animalis subsp. animalis strain 
TEEV 98 GQ913435.1 
ET week 9 12a Bifidobacterium animalis subsp. lactis strain NWL81 99 HQ293104.1 
  12b, c Bifidobacterium pseudolongum subsp. pseudolongum 99 AB507147.1 
CT week 2 19a Bifidobacterium pseudolongum subsp. pseudolongum 100 AB507147.1 
CT week 4 14a, b Bifidobacterium pseudolongum subsp. pseudolongum 100 AB507147.1 
 
The lack of Bifidobacterium diversity in the ostrich gut could be due to this set of primers not 
picking up ostrich specific species, or due to the ostrich GIT not having a diverse population 
of this genus, or the strains being below the detection level of PCR-DGGE.  Janczyk et al. 
(2007) showed that Bifidobacterium  10
5 
per gram digesta) compared to the high numbers of lactobacilli present (10
9 
per gram chyme). 
Zhu et al., (2002) investigated the chicken caecal microbiota and found Bifidobacterium to be 
present at less than 2% of the total bacteria. Zhu and Joerger (2003) confirmed this. In a study 
by Endo et al. (2010), Bifidobacterium were isolated from the faeces of only four out of nine 
herbivores (two springbok and two wallaby). Ostrich faecal material was tested for the 
presence of Bifidobacterium, but none were detected. The Bifidobacterium identified from 















common Bifidobacterium in animal faeces (Lamendella et al., 2008) and possesses probiotic 
properties (Vasquez et al., 2009). 
When the sequences from probiotic strain Bp303.3.2 and B. pseudolongum subsp. 
pseudolongum (AB507147.1), detected here were aligned, only five mismatches were 
detected, whereas 19 mismatches were found between Bp303.3.2 and B. pseudolongum 
subsp. pseudolongum (GU361829.1; data not shown). This may indicate that the 
Bifidobacterium included in the probiotic mix was not detected in the faeces, but that this 
species is a commensal of the ostrich chick gut from as early as day zero, as it is frequently 
detected in all treatments.  These results also suggest that ingesting a probiotic 
Bifidobacterium does increase the diversity of this species found in the gut, as seen in 
treatment E. This agrees with work by Petersson et al. (2009) who found more 
Bifidobacterium-related DGGE bands in pigs ingesting these bacteria.  The only specific 
treatment-related pattern observed here is treatment CT which sh ws the presence of only 




The development of molecular techniques such as PCR-DGGE has allowed for more accurate 
and rapid microbial community profiling. Probiotic LAB and Bifidobacterium are common 
inhabitants of the gut and are generally regarded as markers of a healthy gut..  
The effects of the probiotic and tylosin treatments analysed by the clustering of the DGGE 
banding patterns showed interesting results. Optimally, initial time points would have been 
shown to cluster together given the chicks had not started their respective treatments, and that 
15 faecal samples had been pooled together to reduce intra chick variability. This grouping of 
day zero samples from different treatments was not the case in some instances, presumably 
because the chicks came from three different farms. Although the eggs are incubated in 
sterile incubators, once hatched the chicks would have been exposed to their environments 
and this, on top of their genetic influence, would affect their microbiota differently, as 
previously described (Zoetendal et al., 2001). In addition, an individual’s gut microbiota has 















would be advantageous to use chicks from the same origin and batch to eliminate this 
variable as much as possible.   
The effect of the various treatments on the diversity of bacterial populations found in faecal 
samples showed that feeding probiotics altered the diversity of total bacteria and the 
lactobacilli population when compared to the control chicks, as seen by the clustering of 
these two treatments observed. When compared to the control birds, ingesting probiotics did 
not affect the diversity of the bifidobacteria population. Tylosin causes a shift in total bacteria 
in chicks receiving probiotics but does not appear to affect the autochthonous total bacterial 
microbiota, as seen by the lack of clustering of groups C and CT. It is therefore assumed that 
tylosin affects the ingested probiotics.  As the probiotics were shown to tolerate the level of 
tylosin used in this trial, the clustering may be due to tylosin enriching the probiotic strains, 
altering their proportions. Tylosin did not alter the lactobacilli population diversity when 
compared to the group only receiving probiotics, or the control gr up. When looking at the 
bifidobacteria population, tylosin did not alter the diversity of this bacterial group when 
tested on chicks receiving probiotics, but there was clustering observed for the control chicks 
receiving tylosin. Probiotics do not appear to change the diversity of the total bacteria, 
lactobacilli or bifidobacteria components of the microbiota of chicks receiving tylosin as no 
clustering according to treatment is observed for ET and CT. However, the effect of time on 
the development of the microbiota is evident from the way that weeks four, seven and nine 
form a cluster, as do day zero, week one and week two. 
The bacterial richness measured by the number of bands per lane did not always agree with 
the Shannon-Wiener index of diversity. Given that the Shannon-Wiener is a more sensitive 
measure of diversity, our conclusions shall be drawn from it, rather than the band richness. 
Feeding the probiotic mix alone had no effect on the diversity of the total bacteria or the 
Lactobacillus spp. populations overtime. However, it did result in an increase in 
Bifidobacterium spp. from week one to two. This is in contrast to the control group which 
showed an increase in Lactobacillus spp. The combination of the probiotics and tylosin 
increased the total bacterial diversity and the Bifidobacterium spp., but decreased the 
Lactobacillus diversity. In comparison, the group tylosin alone increased the Lactobacillus 
spp. and had no effect on the Bifidobacterium spp. In conclusion, the probiotics, alone or 
















When comparing treatments, the total bacteria show their highest prevalence in treatment ET 
at week one, compared to the other three treatments indicating this combination enhanced 
bacterial numbers in the gut microbiota. At week two, the control birds exhibited the highest 
lactobacilli prevalence and treatment E the highest bifidobacteria prevalence, showing that 
the probiotics alone enhance diversity of this genus, but not that of the lactobacilli. Hereafter, 
no differences between treatments were observed except at week nine where bifidobacteria 
were more prevalent in ET than CT.   
The sequencing of excised DGGE bands returned results similar to those obtained by Matsui 
et al. (2010b) for ostrich caecal contents, showing similar bacterial group patterns, the 
dominant bacterial group being members of the C. coccoides and C. leptum group. However, 
Bacteroidetes were frequently isolated by Matsui et al., (2010b) whereas in this current study, 
Proteobacteria and Verrucomicrobia were more common than Bacteroidetes. However, this 
study was a very limited study with respect to DGGE bands excised and identified by 
sequencing. A very much larger clone library would need to be included in the future to draw 
any conclusions on the bacteria present in the ostrich gut. No bands aligning with the C. 
perfringens strain included in the reference ladder were observed, as were no excised bands 
identified as this pathogen. This is interesting, given its role in ostrich chick mortality, 
however, this pathogen may not be a transient species and would therefore not be expected to 
be found in the faeces. The L. plantarum strains included in the probiotic mix were not 
detected in the faeces of the chicks receiving the mix, despite having been recovered from the 
day zero samples of treatment C.  B. pseudolongum subsp. pseudolongum was the most 
frequently isolated Bifidobacterium, being detected in all treatments, indicating it may be a 
commensal member of the ostrich gut from the day of birth. The probiotic mix did appear to 
result in higher number of Bifidobacterium species and tylosin seemed to decrease the 
number of species found.   
The limitations of the DGGE technique notwithstanding, one can tentatively claim that 
feeding the probiotics did not significantly alter the microbiota of the chicks, and the 
probiotics used here were not detected in the DGGE and could be due to their lack of ability 
to survive the GIT or, that they successfully adhere to the mucosa, and are not passed out in 
the faeces. Tylosin did not appear to have a detrimental effect on the bacteria in the ostrich 
gut when used in combination with the probiotic mix, but when used alone it appeared to 















This was a limited sequence analysis of the ostrich faecal content, from the time of hatching 
to nine weeks. It gives a brief overview, but a much more comprehensive study of the 
bacteria present is necessary. The PCR amplicons generated using the primers described here 
are short. Longer amplicons would result in better identification of excised bands to allow for 
better differentiation between strains. The future of microbiota analysis lies with 
metagenomics, a powerful tool for expanding our knowledge of the communities harboured 
in the gut. Although identifying the bacterial groups present, it would be extremely useful to 
get a functional description of the microbiota, by detecting functional genes, for example 
those encoding proteins involved in cellulose degradation and butyrate production. 
Functional gene primers have been shown to be appropriate targets for DGGE to characterise 
subpopulations that are responsible for particular metabolic functions. Some examples 
already characterised with DGGE include methyl coenzyme-M reductase (Wilms et al., 
2007), dissimilatory sulfite reductase (Karr et al., 2005; Geets et al., 2006; Wilms et al., 
2007), monooxygenase genes including ammonia and methane monooxygenases (Oved et al., 
2001; Hoffmann et al., 2002; Hendrickx et al., 2006), dioxygenase genes (Morimoto et al., 
2005), and nitrite and nitrous oxide reductases (Throback et al., 2004). 
 
This chapter utilized DNA obtained from faecal samples. Discrepancies are thought to occur 
between faecal samples and mucosal samples (Zoetendal et al., 2002), although Palmer et al. 
(2007) argue that the differences are minimal. It is therefore recommended to do a 
comparison of the two sample sites. Faecal matter poses a potential bias when it comes to 
genomic DNA extraction, the presence of certain insoluble molecules binding to bacteria and 
making them difficult to lyse (Walker et al., 2008). In addition, faecal matter is thought to 
contain several PCR inhibitors which may lead to inaccurate representations of the bacterial 
communities present in the sample (de la Cochetière et al., 2004).  
Although DGGE has given a good representation of the diversity found in ostrich faeces, 
Green et al. (2009) report that DGGE is not ideal for monitoring highly diverse and complex 
bacterial communities such as those found in ostrich faeces. They are thought to give 
indistinct bands which may not be discernable, leading to smearing or poorly resolved 
patterns, as seen in the total bacterial DGGE gels.  In addition, although the use of the 
diversity index, H’, is useful in following the changes procured by different treatments, it is 
difficult to say whether the change in diversity is beneficial or detrimental to the ostrich gut. 















Therefore, a quantitative approach, fluorescent in-situ hybridisation (FISH), is used in the 
following chapter to obtain essential information on the fluctuations of important bacterial 
species found in the samples over time and according to treatment. Chapter five explores 
enumeration of important bacterial groups in both faecal and mucosal samples, with the 
intention of obtaining a more precise understanding of the ostrich microbiota and the 


















Investigation of the ostrich chick intestinal bacterial communities by 16S 
rRNA targeted fluorescent in-situ hybridisation and the observed 
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Microorganisms in the gut of the ostrich are considered vital for their nutritional contribution 
as well as their health benefits to the host. The ostrich is a hindgut fermenter, possessing a 
well-developed, paired caecum and colon which allows for extensive microbial fibre 
digestion. Fluorescent in situ hybridization combined with flow cytometry (FISH-FC) was 
used in this study to quantify specific bacterial groups in ostrich faecal samples as well as gut 
mucosal scrapings from five days post-hatching up to nine weeks of age. The ostrich chicks 
were fed a control diet (C), a diet supplemented with a five strain probiotic mix (E), tylosin 
alone (CT) or probiotics and tylosin (ET). Faecal samples were collected from farmed ostrich 
chicks on the first day of the feeding trial, and one, two, four, seven and nine weeks 
thereafter. At two and five weeks old, one chick per pen was slaughtered and mucosal 
scrapings obtained from the duodenum, caecum and colon. These, along with the faecal 
samples, were analysed using seven bacterial group-specific probes, specifically chosen 
based on previous studies on the avian gut as well as knowledge on ostrich pathogens. The 
effect of feeding probiotics and the antibiotic, tylosin, as well as the change in the major 
bacterial groups, was observed with respect to age. Ostrich chicks were found to be rapidly 
colonised by high numbers of bacteria, having a total bacteria count in faecal matter of 10
8 
cfu/g of faeces one week post-hatching. The faecal samples showed a shift of predominant 
bacteria, from the C. coccoides/E. rectale and Bacteroides groups, to Bacteroides by week 
seven. Studies on the gut samples showed the caecum and colon to be predominated by 
butyrate-producing Clostridium cluster XIVa and the duodenum mostly by Bacteroides. Both 
of these groups contain important fibre-digesting bacteria, producing short-chain fatty acids 
as their main by-products. These provide growing ostrich chicks with up to 76% of their 
metabolic energy. This is the first study using FISH-FC for enumeration of the ostrich gut 
microbiota.  
5.2. Introduction 
The commensal microbiota of the animal gastrointestinal tract (GIT) plays an important role 
in the health status of the host due to its nutritional, immunological and physiological 
functions (Rigottier-Gois et al., 2003). Gut microbiota is influenced by different factors 
including age, environmental conditions, diet and dietary supplements such as probiotics, 
prebiotics or antibiotics. An altered bacterial community in the gut can lead to digestive 















in farmed animals (Anadón et al., 2006). Clostridium perfringens is a particularly important 
pathogen in many animals, causing necrotic enteritis and leading to severe and often fatal 
lesions in the gut (Songer, 1996). This cause of death is especially rampant in chicken and 
ostrich farming (Huchzermeyer, 2002; Hofacre et al., 2003). Antibiotics are commonly used 
in animal farming to control these pathogenic infections, as well as for their growth 
promoting effects. In this study, the macrolide antibiotic, tylosin, was used (Chapter 3). 
Tylosin has a broad spectrum of activity against gram positive bacteria, and a narrower range 
against gram negatives (Shimada et al., 2010). The enteric bacteria E. coli and Salmonella 
spp. are intrinsically resistant to tylosin (Shryock et al., 1998). When used as a growth 
promoting agent, it is used at subtherapeutic levels (10-40mg/kg feed). These concentrations 
have an effect on the commensal microbiota which is not fully understood. However, Poole et 
al. (2003) concluded that the low levels of tylosin adversely affected the microbial ecology of 
the GIT in chickens, with respect to its ability to exclude exogenous and transient bacteria 
such as probiotics or other food-related bacteria. In this study, tylosin was administered to 
ostrich chicks at 20mg/kg feed for nine weeks for its growth promoting properties and the 
probiotics used in the trial were found to tolerate this concentration well (Chapter 3).  
Fluorescent in situ hybridization (FISH) is a commonly used technique in microbial ecology 
and it has been applied for the detection of bacteria that cannot yet be cultivated. It utilizes 
specific regions of the 16S rRNA gene of the bacteria as a target for fluorescently labelled 
oligonucleotide probes, termed “phylogenetic stains” because of their unique character 
(Amann et al., 1990b). By designing probes based on the 16S rRNA genes and some 23S 
rRNA genes, probe specificity can generally be freely adjusted, distinguishing species and 
subspecies by probe hybridisation to the most variable regions of the molecule (Woese et al., 
1985; Stahl et al., 1988). Achieving this specificity in a complex community such as in the 
GIT, however, is difficult and therefore, probes are more frequently targeted at the different 
bacterial groups. By targeting areas of more highly conserved regions, probes can be used to 
include genera or taxons (Woese et al., 1985) and areas which have remained basically 
unchanged between species, allow for the binding of a universal probe to measure total rRNA 
abundance (Stahl et al., 1988). It allows for identification of subpopulations as well as their 
habitat and accurately enumerates defined cell populations (Vaughan et al., 2000). Some 
disadvantages of this technique include: its dependence on SSU rDNA sequences which are 
available on the databases, the fact that only a few probes can be used together per analysis, 















number of ribosomes per cell (Zoetendal et al., 2004). In addition, optimal hybridisation 
conditions need to be determined, taxa occurring in low abundance are not detected, bad 
signal/noise ratio occurs, biofilms and cell aggregates hamper manual counting, and only a 
few samples can be visually counted (Wagner et al., 2003).  
Flow cytometry is a method used for measuring selected physical and chemical 
characteristics of individual cells. Multiple parameters, such as forward and side scatter as 
well as measurement of fluorescence at different wavelengths, can be adjusted and used to 
measure a large number of cells in a very short time, allowing more samples to be analysed 
(Amann et al., 1990). Combined with flow cytometry (FC), FISH provides a high throughput 
screening method, for accurate bacterial counting (Riggotier-Gois et al., 2003). Further, 
FISH-FC offers the possibility of using multiple probes to simultaneously detect several 
bacterial groups (no overlapping of fluorochromes) while enabling reliable quantitation of 
bacteria present and has the added benefit of a low detection limit and cell sorting ability. 
Large scale studies have shown FISH-FC to be a reproducible method for microbiota 
assessment which provides additional information to that obtained by traditional culture 
techniques (Collado and Sanz, 2007). However, flow cytometry also has its downfalls, 
including relying on a machine to do the counting and the need for the microorganism to 
occur as single cells (or be able to be separated into single cells by pre-treatment). There are 
many studies on the use of FISH-FC on the human microbiome and probes are available for 
bacterial species in intestinal samples. About 90% of faecal bacteria have been estimated to 
be detectable with a set of just a few probes (Sghir et al., 2000). There are limited reports on 
the microbiota of animal GITs, and very few on the ostrich microbiota (Melville et al., 2004; 
Matsui et al., 2009; Matsui et al., 2010). However, the chicken model has been well 
characterised using several techniques including FISH-FC (Zhu and Joerger, 2003; Collado 
and Sanz, 2007; Lebeer et al., 2010).   
Characterisation of the microbiota is frequently done on faecal samples using techniques 
based on 16S rRNA amplicon analysis (Zoetendal, et al., 2002). These studies have shown 
that the predominant bacterial communities in mammalian faeces are stable in time, host 
specific, affected by ageing and not changed by consumption of certain probiotic strains 
(Vaughan et al., 1999; Simpson et al., 2000; Zoetendal et al., 2001). This technique does not, 
however, provide information on the spatial orientation of the specific bacteria in their niches 















hatching (Brisbin et al., 2008) and the majority of the bacteria residing in the GIT are found 
in the caeca (Rehman et al., 2007). There are numerous studies on the bacteria found in avian 
crops (Collado and Sanz, 2007; Gong, et al., 2007; Lebeer et al., 2010), but since ostriches do 
not have a crop, and also possess an enlarged caeca and an unusually long intestine of 14 
meters (Swart et al., 1993a), this study chose to examine the microbiota of three sections of 
the ostrich large intestine: the duodenum, the caecum and the colon.    
5.2.1 Aims and objectives of this study 
The aim of this chapter was to use the FISH-FC technique to quantify specific bacterial 
groups in faecal samples and gut mucosal scrapings, and to confirm the diversity profiles 
obtained previously by DGGE patterns (Chapter 4) and selective culture counts (Chapter 3). 
The total numbers of bacteria in faecal matter as well as in different areas of the gut were 
studied, and the effect of tylosin on the total bacteria as well as on specific bacterial taxa was 
observed. The probiotic strains used in this mix were shown to tolerate tylosin well, and grew 
similarly in the presence or absence of tylosin (Chapter 3). The probes were specifically 
chosen based on previous studies of the microbiota of the avian gut as well as knowledge of 
ostrich pathogens. Probe Eub338 was used for total bacterial counts as, to our knowledge; 
this is not known for ostriches. Probe Bif 164 and Lab 158 (Table 5.1) were used to 
enumerate the Lactobacillus and Bifidobacterium populations, as these two taxonomic groups 
are known to represent the health of a gut (Isolauri et al., 2002) and they have beneficial 
properties which favour their use as probiotics. Probes Clit 135, Chis 150 and Erec 482 
(Table 5.1) hybridise to bacteria from various Clostridium clusters. This phylum has been 
shown to be dominant in the avian gut and appears to play an important role. Chis 150 detects 
Clostridium histolyticum (clusters I and II), which includes C. perfringens. As this probe 
would not give data specific to this pathogen, Cperf 191 (Table 5.1) was included, to get a 
more accurate enumeration of this species as it was the main pathogen anticipated here. Clit 
135 targets the Clostridium lituseburense as part of the Clostridium cluster XI, and includes 
detection of Clostridium difficile. The Clostridium coccoides-Eubacterium rectale group 
(cluster XIVa) was detected using probe Erec 482. Bac 303 (Table 5.1) covers the 
Bacteroides group, thought to be dominant in the GIT of most mammals. We also wanted to 
monitor the effect of probiotics and tylosin administration on the major bacterial groups in 















microbiota in different areas of the ostrich gut. For this, statistical analysis was done over 
time and between treatments.  
 
5.3. Methods and Materials  
5.3.1. Faecal collection 
As described in chapter 3. 
5.3.2. Housing of ostrich chicks 
As described in chapter 3. 
5.3.3. Gut mucosa sample collection 
As described in chapter 3. 
5.3.4. Fixation of faecal samples for FISH analysis  
Fresh faecal material (0.1 g) was added to 1ml 1 x PBS and homogenised. The samples were 
centrifuged at 11000 rpm for 2 min, washed twice in filter-sterilized 1 x PBS and 
resuspended in 1 ml filter-sterilized 1 x PBS. This was thoroughly vortexed for 3 min and 
centrifuged at 4500 rpm for 20 – 30 sec. This step was to remove debris, such as grass, and 
reduce the background fluorescence when counting. The supernatant (0.375 ml) was then 
added to 1.125 ml chilled 4% (w/v) paraformaldehyde in a capped eppendorf and left at 4 °C 
for 18 h. The cells were collected by centrifugation at 22000 rpm for 5 min and washed once 
in filtered 1 x PBS and then resuspended in 300µl of 50% v/v ethanol/1 x PBS. The fixed 
cells were stored at -20 °C. Gut mucosal scrapings were fixed in the same way. 
5.3.1. FISH 
Bacterial group-specific and genus-specific 16S rRNA gene targeted oligonucleotide probes 
were commercially synthesized (Thermo Biosciences, Ulm, Germany) and monolabelled, at 
the 5’ end, with FITC (Eub 338 probe) or Cy3 (the rest of the probes). The probes used in this 
study are listed in Table 5.1. 
The specificity of these probes has previously been tested (see individual references). 















FITC probe as well as the genus- or group-specific Cy3 probes. Hybridization was performed 
as previously described (Kalliomäki et al., 2008). In brief, fixed cell suspensions were 
hybridized with each fluorescent probe (50ng/µl) and 2 x hybridisation buffer (40mM/L Tris-
HCl, 1.8M NaCl/L, 10% sodium dodecyl sulphate) for 18h at the respective hybridisation 
temperatures. The cells were collected after washing and resuspended in PBS. All 
experiments were conducted in duplicate and analysis of the samples was performed with the 
use of a BD LSR II flow cytometer (Becton Dickinson & Co, Franklin Lakes, NJ) equipped 
with a 488nm laser at 15mW. Data was analyzed with the use of BD FACSDIVA software, 
version 4.1.1. (Becton Dickinson & Co). Absolute bacterial cell counts were determined by 
addition of Flow-Count fluorospheres (Beckman Coulter, Fullerton, CA). To avoid loss of 
signal intensity, hybridized cells were kept in the dark until analyzed.  
Table 5.1. Sequence and hybridisation temperatures of group specific 16S rRNA probes used 
in this study together with their respective target organisms 
Probe Sequence (3’ – 5’) Hybridisation 
temp (°C) 
Target Reference 
Eub 338 GCTGCCTCCCGTAGGAGT 50 Total bacteria Amman et al. 
(1990) 





Lab 158 GGTATTAGCAYCTGTTTCCA 50 Most 





Clit 135 GTTATCCGTGTGTACAGGG 50 Clostridium 
cluster XI (C. 
difficile) 




50 Most Clostridium 
cluster I and II  
(C. perfringens) 
Franks et al. 
(1998) 
Erec 482 GCTTCTTAGTCARGTACCG 50 Most Clostridium 
cluster XIVa 
Franks et al. 
(1998) 
Bac 303 CCAATGTGGGGGACCTT 45 Cytophaga-
Flavobacter-
Bacteroides 
Manz et al. 
(1996) 
Cperf 191 GCTCCTTTGGTTGAATGATG 35 C. perfringens Fallani et al. 
(2006) 
 
5.3.2. Statistical analysis 
For the faecal sample analysis, all the variables were log10 transformed before data analysis. 















separately at all time points. Subjects within a pen were nested to minimise natural individual 
variation. The effect of time on outcome variables was also studied using mixed models 
separately at each treatment. The selection of covariance structure for these analyses was 
based on the comparisons of Akaike Information Criteria (AIC). Statistical analyses were 
done using SAS for Windows version 9.2. 
The gut mucosal samples had the added variable of gut location. Again, all the variables were 
log10 transformed before data analysis. The effect of slaughter on the outcome variables was 
studied using mixed models with slaughter, treatment and interaction between slaughter and 
treatment as independent variables. Treatment was used as a repeated measures factor and the 
pen was used for intra-individual variation minimisation. These two variables were similarly 
taken into account when the effect of location on the outcome variables was studied. The 
effect of treatment on the outcome variables was studied separately at each slaughter using 
the pens to minimise natural variation. The selection of covariance structure for these 
analyses was based on the comparisons of Akaike Information Criteria (AIC). Statistical 
analyses were done using SAS for Windows version 9.2. 
5.4. Results and Discussion 
5.4.1. Total bacterial numbers in faecal samples from ostrich chicks 
Faecal samples of ostrich chicks were analysed using FISH-FC, investigating the numbers 
and relative proportions of each of seven bacterial groups present in faecal material and 
mucosal samples over the time course of the feeding trial. The purpose of this was to obtain 
data on probiotic efficiency in outcompeting pathogens, their ability to persist in the gut and 
also to observe the effect of feeding tylosin on the endogenous microbiota, as well as on the 
ingested probiotics in vivo.  
The number of cells hybridised to probe Eub338 using FISH are shown in Figure 5.1 and 
allowed for the proportion of species-specific bacterial groups to be calculated (see section 
5.4.2 – 5.4.5). It also gives essential information on the ostrich gut microbiome, about which 
very little is published. Ostrich chicks appear to be rapidly colonised by gut bacteria, having 
a total bacteria count of 10
8
 cfu/g (treatments C and E) and10
7 
cfu/g of faeces (treatment CT 
and ET), one week after hatching. Collado and Sanz (2007) found two month old broiler 
chickens and 12 month old pigs to harbour approximately 10
8 
cfu/g faeces throughout their 
















Figure 5.1 FISH assays showing total bacteria counts in faecal samples from ostrich chicks 
from week one to week nine of the feeding trial from newly-hatched chicks fed a control diet 
(C), tylosin (CT), probiotics (E) or probiotics and tylosin (ET) obtained using probe Eub 338. 
Values are the log of the average from two experiments done in duplicate and the error bars 
represent standard deviation from the mean. Statistical analysis showed any differences 
among the treatments over time (p < 0.05; n = 15).  
 
The total bacterial count in the ostrich chicks appears to remain stable in chicks not treated 
with tylosin. However, due to mortality in these groups, the data for treatments E and C is 
only available up to week two and four, respectively, thus hindering the detection of any 
observable trends seen for the chicks not receiving tylosin, and making any comparisons to 
tylosin-receiving chicks impossible. Both treatments ET and CT showed an increase in total 
bacterial counts over time, having approximately 10
8 
cfu/g of faeces by week nine, 
corresponding to data obtained for broiler chickens and pigs by Collado and Sanz (2007). 
Interestingly, after one week, treatments E and C have a ten-fold higher total bacterial count 
than the groups receiving the antibiotic suggesting that tylosin initially has an effect on 
bacterial numbers, lowering the total count. With time the microbiota levels or counts appear 















their anti-diarrheal effects in dogs by either decreasing the total bacterial load in the gut or by 
altering the proportions of specific bacterial taxa present. They did not include enumerating 
total bacteria into their study and so could not make any conclusions from this. However, in 
this present study, it can be seen that tylosin does not lower the total bacteria load in the gut 
over time. Suchodolski et al. (2009) also showed an initial decrease in certain bacterial taxa 
initially, rebounding after 28 days of treatment with tylosin. The mucosal samples (data not 
shown) show similar total bacteria counts, but do not show any significant changes between 
the two slaughter times (week two and week five). The ostrich gut exhibits a lower total 




per gram of caecal contents 
three days post hatching, using nucleic acid staining and flow cytometry (Apajalahti et al., 
2002; Apajalahti et al., 2004). This study demonstrates that tylosin does not have a 
detrimental effect on total bacteria populations.  
5.4.2. FISH enumeration of faecal samples over time 
Different bacterial groups in faecal samples were enumerated over time using FISH and the 
primers listed in Table 5.1. The primers chosen represent important bacterial taxa with 
regard to animal gut health, including commensal bacteria as well as pathogens, and they 
were monitored to evaluate the maturation of the ostrich microbiome and the effects of 
probiotics and tylosin on this.  
The control group, C, which did not receive any treatment (Table 5.2A), showed a 
significant increase in C. coccoides/E. rectale group (p = 0.0421) and C. perfringens (p = 
0.008). This is in contrast to the group fed probiotics (E) which showed no differences in 
these bacterial phyla suggesting the probiotics may prevent the growth or colonization of 
these clostridial bacteria. In addition, the Bifidobacterium, Lactobacillus and Bacteroides 
populations showed an increasing trend, although not statistically significant.  
Group E, which received only the five strain probiotic mix (10
9
 CFU/day), showed no 
significant differences (Table 5.2B) in the relative proportions of bacteria present for any of 
the bacterial groups tested over time. Again, the Bifidobacterium, Bacteroides and C. 
perfringens showed increasing trends from week one to week two. In contrast to the control 
group, E showed decreasing trends in Lactobacillus populations as well as bacteria 
hybridising to the Erec 482 probe. The animals in this group died after week two and post-
mortems indicated pseudomembranous colitis with lesions resembling those caused by C. 















Table 5.2. Proportions of Bifidobacterium (Bif164), Lactobacillus (Lab158), Clostridium cluster XI 
including C. difficile (Clit135), Clostridium cluster XIVa including C. coccoides and E. rectale 
(Erec482), Clostridium cluster I and II including C. perfringens (Chis150), Bacteroides (Bac303) 
and specifically C. perfringens (C.perf 191)in faecal samples in the group fed the five strain 
probiotic mix (E), the group fed the five strain probiotic mix and the antibiotic Tylson (ET), the 
control group (C) and the control group fed Tylosin (CT). The relative proportions were calculated 
using the universal probe Eub 338 and the respective group specific probe. Results are reported as 
medians of cell numbers per gram of faecal sample; interquartile ranges in parentheses. Significant 
differences over time were calculated using mixed models, P < 0.05. 
E 
Time 
point Wk 1 Wk 2 
   
p value 
Probe 
     
  
Bif 164 8.4 (5.9,11.9) 10.6 (6.5,17.1) 
   
0.3311 
Lab 158 9.4 (6.3,14.0) 8.6 (5.0,14,6) 
   
0.7674 
Clit 135 6.5 (4.2,10.1) 4.5 (2.4,8.6) 
   
0.1216 
Erec 482 13.1 (8.4,20.5) 12.2 (8.7,17.2) 
   
0.5558 
Chis 150 7.1 (4.4,11.4) 7.5 (4.1,13.8) 
   
0.8132 
Bac 303 13.7 (8.0,23.7) 19.8 (12.6,31.0) 
   
0.4035 
Cperf 191 6.5 (4.1,10.1) 9.9 (5.4,18.2)       0.4441 
 
      ET 
Time 
point Wk 1 Wk 2 Wk 4 Wk 7 Wk 9 p value 
Probe 
     
  
Bif 164 11.5 (8.0,16.4) 8.6 (5.3,13.9) 7.7 (6.2,9.5) 6.7 (5.4,8.4) 5.4 (3.9,7.6) 0.1711 
Lab 158 13.6 (9.2,20.3) 10.6 (6.2,18.1) 7.2 (4.8,11,0) 7.8 (5.0,12.2) 5.1 (3.5,7.2) 0.0836 
Clit 135 12.0 (7.8,18.5) 8.4 (4.5,15.9) 6.2 (4.4,8.7) 8.3 (6.0,11,7) 8.6 (6.4,11.6) 0.0713 
Erec 482 14.4 (9.2,22.5) 19.0 (13.5,26.6) 19.1 (13.6,26.7) 11.1 (8.3,14.9) 8.6 (6.4,11.5) 0.0089dfghi 
Chis 150 11.1 (7.0,17.9) 7.9 (4.3,14.5) 9.1 (7.3,11.5) 5.8 (3.4,9.9) 4.5 (3.4,5.6) 0.0935 
Bac 303 24.8 (14.4,42.7) 15.1 (9.7,23.7) 14.6 (11.2,19.0) 15.3 (11.8,19.8) 19.5 (9.9,38.5) 0.4694 
Cperf 191 11.9 (7.6,18.5) 10.7 (5.8,19.7) 5.0 (3.6,6.9) 7.8 (5.8,10.4) 4.8 (3.4,6.6) 0.0031bdeg 
       C 
Time 




     
  
Bif 164 5.8 (4.1,8.3) 7.5 (4.6,12.2) 7.6 (6.1,9.4) 
  
0.0653 
Lab 158 5.2 (3.5,7.7) 6.0 (3.5,10.3) 8.6 (5.7,13.1) 
  
0.0566 
Clit 135 4.9 (3.2,7.6) 4.6 (2.5,8.7) 6.6 (4.7,9.2) 
  
0.4055 
Chis 150 5.1 (3.2,8.3) 8.0 (4.3,14.7) 7.7 (6.1,9.6) 
  
0.1389 
Bac 303 9.3 (5.4,16.1) 13.4 (8.5,21.0) 14.6 (11.2,19.1) 
  
0.1093 
Cperf 191 5.0 (3.2,7.8) 9.7 (5.2,17.8) 7.9 (5.7,10.9)     0.0080ab 
 
        CT 
Time 
point Wk 1 Wk 2 Wk 4 Wk 7 Wk 9 p value 
Probe 
     
  
Bif 164 11.4 (8.0,16.2) 16.9 (10.4,27.3) 7.9 (6.3,9.8) 6.8 (5.4,8.4) 7.2 (5.2,10.1) 0.0662 
Lab 158 11.7 (7.8,17.3) 21.0 (12.3,35.8) 7.8 (5.2,12.0) 5.9 (3.8,9.3) 6.3 (4.4,9.1) 0.0441cfg 
Clit 135 9.7 (6.3,15.0) 12.6 (6.7,23.8) 6.2 (4.4,8.7) 8.01 (5.9,10.8) 8.01 (5.9,10.8) 0.4297 
Erec 482 15.9 (10.1,24.9) 22.2 (15.8,31.2) 16.6 (11.8,23.2) 11.0 (8.2,14.6) 9.8 (7.3,13.0) 0.0583 
Chis 150 9.3 (5.8,15.0) 10.7 (5.8,19.8) 8.7(7.0,11.0) 8.2 (4.8,14.0) 6.0 (4.6,7.7) 0.3513 
Bac 303 17.7 (10.3,30,6) 20.3 (13.0,31.9) 16.9 (13.0,22.1) 12.6 (9.7,16.4) 14.9 (7.6,29.5) 0.4383 




















The group receiving only tylosin supplementing their diet, CT (Table 5.2C), showed a 
significant decrease in proportions of Lactobacillus species (p = 0.0441) from week one to 
week seven, after an initial increase at week two.  The same decreasing trend is seen for 
treatment ET, although it was not significant (p = 0.0836). This may imply a sensitivity to 
tylosin as this decrease was observed in treatment CT too. In contrast, treatment C showed 
an increasing trend in this bacterial group (close to significant, p = 0.0566) up to week four. 
Treatment CT also showed a decrease over time in the C. coccoides/E. rectale group which 
was almost significant (p = 0.0583), perhaps due to the high proportion of this group at 
week two and the decrease observed thereafter.  Treatment ET shows a similar decrease in 
this group, although statistically significant (p = 0.0089), indicating the effect of tylosin. 
However, the control treatment also shows a decreasing trend from week two to week four, 
but not a significant difference.  
The group, named ET, received the probiotic mix  10
9
 CFU/day) and tylosin (Table 
5.2D). This group showed significant decreases in the proportions of C. coccoides/E. rectale 
group (p = 0.0089) as well as for the C. perfringens group (p = 0.0031) over the feeding 
period. This infers a role of tylosin in decreasing this bacterial phylum, as well as the 
potential pathogen, C. perfringens.  Treatment CT also showed a decreasing trend in C. 
perfringens after week two, although this was not statistically relevant.  In contrast, the 
levels for this pathogen in treatment C were still significantly higher at weeks two and four 
than at week one. Young and Schmidt (2004) found that during the administration of a broad 
spectrum antibiotic in humans suffering from antibiotic-associated diarrhea, there was a 
significant decrease in butyrate-producing bacteria, most of which belong to Clostridum 
cluster XIVa, including C. coccoides/E. rectale. Treatment ET showed decreasing trends in 
the Bifidobacterium and Lactobacillus populations, but again these were not as statistically 
significant as the decrease in group CT, and may be a result of probiotic administration.  
Since all the ostrich chicks in group E died after week two and by week four, this time frame 
was studied for all treatments to see if there were any trends, which may elucidate the cause 
of this mortality. At two weeks, Group E showed no significant differences for any of the 
bacteria tested, and was found to be predominated by Bacteroides (19.8%) whereas the other 
three treatments, C, CT and ET, were dominated by C. coccoides and E. rectale (22.4%, 
22.2% and 19%, respectively) at this time point. In addition, Groups C, E and CT all showed 















treatments ET (p = 0.0065) and CT (p = 0.07) showed a significant decrease in C. 
perfringens, 10.7% to 5.0% and 13.6% to 6.5% respectively, half the amount seen at week 
two (Table 5.2D). This indicates that the administration of tylosin in the feed of these groups 
has a significant effect on the numbers of the pathogenic bacterium, C. perfringens. The 
incidence of the C. perfringens group is of particular interest given that this pathogen is a 
main cause of mortality in ostrich chicks (Huchzermeyer, 2002). Tylosin is well known for 
being an effective treatment against C. perfringens infection (Collier et al., 2003; Martel et 
al., 2004), but recent work has suggested that the overuse of this antibiotic as a prophylactic 
has lead to chronic resistance in this pathogen (Gharaibeh et al., 2010).  
The significant decrease in the C. perfringens levels in treatment ET, as opposed to those 
seen in CT, may suggest a protective role of the administered probiotics to the host against 
this pathogen, although the Lactobacillus numbers remained relatively constant in group ET. 
Gérad et al., (2008) also found that feeding a Lactobacillus strain excluded C. perfringens 
from inhabiting the ceca of chickens. Adhesion studies performed on our specific probiotic 
mix showed it to be able to inhibit and displace C. perfringens, but unable to out compete it 
(Chapter 2). From our FISH results it appears this pathogen was present from the start of the 
feeding trial.  This data suggests that feeding the probiotics alone did not offer sufficient 
protection against gut pathogens, resulting in the death of the chicks in treatment E after 
week two and those in group C after four weeks. It also reinforces the important role of 
tylosin in pathogen control. It appears that feeding chicks with the probiotics alone (group 
E) enhanced pathogen invasion (as also shown by adhesion-competition studies in Chapter 
3). The adhesion studies suggest that if the probiotic mix could be administered before or 
early in C. perfringens infection, they would be able to inhibit or displace the pathogen. It 
appears in this case that the pathogens had already been acquired by the time the probiotics 
were fed to the chicks. The close proximity of the pens may have contributed to the spread 
of these pathogenic bacteria.  
The effect of tylosin on the autochthonous microbiota (group CT) only showed a significant 
decrease in Lactobacillus over the feeding trial. The effects of tylosin do not appear 
immediately. Only by week four is there a decrease in Bifidobacterium and Lactobacillus 
spp., as well as Bacteroides and C. perfringens. Wagner and Cerniglia (2005) showed L. 
salivarius and L. ruminus of human origin to be sensitive to tylosin, but Collier et al. 















after two weeks, specifically L. gasseri, found to be particularly resistant to tylosin. In our 
study, tylosin fed together with the probiotic mix initially has a detrimental effect on the 
Bifidobacterium spp., but over the nine weeks, significantly decreased C. perfringens and 
the C. coccoides/E. rectale group, agreeing with work by Collier et al. (2003b). 
In conclusion, tylosin fed together with the five strain probiotic mix (three Lactobacillus 
plantarum, one L. reuteri and one Bifidobacterium pseudolongum subsp. pseudolongum), 
successfully decreased the C. perfringens levels over time in faecal samples. The 
probiotic/antibiotic combination significantly decreased C. coccoides/E. rectale numbers with 
time, and when the antibiotic was fed alone, it had a decreasing effect on the Lactobacillus 
population. The number of C. perfringens and C. coccoides/E. rectale increased in the control 
group with time and the birds in this control group died at week four, with the chicks showing 
similar lesions in the gut to those for group E. Due to the nature of the observed symptoms 
the death of the chicks were attributed to C. perfringens infection.  
5.4.3. FISH enumeration of faecal samples between treatments  
Comparing the relative proportions of each bacterial group between treatments (C, E, CT 
and ET) at week one (Table 5.3A), we found that ET and CT treatments showed 
significantly higher Bifidobacterium species compared to control group C (p = 0.011 and p = 
0.0117, respectively), indicating that tylosin may be involved in selectively enriching for 
Bifidobacterium during early colonisation. Hereafter, the frequency of Bifidobacterium does 
not differ significantly between groups. Week one also displayed a significant increase in 
Lactobacillus for groups E, ET and CT when compared to C (p = 0.0375, p = 0.0018 and p = 
0.0067, respectively) suggesting that either the probiotics or tylosin, or both, play a role in 
increasing these bacterial proportions. A higher percentage of the Clostridium cluster XI 
was observed for ET and CT when compared to C (p = 0.0067 and p = 0.032, respectively). 
Treatment ET shows a close to significant increase in this bacterial group when compared to 
E (p = 0.0523). C. difficile is an important pathogen which is included in this cluster and it is 
interesting to note that tylosin appears to increase the prevalence of this group.  However, 
the probe was not specifically designed to detect C. difficile.  
In week two (Table 5.3B), bifidobacteria were present at a higher frequency in treatment CT 
than in both C and ET (p = 0.0224 and p = 0.052), again suggesting the Bifidobacterium 
enriching role of tylosin. The Lactobacillus group was more common in CT than groups E 















with previous work showing that it increases the number of Lactobacillus when 
administered to pigs (Collier et al., 2003a). Although no overall significant differences were 
observed for the Clostridium cluster XI, CT harboured a significantly higher prevalence of 
this group than C and E (p = 0.0304 and p = 0.0278), as in week one. At this time point, 
treatment E also showed a significantly lower prevalence of the C. coccoides/E. rectale 
group than C and CT (p = 0.0157 and 0.0174, respectively), showing that the probiotics had 

































Table 5.3. (A to E) Proportions of Bifidobacterium (Bif164), Lactobacillus (Lab158), Clostridium cluster XI 
including C. difficile (Clit135), Clostridium cluster XIVa including C. coccoides and E. rectale (Erec482), 
Clostridium cluster I and II including C. perfringens (Chis150), Bacteroides (Bac303) and specifically C. 
perfringens (C.perf 191)in faecal  samples in the group fed the five strain probiotic mix (E), the group fed the 
five strain probiotic mix and the     antibiotic Tylosin (ET), the control group (C) and the control group fed 
Tylosin (CT). The relative proportions were calculated using the universal probe Eub 338 and the respective 
group specific probe. Results are reported as medians of cell numbers per gram of faecal sample; interquartile 
ranges in parentheses. Significant differences over time were calculated using mixed models, P < 0.05, n = 15. 
Key: a. C vs CT; b. C vs E; c. C vs ET; d. CT vs E; e. CT vs ET; f. E vs ET.  
  Week 1 
  E ET C CT p value 
Probe 
    
  
Bif 164 8.4 (5.9,11.9) 11.5 (8.0,16.4) 5.8 (4.1,8.3) 11.4 (8.0,16.2) 0.0338ac 
Lab 158 9.4 (6.3,14.0) 13.6 (9.2,20.3) 5.2 (3.5,7.7) 11.7 (7.8,17.3) 0.0095abc 
Clit 135 6.5 (4.2,10.1) 12.0 (7.8,18.5) 5.0 (3.2,7.6) 9.7 (6.3,15.0) 0.0298ac 
Erec 482 13.1 (8.4,20.5) 14.4 (9.2,22.5) 12.1 ( 7.7,18.9) 15.9 (10.1,24.9) 0.8229 
Chis 150 7.1 (4.4,11.4) 11.1 (6.9,17.9) 5.1 (3.2,8.3) 9.3 (5.8,15.0) 0.1217 
Bac 303 13.7 (8.0,23.7) 24.8 (14.4,42,7) 9.3 (5.4,16.1) 17.7 (10.3,30.6) 0.0906 
Cperf 191 6.5 (4.1,10.1) 11.9 (7.6,18.5) 5.0 (3.2,7.8) 7.7 (5.0,12.0) 0.0601 
        Week 2 
  E ET C CT p value 
Probe 
    
  
Bif 164 10.6 (6.5,17.1) 8.6 (5.3,13,9) 7.5 (4.6,12.2) 16.9 (10.4,27.3) 0.1028 
Lab 158 8.6 (5.0,14.6) 10.6 (6.2,18.1) 6.0 (3.5,10.3) 21.0 (12.3,35.7) 0.0186ad 
Clit 135 4.5 (2.4,8.6) 8.4 (4.5,15.9) 4.6 (2.5,8.7) 12.6 (6.7,23.8) 0.0762 
Erec 482 12.2 (8.7,17.2) 19.0 (13.5,26.6)  22.4 (16.0,31.5) 22.2 (15.8,31.2) 0.0519 
Chis 150 7.5 (4.1,13.8) 7.9 (4.3,14.5) 8.0 (4.3,14.7) 10.7 (5.8,19.8) 0.8175 
Bac 303 19.8 (12.6,31.0) 15.1 (9.7,23.7) 13.4 (8.5,21.0) 20.3 (13.0,31.8) 0.4575 
Cperf 191 9.9 (5.4,18.2) 10.7 (5.8,19.7) 9.7 (5.2,17.8) 13.6 (7.4,25.1) 0.8378 
        Week 4   
  ET C CT 
 
p value  
Probe 
    
  
Bif 164 7.7 (6.2,9.5) 7.6 (6.1,9.4) 7.9 (6.3,9.8) 
 
0.9619 
Lab 158 7.2 (4.8,11.0) 8.6 (5.7,13.1) 7.8 (5.2,12.0) 
 
0.8232 
Clit 135 6.2 (4.4,8.7) 6.6 (4.7,9.2) 6.2 (4.4,8.7) 
 
0.9548 
Erec 482 19.1 (13.6,26.7) 17.3 (12.4,24.2) 16.6 (11.8,23.2) 
 
0.8124 
Chis 150 9.1 (7.3,11.5) 7.7 (6.1,9.6) 8.7 (7.0,11.0) 
 
0.4849 
Bac 303 14.6 (11.2,19.0) 14.6 (11.2,19.1) 16.9 (13.0,22.1) 
 
0.6387 
Cperf 191 5.0 (3.6,6.9) 7.9 (5.7,10.9) 6.5 (4.7,9.0)  0.1364 
  
       Week 7     




    
  
Bif 164 6.7 (5.4,8.4) 6.8 (5.4,8.4) 
  
0.9624 
Lab 158 7.8 (5.0,12.2) 5.9 (3.8,9.3) 
  
0.3569 
Clit 135 8.4 (6.0,11.7) 8.8 (6.3,12.2) 
  
0.8331 
Erec 482 11.1 (8.3,14.9) 10.9 (8.2,14.6) 
  
0.9170 
Chis 150 5.8 (3.4,9.9) 8.2 (4.8,14.0) 
  
0.3188 
Bac 303 15.3 (11.8,19.8) 12.6 (9.7,16.4) 
  
0.2745 
Cperf 191 7.8 (5.8,10.4) 6.0 (4.5,8.0)   0.1867 
  
       Week 9     




    
  
Bif 164 5.5 (3.9,7.6) 7.2 (5.2,10.1) 
  
0.2062 
Lab 158 5.1 (3.5,7.2) 6.3 (4.4,9.1) 
  
0.3419 
Clit 135 8.6 (6.4,11.6) 8.0 (5.9,10.8) 
  
0.7085 
Erec 482 8.6 (6.4,11.5) 9.8 (7.3,13.0) 
  
0.5026 
Chis 150 4.4 (3.4,5.6) 6.0 (4.6,7.7) 
  
0.0798 
Bac 303 19.5 (9.9,38.5) 14.9 (7.6,29.5) 
  
0.5500 




















Initially, chicks in treatments E, ET and CT are dominated by Bacteroides (13.7; 24.8 and 
17.7%, respectively) and treatment C by the C. coccoides/E. rectale group (12.1%). By 
week two, treatments ET, C and CT, were dominated by the C. coccoides/E. rectale group 
(19.0; 22.4 and 22.2% respectively), with treatment E still being dominated by Bacteroides. 
From week seven onwards, the Bacteroides group was the dominant gut bacteria of those 
tested in this study, suggesting that this may be the dominant group of bacteria in ostriches.  
Work by Zhu and Joerger (2003) found a similar trend in broiler chicken caeca, where the 
highest percentage of bacteria hybridised to the C. coccoides/E. rectale probe at two weeks, 
and decreased thereafter. Similar to this study, they also found that Bacteroides and 
Bifidobacterium groups proportions did not change from one week old onwards, although 
the proportions of these bacteria were much lower (3 – 6% for the chicken vs 14.4 – 39.9% 
for the ostrich chick and 3 – 8% for chickens vs 9.8 – 13.4% for ostrich chicks) respectively.   
Although there were few significant differences seen between treatments, it was always 
treatment C which showed the lowest proportions of the tested bacterial group, except in 
week two where both E and C showed significantly lower levels of Lactobacillus than CT. 
In week one, ET and CT show higher proportions of Bifidobacterium and Lactobacillus. 
Again, this suggests that tylosin may select Bifidobacterium and Lactobacillus, agreeing 
with the theory that this antibiotic enriches potentially beneficial bacteria (Suchodolski et 
al., 2009), and that feeding probiotics containing these two species may help to maintain the 
Lactobacillus level. From week four onwards, the microbiota in both surviving groups, ET 
and CT, appears to have stabilised. It is unknown whether it was the tylosin which stabilised 
the microbiota or if it occurred naturally as the control groups E and C had both died by this 
stage.  
5.4.4. FISH enumeration of gut mucosal samples between two slaughter times 
Mucosal scrapings from three areas of the ostrich GIT, namely, the duodenum, the caecum 
and the colon, were collected at two time points (week two and week five), when one chick 
from each pen was slaughtered by cervical dislocation and the mucosal scrapings were 
analysed using FISH and the probes listed in Table 5.1. This aimed to get an insight into the 
autochthonous microbiota as well as to test the adhesion capabilities of the probiotics, and to 
see if the ingested probiotics were transient or adhesive to the gut mucosa. Treatment E could 
not be included in this section of work since the group had died after week two. Also, the 















FISH was performed. This is because when the effect of location, together with the slaughter 
time was compared, no significant differences were seen.  
At slaughter one (two weeks of age), the colon and caecum samples were shown to harbour 
10
8
 cells/g mucosa compared to the duodenum, having 10
7
 cells/g mucosa. At slaughter two 
(five weeks of age), the colon and caecum had 10
9 
cells/g mucosa and the duodenum had 10
8 
cells/g mucosa. The enumeration of bacterial species between slaughters (at week two and 
week five; Table 5.4A) showed a significant increase in the Clostridium cluster XI group for 
treatments C and ET (p = 0.01 and 0.002, respectively), and the C. coccoides/E. rectale group 
for C (p = 0.001), ET (p < 0.001) and CT (p = 0.002). By week five, this phylum was now the 
dominant group in the gut, followed by the Bacteroides group, which significantly increased 
for treatments C and ET (p = 0.02 and 0.03, respectively). C. perfringens increased 
significantly for treatments C (p = 0.01) and ET (p = 0.02), and almost significantly for 
treatment C (p = 0.06). It is interesting to note that birds from treatments C and ET showed 
an increase in proportions of both important pathogens, i.e. C. difficile and C. perfringens. 
Although treatment CT did not show a significant increase in C. perfringens, it showed an 
increasing trend (p = 0.0582). This does not correspond with the previous findings in this 
study where tylosin was found to decrease the number of C. perfringens in the faeces and 
may suggest that C. perfringens was less prevalent in the faecal samples as they adhere well 
to the gut mucosa. Gérard et al., (2008) fed broiler chickens a Lactobacillus strain and gut 
samples were taken four and 19 days after the start of the trial. At 19 days a significant 
decrease (p < 0.05) was observed for the C. coccoides/E. rectale group, a significant increase 
in the Faecalibacterium prausnitzii group, and a significant increase in Bacteroides, between 
the experimental and the control group were observed.  In the case of the ostrich chicks, 
Bacteroides also increased significantly by week five, becoming one of the predominant 
species. In chickens, F. prausnitzii is the dominant species present at this time point, with the 
C. coccoides/E. rectale group decreasing over time, as opposed to the increase seen in ostrich 
chicks. The increase in the presence of C. coccoides/E. rectale for groups CT and ET may be 
due to the tylosin, and in treatment C due to the lack of feeding probiotics. Gérard et al. 
(2008) fed Lactobacillus to broiler chickens and found they decreased the counts of C. 

















Table 5.4 (A and B). Proportions of Bifidobacterium (Bif164), Lactobacillus (Lab158), Clostridium cluster XI 
including C. difficile (Clit135), most of Clostridium cluster XIVa including C. coccoides and E. rectale 
(Erec482), most of Clostridium cluster I and II including C. perfringens (Chis150), Bacteroides (Bac303) and 
specifically C. perfringens (C.perf 191)in gut biopsies in the group fed the five strain probiotic mix (E), where 
applicable, the group fed the five strain probiotic mix and the antibiotic tylosin (ET), the control group (C) and 
the control group fed tylosin (CT). The relative proportions were calculated using the universal probe Eub 338 
and the respective group specific probe. Results are reported as medians of cell numbers per gram of faecal 
sample; interquartile ranges in parentheses . Significant differences between treatments were calculated using 
mixed models, P < 0.05, n = 18.  
  Between slaughters 
 
    Between treatments 




Probe Treatment Slaughter 1 Slaughter 2 
Bif 164 C 10.5 (6.8, 16.2) 11.4 (7.4, 17.6) 0.78 
 
Bif 164 C 10.5 (6.0, 18.5) 11.4 (8.6, 15.1) 
  CT 13.4 (8.7, 20.7) 12.1 (7.9, 18.6) 0.72 
 
  CT 13.4 (7.7, 23.6) 12.1 (9.2, 16.0) 
  ET 9.8 (6.4, 15.2) 12.1 (7.9, 18.6) 0.49 
 
  E 14.4 (8.3, 25.4)   
Lab 158 C 13.2 (8.8, 19.8) 13.8 (9.2, 20.7) 0.88 
 
  ET 9.8 (5.6, 17.3) 12.1 (9.2, 16.0) 
  CT 10.5 (7.0, 15.8) 15.5 (10.0, 23.3) 0.20   p value 0.71 0.94 
  ET 10.7 (7.1, 16.0) 15 (7.1, 16.0) 0.26 
 
Lab 158 C 13.2 (7.9, 22.1) 13.8 (10.4, 18.2) 
Clit 135 C 17.3 (12.0, 25.0) 36.3 (25.1, 52.6) 0.01 
 
  CT 10.5 (6.3, 17.6) 15.5 (11.7, 20.6) 
  CT 23.2 (16.1, 33.6) 35.4 (24.4, 51.2) 0.14 
 
  E 13.6 (8.1, 22.7)   
  ET 13.7 (9.4, 19.8) 35.9 (24.8, 51.9) 0.002 
 
  ET 10.7 (6.4, 17.9) 15.0 (11.3, 19.8) 
Erec 482 C 19.8 (14.3, 27.2) 45.9 (33.3, 63.3) 0.001 
 
  p value 0.84 0.82 
  CT 20.3 (14.8, 28.0) 44.4 (32.2, 61.2) 0.002 
 
Clit 135 C 17.3 (8.8, 33.9) 36.3 (28.5, 46.3) 
  ET 16.5 (12.0, 22.7) 46.9 (34.0, 61.6) <0.001 
 
  CT 23.2 (11.8, 45.6) 35.4 (27.8, 45.1) 
Chis 150 C 9.3 (6.5, 13.2) 10.1 (7.0, 14.3) 0.74 
 
  E 26.4 (13.5, 51.9)   
  CT 8.5 (5.9, 12.1) 12.4 (8.7, 17.8) 0.13 
 
  ET 13.7 (7.0, 26.8) 35.9 (28.1, 45.7) 
  ET 6.5 (4.6, 9.3) 10.1 (7.1, 14.5) 0.09 
 
  p value 0.43 0.99 
Bac 303 C 





19.8 (12.9, 30.3) 45.9 (36.8, 57.2) 
  CT 21.1 (13.2, 33.9) 37.6 (23.4, 60.2) 0.12 
 
  CT 20.3 (13.3, 31.2) 44.4 (35.7, 55.4) 
  ET 17.7 (11., 28.4) 39.9 (24.9, 64.0) 0.03 
 
  E 22.1 (14.4, 33.9)   
Cperf 
191 C 
10 (6.4, 15.8) 24.5 (15.6, 38.7) 
0.01 
 
  ET 
16.5 (10.8, 25.2) 46.9 (37.6, 58.4) 
  CT 13.6 (8.6, 21.5) 26.0 (16.5, 41.0) 0.06 
 
  p value 0.79 0.94 
  ET 





9.3 (6.3, 13.6) 10.1 (6.4, 15.8) 
      
  CT 8.5 (5.8, 12.4) 12.4 (7.9, 19.5) 
      
  E 9.0 (6.1, 13.3)   
      
  ET 6.5 (4.4, 9.6) 10.1 (6.5, 15.9) 
      
  p value 0.55 0.67 
      
Bac 303 C 14.4 (8.1, 25.8) 35.6 (25.8, 49.1) 
      
  CT 21.1 (11.8, 37.7) 37.6 (27.2, 51.8) 
      
  E 19.6 (11.0, 34.9)   
      
  ET 17.7 (9.9, 31.6) 39.9 (28.9, 55.1) 
      
  p value 0.80 0.87 
      
Cperf 
191 C 
10.0 (5.3, 19.0) 24.5 (15.6, 38.6) 
      
  CT 13.6 (7.2, 25.8) 26.0 (16.5, 40.9) 
      
  E 10.1 (5.4, 19.1)   
      
  ET 10.6 (5.6, 20.0) 24.0 (15.3, 37.7) 
      
  p value 0.88 0.95 
 
The control group C, as well as treatment ET, showed significant increases in the same 
bacterial taxa (Clostridia cluster XI, C. coccoides and E. rectale, Bacteroides and C. 
perfringens; Table 5.4A).  The reason that treatment C died soon after the second slaughter 
















suggesting this bacterial group is not controlled by tylosin or the combination of antibiotic 
and probiotic. Most members of this bacterial group (Clostridium cluster XIVa) are butyrate 
producers and are therefore assumed to be important members of the ostrich microbiota, 
given the fact that ostriches derive approximately 76% of their metabolisable energy from 
volatile fatty acids such as butyrate (Swart et al., 1993b).   
At two weeks, the gut mucosal samples were dominated by C. coccoides/E. rectale (treatment 
C), the Clostridium cluster XI (treatment CT) and Bacteroides (treatment ET; Table 5.4A). 
By week five, all three treatments were dominated by C. coccoides/E. rectale (Table 5.4A). 
Bacteroides and Clostridium cluster XI were found to be the second predominant group of 
bacteria in the gut of ostrich chicks by week five. This differs from the faecal samples (Table 
5.3), week two and four dominated by C. coccoides/E. rectale with the exception of treatment 
CT which shows an equal prevalence of Bacteroides and C. coccoides/E. rectale at week 
four. This initial difference could be due to the adhesion capabilities of C. coccoides/E. 
rectale, being flushed out to begin with, but adhering well by week four/week five. It would 
have been useful to take another gut mucosal scraping at week nine to truly compare the 
patterns observed between the gut and faecal counts.   
5.4.5. FISH enumeration of gut mucosal samples between treatments at each 
slaughter time 
In an attempt to monitor the change in microbiota of ostrich chicks with age, ie week two 
versus week five (Table 5.4B), the effect of each treatment at the two slaughter times was 
compared. No significant differences were observed for any bacterial phyla tested. This may 
suggest that the microbiota of the ostrich chick is settled by week two or that the ingested 
probiotics were transient in the ostrich gut, not adhering to the gut mucosa. This is unlikely as 
DGGE analysis combined with 16S rRNA sequencing of excised bands on faecal samples in 
the previous chapter, did not detect either of the two Lactobacillus species included in the 
probiotic mix. Previous work by Poole et al. (2003) suggested that once the bacterial 
population has equilibrated, it becomes very difficult for exogenous strains to colonise. This 
may be due to the diversity of inhibitory products such as volatile fatty acids or bacteriocins 
which could act on exogenous bacteria faster than they can adapt.  It may also imply that 
tylosin has no effect on the bacteria which are adhered to the gut wall.  
Although at week two, there were no clear differences between proportions of the bacteria in 















hybridised to probe Clit 135 showed a higher prevalence in the gut samples (Table 5.4B) than 
in the faecal samples (Table 5.3B), but by week five, all bacterial groups showed higher 
prevalence in the gut samples than in the faecal samples. This may suggest that all the 
bacterial groups studied here, adhere well to the gut mucosa as fewer counts were found in 
the faecal samples. Zoetendal et al., (2002) also found that mucosa-associated bacterial 
communities differed significantly from faecal samples. They propose that since biopsy 
samples are small and therefore more easily exposed to oxygen during sampling, a highly 
reduced number of strict anaerobes may be found in the gut than in the faecal samples, which 
are larger and offer more protection to the inside of the sample from oxygen exposure. True 
to this, Zoetendal et al., (2002) found more facultative anaerobes in the biopsy samples than 
in the faecal samples. In this current study this is not so as most of the bacterial groups tested 
here are strict anaerobes, and higher proportions of each taxon were detected in mucosal 
samples than in faecal samples. This may be due to efficient sampling, with mucosal samples 
being rapidly transferred into a mixture of PBS and paraformaldehyde, immediately after 
scraping the GIT. The faecal samples were exposed to oxygen for longer periods of time 
before collection, and although samples were obtained from the centre of the faecal matter, 
oxygen damage may have occurred throughout the faecal sample. Marteau et al., (2001) also 
found that the caecal microbiota differs qualitatively and quantitatively from the faecal 
microbiota, harbouring fewer strict anaerobes such as Bacteroides and Bifidobacterium. They 
also found that the facultative anaerobes did not differ significantly between the faeces and 
biopsies.    
5.4.6. FISH enumeration of gut mucosal samples between different areas of the 
ostrich gastrointestinal tract 
The ostrich has an unusually long hindgut (approximately 11m in length) with well 
developed, sacculated ceca, and a capacious, haustrated colon (Cho et al., 1984; Swart et al., 
1993), and although the hindgut is known to be the site of fibre digestion (Matsui et al., 
2010), little is known about the microbial diversity present. In this study, the differences in 
microbiota were studied between three different areas of the ostrich gut to investigate the 
predominance of each bacterial group tested in the caecum, the colon and the duodenum 
(Table 5.5). Interestingly, the proportions of each tested bacterial group in the duodenum 
were significantly higher than in the colon and caecum. In the case of the groups hybridising 















by significant amounts. Also, the Bacteroides group only differed significantly between the 
colon and duodenum. This is surprising as the duodenum would be expected to harbour 
more facultative anaerobes than strict anaerobes such as the bacteria hybridising to the 
probes Bac 303, Clit 135, Cperf 191 and Erec 482 and Chis 150. The caecum and colon 
were both predominantly C. coccoides/E. rectale group (24.4 and 30.4%, respectively), 
followed by the Clostridium cluster XI (25.5% and 20.8%, respectively). Since the hindgut 
is the site of fibre digestion (Matsui et al., 2010), it would be expected to be dominated by 
fibre-digesting and butyrate-producing bacteria. Most of the strains belonging to C. 
coccoides/E. rectale perform both these functions. The duodenum, however, was dominated 
by the Bacteroides group (34.7%) followed by the C. coccoides/E. rectale group (31.7%) 
and Clostridium cluster XI (30.3%). The actual numbers of each bacterial group tested are 
significantly lower in the duodenum than in the caecum and colon, in accordance with 
previous work which shows that the pig and chicken duodenum harbours fewer bacteria than 
the large intestine (Collado and Sanz, 2007).  
Table 5.5. Proportions of Bifidobacterium (Bif164), Lactobacillus (Lab158), Clostridium cluster XI including 
C. difficile (Clit135), Clostridium cluster XIVa including C. coccoides and E. rectale (Erec482), Clostridium 
cluster I and II including C. perfringens (Chis150), Bacteroides (Bac303) and specifically C. perfringens 
(C.perf 191) in gut biopsies of ostrich chicks from all treatments at both slaughter times (week two and week 
five). The relative proportions were calculated using the universal probe Eub 338 and the respective group 
specific probe. Results are reported as medians of cell numbers per gram of faecal sample; interquartile ranges 
in parentheses.  Significant differences between treatments were calculated using mixed models, P < 0.05, n = 
18. Key a. caecum vs colon; b. caecum vs duodenum; c. colon vs duodenum. 
Between gut locations 
Probe  Caecum Colon Duodenum p value 
Bif 164 
9.6 (7.6, 12.3) 9.1 (7.1, 11.6) 19.0 (14.9, 24.2) 
<0.001bc 
Lab 158 
11.2 (8.8, 14.2) 11.1 (8.7, 14.1) 17.9 (14.0, 22.8) 
0.01bc 
Clit 135 
25.5 (19.9, 32.8) 20.8 (16.2, 26.7) 30.3 (23.6, 38.9) 
0.11 
Erec 482 
30.4 (24.5, 37.6) 24.4 (19.7, 30.3) 31.7 (25.6, 39.3) 
0.19 
Chis 150 
8.0 (6.6, 9.7) 7.9 (6.5, 9.6) 12.6 (10.4, 15.4) 
0.002bc 
Bac 303 
24.2 (18.7, 31.5) 18.7 (14.4, 24.2) 34.7 (26.8, 45.1) 
0.008c 
Cperf 191 





















5.4.7. Comparison of microbiota from the GIT of various animals   
The upper intestinal tract is seen as a transition zone for microorganisms because of motility, 
the presence of bile salts and low pH (Collado and Sanz, 2007). Their work also showed the 





). Studies on chicken microbiota have shown that the 




per g faecal contents but the 
microbial contents of faecal samples may not be representative of  the numbers present in 
different GIT sections (Sghir et al., 2000; Zoetendal et al., 2002). In this study, faecal counts 
contained 10
8
cells/g faeces (Figure 5.1), while slaughter one showed colon and caecum 
samples to harbour 10
8
 cells/g mucosa compared to the duodenum, having 10
7
 cells/g 
mucosa. At slaughter two, at five weeks of age, the colon and caecum had 10
9 
cells/g mucosa 
and the duodenum had 10
8 
cells/g mucosa. Although these numbers are lower than expected 
(the faecal counts in particular), similar results have been found in the chicken and pig 
intestines using FCM-FISH (Collado and Sanz, 2007). It could, however, also be due to the 
technique used. FCM-FISH relies on single cells and therefore any clumps of cells would be 
detected as a single cell. The permeability of the cells to probes is another limiting factor. 
Collado and Sanz (2007) reported that the probe Bif 164 did not hybridise with all the 
particular Bifidobacterium species previously reported to be present in pigs and chickens. 
These factors can all contribute to lower counts. Collado and Sanz (2007) studied mucosa-
associated microbiota of pigs and chickens and found the total eubacterial counts to be 
similar throughout the GIT, from the crop to the large intestine.  They also found that the 
dominant bacteria in all chicken samples at 2 months old were E. coli, Bacteroides, 
Bifidobacterium, Lactobacillus and Atopobium, whereas in the ostrich gut Bacteroides, the C. 
coccoides/E. rectale group and Clostridium cluster XI were the predominant bacteria 
throughout the gut. The same study by Collado and Sanz (2007) found lactic acid bacteria to 
be one of the predominant mucosa-associated bacteria in pigs and chickens and suggested a 
possible role as a health index status of these animals.   
Zhu and Joerger (2003) studied the microbial composition of broiler chickens using FISH and 
compared the microbial numbers of the cecal contents and the cecal mucosa. They found no 
significant differences between these two samples for any probes used except for the general 















in the cecal contents. They suggested this may be due to these bacteria’s ability to utilize 
oxygen transported to the cecal tissue through the blood supply.   
In this study, gut mucosal scrapings were taken at two time points.  When comparing the 
average bacterial proportions of the ostrich chick gut and faecal samples at two weeks 
(slaughter one), all the bacterial group proportions were similar, except Clostridum cluster XI 
where gut mucosa contained 23.8% and faecal samples show 12.4%, and C. perfringens 
where gut mucosal samples show 10.7% and faecal samples 17.6%.  
At the second slaughter (week five) in this study, gut biopsies showed higher proportions of 
Clostridum cluster XI (34.5% vs 10.7%), C. coccoides/E. rectale (46.1% vs 11.8%), 
Bacteroides (39.2% vs 16.6%) and C. perfringens (23.7% vs 6.2%) than faecal counts. This 
confirms earlier findings in this study and work done by Torok et al., (2008) that suggested 
that the microbiota had been established and settled by this stage, and that the above 
mentioned taxa form the basic endogenous microbiota in ostrich chicks.  
Two probes were used in this study for the detection of C. perfringens. They are Chis 150 
(Franks et al., 1998), aimed at targeting the C. histolyticum group (C. perfringens being a 
member) and Cperf 191 (Fallani et al., 2006), validated to hybridise specifically to C. 
perfringens. Since C. perfringens is one of the most important pathogens in ostriches, Chis 
150 may not have given sufficiently specific data on the pathogens abundance in faecal 
samples, and therefore the more specific Cperf 191 was also used in this study. It would be 
expected that the Chis 150 probe would hybridise to more cells than the Cperf 191 probe, 
since Chis 150 would detect several members of the C. histolyticum group, for example C. 
histolyticum, C. butyricum, C. putrificum and C. cadaveris (Franks et al., 1998). However, in 
this study, the Cperf 191 probe detected more targets than those for the Chis 150 probe. 
Fallani et al., (2006) reported the Cperf 191 probe to be suitable for detection of dominant 
populations of C. perfringens but less suitable for detecting sub-dominant populations of this 
species. This inconsistency may also be due to the fact that C. perfringens may have been the 
main or only species present in the C. histolyticum cluster in some of these samples.  
In studies such as this, it is considered preferable to use gut mucosal samples rather than 
faecal samples, as faecal samples may be contaminated by floor litter, and do not give 
information on bacteria in separate gut locations. Tracking the faecal matter to the donor was 















The microbiota of animals is thought to change constantly due to host and environmental 
factors, especially over the development stage of the host (Zhou et al., 2007). Animals also 
show a considerable intra-individual variation as seen in broiler chickens (Gong et al., 2005) 
and pigs (Richard et al., 2005). The use of in-feed antibiotic is a common practice and is 
thought to affect the microbiota considerably. Knarreborg et al. (2002) showed that treatment 
of broiler chickens with subtherapeutic levels of avilamycin and salinomycin decreased the 
levels of C. perfringens and lactobacilli specifically. Collier et al. (2003) showed that the use 
of tylosin greatly reduced the number of mucolytic bacteria, C. perfringens particularly. They 
showed that birds receiving tylosin had a more homogenous and distinct microbiota than the 
control birds, as well as an increase in Lactobacillus gasseri. In South Africa, tylosin is a 
commonly used antibiotic in animal farming, including ostrich rearing. This study has shown 
that tylosin can effectively protect the ostrich chicks from pathogens especially C. 
perfringens, which appears to be a major pathogen of ostrich chicks.  
Gérard et al. (2008) found no effect of feeding Lactobacillus species on the composition of 
the cecal microbiota of chickens. This is consistent with previous work (Tannock et al., 
2000), where FISH showed that probiotic supplementation did not change the proportion of 
dominant phylogenetic groups in the human microbiota, which could be regarded as an 
advantage. However, the FISH technique does not account for alteration at the species level. 
In this work, no significant findings were seen for the group receiving probiotics, and the five 
strain probiotic mix alone did not provide sufficient protection to the chicks, with group E 
dying after two weeks.  
 
5.5. Conclusion 
The use of FISH in this study was to obtain more accurate and specific enumeration of 
bacterial groups found in faecal and gut mucosal scrapings, and to be able to compare the 
prevalence of bacterial groups in these different samples. Since the work described in the two 
previous chapters used faecal matter as the template, comparing the bacteria found in the 
mucosal scrapings would give invaluable information on the commensal bacteria which 
adhere to the mucosal lining of the ostrich gut rather than pass through. It also allowed for 
more precise comparisons between the bacterial proportions found in the different areas of 















Although treatment C shows increasing trends in important beneficial bacteria, it also appears 
to manifest C. perfringens, thought to be one of the most prevalent pathogens and causes of 
mortality in this feeding trial. Feeding the chicks the probiotic mix only (group E) appears to 
be insufficient in protecting them from pathogenic invasion. The mix alone also does not 
seem to contribute to the microbiota, as no increase in lactic acid bacteria or Bifidobacterium 
spp. was observed in the faecal matter. Group ET, the combination of tylosin and the 
probiotic mix appeared to be the most beneficial, offering protection against common 
pathogens as well increasing the prevalence of Bifidobacterium and Lactobacillus in the 
mucosal samples. Treatment ET also shows a decrease in C. coccoides/E. rectale which may 
be detrimental to gut health since most of these members are butyrate producers. No obvious 
trends were observed here, and further trials are needed to confirm the effects of each new 
proposed probiotic. 
Microbial enumeration between faecal and mucosal populations can vary, showing little 
difference or significant differences. Optimally, both locations should be studied in each 
separate trial as adhesion potential and effect of probiotics differ in each host. In this study, 
examining both was of great importance given the fact that ostriches are hindgut fermenters 
and fermentative bacteria are passed out with the faeces (as opposed to foregut fermenters 
where the microbes are digested as a protein source; Ley et al., 2008).  The mucosal 
scrapings also gave important information on the commensal microbiota of the ostrich on 
which there is very little known. 
This chapter has shown the usefulness of FISH-FCM in analysing the microbiota using 
probes based on 16S rRNA, especially for those genera difficult to cultivate like Bacteroides 
and Clostridium. It also allows objective analysis of intra-individual, inter-treatment, and 
longitudinal data. This work has given the first in-depth data of the microbes associated with 
ostriches in a farmed environment obtained using FISH, and provides important information 
on the use of tylosin, showing that it is beneficial and promotes the health of the ostrich 
microbiota. The five strain probiotic mix used in this study with the intention of replacing 
tylosin, is not effective at protecting the chicks from fatal pathogen invasions. Previous work 
has shown probiotics to be promising candidates for an antibiotic replacement, beneficially 
changing pig, chicken and cattle faecal microbiota, improving weight gain and reducing the 


















The gut microbiota of humans and animals is an extremely diverse and complex environment 
and has been a main focus of ongoing research due to its vital role in health and disease. Due 
to this complexity, the study of this microbiome has been made possible by recent advances 
in molecular and bioinformatics techniques. Large metagenomics studies on the human 
microbiota have lead to aiding the definition of a healthy gut and monitoring the effects of 
shifts in this microbiota (Tap et al., 2009; Candela et al., 2010), and allow for an 
understanding of the phylogenetic composition and functional potential of the microbial 
community present.  For example, Li et al. (2011) studied the rumen microbiome of pre-
ruminant calves and reported that the rumen microbial communities of these calves 
maintained a stable function and metabolic potential while their phylogenetic composition 
fluctuated greatly.  The work presented in this thesis was divided into three main objectives, 
each focusing on a particular step in the process involved in selecting probiotics for use in the 
ostrich farming industry in South Africa.  
 
The first step involved in this process revolved around the identification and characterisation 
of ostrich isolates as probiotics. The ability to persist in the intestine is an added advantage in 
achieving maximal probiotic efficiency (Vaughan et al., 2002) and in order to survive and 
proliferate in the gastrointestinal tract the probiotics must tolerate several harsh 
environmental hurdles including the low pH and high bile concentrations. The original 71 
ostrich isolates were preliminarily screened for probiotic properties and of these, five were 
chosen based on their probiotic potential including acid and bile tolerance. All five strains 
could tolerate up to 2% bile and pH2, and also showed successful auto- and co-aggregation 
abilities with the tested pathogens. In mucous-binding experiments, the five strains and their 
various combinations could inhibit and displace these pathogens in most cases, however they 
were less successful at out-competing them. This highlights the importance of early 
colonisation of the gut by beneficial bacteria. The five strains were able to produce 
antimicrobial compounds active against pathogens E. coli and S. typhimurium, but only one 
strain was active against C. perfringens. In addition, the isolates produced enzymes important 
in the high plant fibre diet the ostrich chicks are fed. While bacterial strains can evolve to 















to improve physiological robustness of potential probiotics would be desirable (Sleator and 
Hill, 2006).  Pathogenic strains have developed mechanisms whereby they ensure their 
continued survival in diverse ecological niches and may therefore act as useful reservoirs for 
stress survival mechanisms, termed “patho-biotechnology” (Sleator and Hill 2005, 2006). 
Shehaan et al. (2006) successfully improved the stress tolerance of Lactobacillus salivarius 
UCC118 by heterologous expression of the betaine uptake system BetL, isolated from 
Listeria monocytogenes. Similarly, Shehaan et al. (2007) introduced BetL into 
Bifidobacterium breve UCC2003, resulting in this probiotic bacterium showing improved 
gastric transit and intestinal persistence, as well as improving the clinical efficacy of the 
strain when fed to mice. Although recombinant DNA technology may not be accepted by the 
regulatory authorities, these studies prove the concept of developing more versatile strains is 
possible. The natural selection of probiotic expressing such homologues may discard the 
necessity of genetic engineering all together (Shehaan et al., 2007).  
 
The second stage of this work involved the in-vivo assessment of the effect of the selected 
probiotic mix on the microbiota of the ostrich chicks and the comparison to the effect of 
tylosin. For this, a suitable mode of delivery was developed, encapsulating the strains in 
calcium alginate, which maintained their viability. The five strains were fed together in a mix 
in equal amounts, with the intention of having a multi-species mix, often more effective than 
a single-strain probiotic (Timmerman et al., 2004). During the feeding trial, important factors 
such as growth and mortality rates and feed conversion ratios were also measured. No 
significant differences were observed for the feed conversion ratio or the weight gain of the 
chicks between those fed probiotics or antibiotics. However, the mortality rate of the control 
and probiotic-fed birds was noticeably higher than those receiving tylosin. Although there is a 
lot of interest in the use of probiotics, there are relatively few strains which have shown 
efficacy in-vivo (Gardiner et al., 2004) and it is important to test strains in in-vivo trials.  
 
The final stage involved using a combination of both modern and classical techniques to 
monitor the effect of the probiotics and antibiotic tylosin on the mucosal and faecal 
microbiota of ostrich chicks over nine weeks. Lahtinen et al. (2006) suggest that the choice of 
method used for enumeration of bacteria may have significant effects on the results. The 
strain-specific properties and the objects of the analysis should be considered when choosing 
a method of enumeration as well as when analysing the results. For example, enumerating 















contrast, the FISH method has potential to be used for viability testing as the half-life of 
rRNA is shorter than that of DNA but depends on the rate of rRNA decay after cell death 
(Lahtinen et al., 2006). Each method has benefits and downfalls, and therefore using more 
than one technique allows for a broader results base. 
 
The work in this thesis used culture-dependent techniques on selective growth media, PCR-
DGGE with species-specific primers, and FISH-FC, with species- and strain-specific probes, 
to investigate the initial colonisers of the ostrich chick gut and to monitor the maturation of 
these bacterial populations with age. Chicks are born with a sterile GIT and the immediate 
colonisation of the gut by beneficial bacteria would provide a barrier against ingested 
pathogens. Culturing of the faecal samples did not show many significant differences in the 
bacterial populations between the treatments, but most groups increased over time for each 
treatment. Chicks receiving the probiotic mix showed higher counts for LAB and 
Bifidobacterium spp., while the probiotic group not receiving tylosin also showed higher 
coliform and C. perfringens counts at week two. Culturing of the mucosal samples showed 
increasing trends for total bacteria, LAB and Enterobacteriaceae, and by slaughter two, C. 
perfringens was only detected in treatment ET in the colon and caecum. This pathogen was 
found to be present in all gut areas tested for chicks in treatment E. Post-mortems on the birds 
from all treatments, confirmed the death was due to this pathogen. C. perfringens has been 
suggested to be an important pathogen present in ostrich chicks (Huchzermeyer, 2002) but 
this is the first study to confirm that it is a major pathogen in ostrich chick mortality.  
DGGE analysis of faecal samples indicated that the probiotics alone had no effect on the total 
bacteria or Lactobacillus spp. populations, but did alter the Bifidobacterium spp. populations. 
Together with tylosin, the probiotic mix did not change the diversity of the total bacterial 
population or the Bifidobacterium spp., but decreased the diversity of the Lactobacillus spp. 
population. In comparison to the culture-dependent technique, DGGE did not show the 
presence of C. perfringens. The identification of excised DGGE bands showed that the faeces 
were dominated by bacteria belonging to the C. coccoides and C. leptum group. 
FISH-FC analysis of faecal and mucosal samples showed ostrich chicks to be colonised by 
10
8 
cfu/g of faeces by week one. The faecal samples were dominated by the C. coccoides/E. 
rectale and Bacteroides groups initially, but Bacteroides was the major group present by 
week seven. Studies on the gut samples showed the caecum and colon to be predominated by 















technique showed the presence of C. perfringens in all areas of the gut, but its proportions in 
the duodenum were highest.  
Although these techniques all give an idea of the diversity of the species present in the 
samples tested, the results obtained from each method differed. The enumerating techniques 
(culturing and FISH-FC) showed similar results in some cases. For example, the culturing of 
samples on TSC agar used to enumerate C. perfringens, showed a decrease of this pathogen 
in faecal samples over time for treatment ET, as did the Cperf191 probe used in FISH-FC.  
The DGGE method was used primarily to get an indication of the diversity in the faecal 
samples, and the majority of excised bands sequenced did agree with the FISH-FC results 
which showed C. coccoides/E. rectale to be the dominant group present in the ostrich gut. 
Even though the culture-dependent techniques give important information on the 
microbiome, and the use of this method together with the molecular methods is invaluable, 
the difficulty associated with culturing anaerobic bacteria, and the possibility of the bacteria 
being dormant and not readily culturable should be taken into consideration. However, a 
recent study by Bomar et al. (2011) suggested using metatranscriptomics to growing bacteria 
in diverse habitats to enable the design of media allowing for their cultivation.  
 
Overall, no significant effect was seen for either the probiotics or tylosin on the microbiota of 
the ostrich. Tylosin clearly allowed for the survival of the chicks in the presence of C. 
perfringens, where the probiotic mix did not, the chicks in this group dying prematurely, 
reportedly due to C. perfring ns-like lesions. The combination of these two supplements 
appeared to be the most beneficial, not only increasing the survival rates but also increasing 
the beneficial bacterial groups in the mucosal samples.  
 
Further investigations into the ostrich gut microbiota need to be carried out, as well as the 
testing of more effective probiotics or an alternative combination of bacterial strains. A 
probiotic which can more successfully out-compete C. perfringens would be optimal. As 
ostrich chicks are naturally coprophagous and in the wild obtain their first inoculums of 
beneficial bacteria almost immediately, spray-inoculating the hatcheries to aid this process of 
colonisation may be a strategy to prevent such high rates of mortality. In addition, the layout 















treatments was possible. In future, the different treatments should be housed in separate 
buildings to make this less likely. 
It would be beneficial to design species-specific probes to particularly detect the probiotic 
strains added to the mix to confirm if they persist in the gut and their location in the gut. Due 
to the limitations of both DGGE and FISH-FCM, detection to the species level was not 
possible. The addition of enumeration by quantitative PCR to this data would allow 
confirmation of results obtained with FISH-FCM. Studies of metagenomics and the 
microbiome could expand our knowledge of microbial communities hugely, aiding in the 
understanding of bacterial variations and genetic parameters and development of therapeutic 
approaches in the treatment of acute and chronic disorders, in humans and animals. 
Effectively assessing the total bacterial community is a challenge, and Holben et al. (2004) 
reported a novel strategy involving GC fractionation combined with DGGE to improve the 
accuracy of these studies. The fractionation step reduces the complexity of the community in 
each fraction which subsequently facilitates detection of diversity in these fractions and 
combines mechanistically different community analysis approaches (Holben et al., 2004). 
Although the information of the diversity of the gut microbiota in humans and animals is 
highly important, knowledge of the functionality of the gut microbiota would be of 
indispensible use, giving an idea of why each taxon is present. Eeckhaut et al. (2011) used 
PCR to detect functional genes involved in the butyrate-production pathway from culturable 
Firmicutes isolated from the chicken gut. This allows enumeration as well as functionality of 
the microbiome, information which could later be used for improved gut health and treatment 
of disorders.  
Next generation antibiotics, including antimicrobial peptides and new drug classes, will be 
identified as the study of the commensal gut bacteria increases, and instead of mining the 
soils for these products, it is predicted that the 21
st
 century antimicrobial agents will be found 
by exploring the human and mammalian microbiomes (Preidis and Versalovic, 2009). These 
compounds may be evolutionarily tailored to preserve health-associated microbiomes while 
increasing defences against pathogens. Identification of key substrate and signalling 
mediators will help understand microbe-microbe and microbe-host interactions and 
therapeutic treatments will target specific microorganisms, as well as metabolites of entire 
microbial populations (Preidis and Versalovic, 2009). Further knowledge of the ostrich 
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